Part 3 / GEHARMONISEERDE INDELING EN ETIKETTERING
Tabel 3
Lijst van geharmoniseerde indeling en etikettering van gevaarlijke stoffen
|
Catalogusnummer |
►M18 Chemische naam ◄ |
EG-nr. |
CAS-nr. |
Indeling |
Etikettering |
►M18 Specifieke concentratiegrenzen, M-factoren en ATE's (*1) ◄ |
Opmerkingen |
|||
|
Gevarenklasse en -categorie |
Gevarenaanduiding |
Pictogram, signaalwoord |
Gevarenaanduiding |
Aanvullende gevarenaanduiding |
||||||
|
001-001-00-9 |
waterstof |
215-605-7 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
001-002-00-4 |
lithiumaluminiumhydride |
240-877-9 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
|
|
|
|
|
001-003-00-X |
natriumhydride |
231-587-3 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
|
|
001-004-00-5 |
calciumhydride |
232-189-2 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
|
|
003-001-00-4 |
lithium |
231-102-5 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
003-002-00-X |
n-hexyllithium |
404-950-0 |
Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
|
|
003-003-00-5 |
(2-methylpropyl)lithium; isobutyllithium |
440-620-2 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H314 H336 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H260 H250 H314 H336 H410 |
EUH014 |
|
|
|
|
004-001-00-7 |
beryllium |
231-150-7 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|
|
|
|
|
004-002-00-2 |
berylliumverbindingen met uitzondering van berylliumaluminiumsilicaat, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
|
|
A |
|
004-003-00-8 |
berylliumoxide |
215-133-1 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|
|
|
|
|
005-001-00-X |
boortrifluoride |
231-569-5 |
Press. Gas Acute Tox. 2 * Skin Corr. 1A |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
EUH014 |
|
U |
|
|
005-002-00-5 |
boortrichloride |
233-658-4 |
Press. Gas Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1B |
H330 H300 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
U |
|
|
005-003-00-0 |
boortribromide |
233-657-9 |
Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A |
H330 H300 H314 |
GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
|
|
|
005-004-00-6 |
trialkylboranen, vast |
— |
— |
Pyr. Sol. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
|
005-004-01-3 |
trialkylboranen, vloeibaar |
— |
— |
Pyr. Liq. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
|
005-005-00-1 |
trimethylboraat |
204-468-9 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4* |
H226 H360FD H312 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H312 |
|
|
11 |
|
|
005-006-00-7 |
dibutyltinwaterstofboraat |
401-040-5 |
Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H341 H372** H312 H302 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H360FD H341 H372** H312 H302 H318 H317 H410 |
|
|
|
|
|
005-007-00-2 |
boorzuur; [1] boorzuur [2] |
233-139-2 [1] 234-343-4 [2] |
10043-35-3 [1] 11113-50-1 [2] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
11 |
|
005-008-00-8 |
diboortrioxide |
215-125-8 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
11 |
|
|
005-009-00-3 |
tetrabutylammonium-butyltrifenylboraat |
418-080-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
005-010-00-9 |
N, N-dimethylaniliniumtetrakis(pentafluorfenyl)boraat |
422-050-6 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H351 H302 H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H351 H302 H315 H318 |
|
|
|
|
|
005-011-00-4 |
tetraboordinatriumheptaoxide, hydraat; [1] dinatriumtetraboraat, watervrij; [2] orthoboorzuur, natriumzout; [3] dinatriumtetraboraat-decahydraat; [4] dinatriumtetraboraat-pentahydraat [5] |
235-541-3 [1] 215-540-4 [2] 237-560-2 [3] 215-540-4 [4] 215-540-4 [5] |
12267-73-1 [1] 1330-43-4 [2] 13840-56-7 [3] 1303-96-4 [4] 12179-04-3 [5] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
11 |
|
005-012-00-X |
diëthyl{4-[1,5,5-tris(4-diëthylaminofenyl)penta-2,4-diënylideen]cyclohexa-2,5-diënylideen}ammonium-butyltrifenylboraat |
418-070-1 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
005-013-00-5 |
diëthylmethoxyboraan |
425-380-9 |
Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H250 H332 H312 H302 H373** H314 H317 H413 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H250 H332 H312 H302 H373** H314 H317 H413 |
|
|
|
|
|
005-014-00-0 |
4-formylfenylboronzuur |
438-670-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
005-015-00-6 |
1-chloormethyl-4-fluor-1,4-diazoniabicyclo[2.2.2]octaanbis(tetrafluorboraat) |
414-380-4 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
|
|
005-016-00-1 |
tetrabutylammonium-butyl-tris-(4-tert-butylfenyl)boraat |
431-370-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
▼M36 ————— |
||||||||||
|
005-020-00-3 |
dinatriumoctaboraat watervrij; [1] dinatriumoctaboraat tetrahydraat [2] |
234-541-0 [1] 234-541-0 [2] |
12008-41-2 [1] 12280-03-4 [2] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
005-022-00-4 |
perboorzuur, natriumzout [1] perboorzuur, natriumzout, monohydraat [2], perboorzuur (HBO(O2)), natriumzout, monohydraat [3] natriumperoxoboraat [4], natriumperboraat [5] |
234-390-0 [1] 234-390-0 [2] — [3] — [4] 239-172-9 [5] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] — [4] 15120-21-5 [5] |
Ox. Sol. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H272 H360FD H331 H302 H335 H318 |
GHS03 GHS08 GHS06 GHS05 Dgr |
H272 H360FD H331 H302 H335 H318 |
|
inademing: ATE = 0,75 mg/l (stofdeeltjes of nevels) oraal: ATE = 890 mg/kg lg Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
11 |
|
005-023-00-X |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat [1] perboorzuur, natriumzout, tetrahydraat [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat [3] natriumperoxoboraat, hexahydraat [4] |
239-172-9 [1] 234-390-0 [2] — [3] — [4] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] — [4] |
Repr. 1B Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H360FD H332 H335 H318 |
GHS08 GHS05 GHS07 Dgr |
H360FD H332 H335 H318 |
|
inademing: ATE = 1,2 mg/l (stofdeeltjes of nevels) Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
11 |
|
005-024-00-5 |
natriumperoxometaboraat |
231-556-4 |
Ox. Sol. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H272 H360FD H331 H302 H335 H318 |
GHS03 GHS08 GHS06 GHS05 Dgr |
H272 H360FD H331 H302 H335 H318 |
|
inademing: ATE = 0,62 mg/l (stofdeeltjes of nevels) oraal: ATE = 730 mg/kg lg Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
11 |
|
|
006-001-00-2 |
koolstofmonoxide |
211-128-3 |
Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3 * STOT RE 1 |
H220 H360D *** H331 H372 ** |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H360D *** H331 H372 ** |
|
|
U |
|
|
006-002-00-8 |
fosgeen; carbonylchloride |
200-870-3 |
Press. Gas Acute Tox. 2 * Skin Corr. 1B |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
|
|
U |
|
|
006-003-00-3 |
koolstofdisulfide |
200-843-6 |
Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H361fd H372 ** H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H361fd H372 ** H319 H315 |
|
Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
|
|
006-004-00-9 |
calciumcarbide |
200-848-3 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
T |
|
|
006-005-00-4 |
thiram (ISO); tetramethylthiuramdisulfide |
205-286-2 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H332 H302 H373 ** H319 H315 H317 H410 |
|
M = 10 |
|
|
|
006-006-00-X |
waterstofcyanide; cyaanwaterstof; blauwzuur |
200-821-6 |
Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H224 H330 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H330 H410 |
|
|
|
|
|
006-006-01-7 |
waterstofcyanide … %; cyaanwaterstof … %; blauwzuur … % |
200-821-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
B |
|
|
006-007-00-5 |
zouten van waterstofcyanide met uitzondering van complexe cyaniden zoals hexacyanoferraten(II), hexacyanoferraten(III) en kwikoxycyanide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
EUH032 |
|
A |
|
006-008-00-0 |
antu (ISO); 1-(1-naftyl)-2-thio-ureum |
201-706-3 |
Acute Tox. 2 * Carc. 2 |
H300 H351 |
GHS06 GHS08 Dgr |
H300 H351 |
|
|
|
|
|
006-009-00-6 |
1-isopropyl-3-methylpyrazool-5-yldimethylcarbamaat; isolan |
204-318-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
006-010-00-1 |
5,5-dimethyl-3-oxocyclohex-1-enyldimethylcarbamaat; 5,5-dimethyldihydroresorcinoldimethylcarbamaat; dimetan |
204-525-8 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
006-011-00-7 |
carbaryl (ISO); 1-naftylmethylcarbamaat |
200-555-0 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H351 H332 H302 H400 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H302 H400 |
|
M=100 |
|
|
|
006-012-00-2 |
ziram (ISO); zink-bis(N,N-dimethyldithiocarbamaat) |
205-288-3 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H373 ** H335 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H302 H373 ** H335 H318 H317 H410 |
|
M = 100 |
|
|
|
006-013-00-8 |
metam-natrium (ISO); natrium-N-methyldithiocarbamaat |
205-293-0 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
EUH031 |
|
|
|
|
006-014-00-3 |
nabam (ISO); dinatriumethyleenbisdithiocarbamaat |
205-547-0 |
Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H317 H410 |
GHS07 GHS09 Wng |
H302 H335 H317 H410 |
|
|
|
|
|
006-015-00-9 |
diuron (ISO); 3-(3,4-dichloorfenyl)-1,1-dimethylureum |
206-354-4 |
Carc. 1B STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H373 (bloed) H400 H410 |
GHS08 GHS09 Dgr |
H350 H373 (bloed) H410 |
|
M = 100 M = 100 |
|
|
|
006-016-00-4 |
propoxur (ISO); 2-isopropyloxyfenyl-N-methylcarbamaat; 2-isopropoxyfenylmethylcarbamaat |
204-043-8 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-017-00-X |
aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxim |
204-123-2 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
|
|
|
|
006-018-00-5 |
aminocarb (ISO); 4-dimethylamino-3-tolylmethylcarbamaat |
217-990-7 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
006-019-00-0 |
diallaat (ISO); S-(2,3-dichloorallyl)-N,N-diisopropylthiocarbamaat |
218-961-1 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
006-020-00-6 |
barban (ISO); 4-chloorbut-2-ynyl-N-(3-chloorfenyl)carbamaat |
202-930-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
006-021-00-1 |
linuron (ISO); 3-(3,4-dichloorfenyl)-1-methoxy-1-methylureum |
206-356-5 |
Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H351 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H351 H302 H373 ** H410 |
|
|
|
|
|
006-022-00-7 |
decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl-methylcarbamaat |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
006-023-00-2 |
mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiofenyl-N-methylcarbamaat |
217-991-2 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-024-00-8 |
proxan-natrium (ISO); natrium-O-isopropyldithiocarbonaat |
205-443-5 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
|
|
006-025-00-3 |
allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat; [1] S-bioallethrin; [3] (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat; [2] esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat [3] |
209-542-4 [1] 249-013-5 [2]-[3] |
584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
C |
|
006-026-00-9 |
carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl-N-methylcarbamaat |
216-353-0 |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
|
|
|
006-028-00-X |
dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrofenylisopropylcarbonaat |
213-546-1 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-029-00-5 |
dioxacarb (ISO); 2-(1,3-dioxolaan-2-yl)fenyl-N-methylcarbamaat |
230-253-4 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
|
006-030-00-0 |
EPTC (ISO); S-ethyldipropylthiocarbamaat |
212-073-8 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-031-00-6 |
formetanaat (ISO); 3-[(EZ)-dimethylaminomethyleenamino]fenylmethylcarbamaat |
244-879-0 |
Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
|
|
006-032-00-1 |
monolinuron (ISO); 3-(4-chloorfenyl)-1-methoxy-1-methylureum |
217-129-5 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H410 |
|
|
|
|
|
006-033-00-7 |
metoxuron (ISO); 3-(3-chloor-4-methoxyfenyl)-1,1-dimethylureum |
243-433-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
006-034-00-2 |
pebulaat (ISO); N-butyl-N-ethyl-S-propylthiocarbamaat |
214-215-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-035-00-8 |
pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamaat |
245-430-1 |
Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H301 H317 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H351 H331 H301 H317 H410 |
|
M = 10 M = 100 |
|
|
|
006-036-00-3 |
benzthiazuron (ISO); 1-benzothiazool-2-yl-3-methylureum |
217-685-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-037-00-9 |
promecarb (ISO); 3-isopropyl-5-methylfenyl-N-methylcarbamaat |
220-113-0 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-038-00-4 |
sulfallaat (ISO); 2-chloorallyl-N, N-dimethyldithiocarbamaat |
202-388-9 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
|
006-039-00-X |
triallaat (ISO); S-2,3,3-trichloorallyldiisopropylthiocarbamaat |
218-962-7 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
|
|
006-040-00-5 |
3-methylpyrazool-5-yl-dimethylcarbamaat; monometilan |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
006-041-00-0 |
dimethylcarbamoylchloride |
201-208-6 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H331 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H331 H302 H319 H335 H315 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
|
|
006-042-00-6 |
monuron (ISO); 3-(4-chloorfenyl)-1,1-dimethylureum |
205-766-1 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
006-043-00-1 |
3-(4-chloorfenyl)-1,1-dimethyluroniumtrichlooracetaat; monuron-TCA |
— |
Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H319 H315 H410 |
|
|
|
|
|
006-044-00-7 |
isoproturon (ISO); 3-(4-isopropylfenyl)-1,1-dimethylureum |
251-835-4 |
Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H373 (bloed) H400 H410 |
GHS08 GHS09 Wng |
H351 H373 (bloed) H410 |
|
M = 10 M = 10 |
|
|
|
006-045-00-2 |
methomyl (ISO); 1-(methylthio)ethylideenamino-N-methylcarbamaat |
240-815-0 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
|
M=100 |
|
|
|
006-046-00-8 |
bendiocarb (ISO); 2,2-dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamaat; 2,2-dimethyl-1,3-benzodioxol-4-yl-methylcarbamaat |
245-216-8 |
Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H300 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H300 H410 |
|
M = 10 M = 100 |
|
|
|
006-047-00-3 |
bufencarb (ISO); reactiemassa van 3-(1-methylbutyl)fenyl-N-methylcarbamaat en 3-(1-ethylpropyl)fenyl-N-methylcarbamaat |
— |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
006-048-00-9 |
ethiofencarb (ISO); 2-ethylthiomethylfenyl-N-methylcarbamaat |
249-981-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-049-00-4 |
dixanthogeen; O, O-diëthyldithiobis(thioformiaat) |
207-944-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-050-00-X |
1,1-dimethyl-3-fenyluroniumtrichlooracetaat; fenuron-TCA |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
006-051-00-5 |
ferbam (ISO); ijzertris(dimethyldithiocarbamaat) |
238-484-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
|
|
006-052-00-0 |
formetanaathydrochloride; 3-(N, N-dimethylaminomethyleenamino)fenyl-N-methylcarbamaat |
245-656-0 |
Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
|
|
006-053-00-6 |
isoprocarb (ISO); 2-isopropylfenyl-N-methylcarbamaat |
220-114-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-054-00-1 |
mexacarbaat (ISO); 3,5-dimethyl-4-dimethylaminofenyl-N-methylcarbamaat |
206-249-3 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
|
006-055-00-7 |
xylylcarb (ISO); 3,4-dimethylfenyl-N-methylcarbamaat; 3,4-xylylmethylcarbamaat; MPMC |
219-364-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-056-00-2 |
metolcarb (ISO); m-tolylmethylcarbamaat; MTMC |
214-446-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-057-00-8 |
nitrapyrin (ISO); 2-chloor-6-trichloormethylpyridine |
217-682-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-058-00-3 |
noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoïndeen-5-yl)ureum |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-059-00-9 |
oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamine-N-methylcarbamaat; |
245-445-3 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Chronic 2 |
H330 H300 H312 H411 |
GHS06 GHS09 Dgr |
H330 H300 H312 H411 |
|
|
|
|
|
006-060-00-4 |
oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-fenylcarbamoyl)-1,4-oxothiine-4,4-dioxide |
226-066-2 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
006-061-00-X |
S-ethyl-N-(dimethylaminopropyl)thiocarbamaathydrochloride; prothiocarb-hydrochloride |
243-193-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-062-00-5 |
methyl-3,4-dichloorfenylcarbamaat; swep |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-063-00-0 |
thiobencarb (ISO); S-4-chloorbenzyldiëthylthiocarbamaat |
248-924-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-064-00-6 |
thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanon-O-(N-methylcarbamoyl)oxim |
254-346-4 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
006-065-00-1 |
3-chloor-6-cyaan-bicyclo[2.2.1]heptaan-2-on-O(N-methylcarbamoyl)oxim; tranid |
— |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Chronic 2 |
H300 H311 H411 |
GHS06 GHS09 Dgr |
H300 H311 H411 |
|
|
|
|
|
006-066-00-7 |
vernolaat (ISO); S-propyldipropylthiocarbamaat; |
217-681-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
006-067-00-2 |
XMC; 3,5-xylylmethylcarbamaat |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
006-068-00-8 |
diazomethaan |
206-382-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
006-069-00-3 |
thiofanaat-methyl (ISO); dimethyl(1,2-fenyleendicarbamothioyl)biscarbamaat; dimethyl 4,4′-(o-fenyleen)bis(3-thioallofanaat) |
245-740-7 |
Carc. 2 Muta. 2 Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H341 H332 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H341 H332 H317 H410 |
|
inademing: ATE = 1,7 mg/l (stofdeeltjes en nevels) M = 10 M = 10 |
|
|
|
006-070-00-9 |
furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide |
262-302-0 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
|
006-071-00-4 |
cycloöct-4-een-1-ylmethylcarbonaat |
401-620-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
006-072-00-X |
prosulfocarb (ISO); S-benzyl N, N-dipropylthiocarbamaat |
401-730-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
006-073-00-5 |
3-(dimethylamino)propylureum |
401-950-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
006-074-00-0 |
2-(3-(prop-1-een-2-yl)fenyl)prop-2-ylisocyanaat |
402-440-2 |
Acute Tox. 2 * Skin Corr. 1B STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H314 H373 ** H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H314 H373 ** H334 H317 H410 |
|
|
|
|
|
006-076-00-1 |
mancozeb (ISO); mangaanethyleenbis(dithiocarbamaat)(polymeer)complex met zinkzout |
— |
Carc. 2 Repr. 1B STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360D H373 (schildklier, zenuwstelsel) H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D H373 (schildklier, zenuwstelsel) H317 H410 |
|
M = 10 M = 10 |
|
|
|
006-077-00-7 |
maneb (ISO); mangaanethyleenbis(dithiocarbamaat) (polymeer) |
235-654-8 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H332 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d*** H332 H319 H317 H410 |
|
M=10 |
|
|
|
006-078-00-2 |
zineb (ISO); zinkethyleenbis(dithiocarbamaat) (polymeer) |
235-180-1 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
|
|
|
|
006-079-00-8 |
disulfiram; tetraëthylthiuramdisulfide |
202-607-8 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
|
|
006-080-00-3 |
tetramethylthiurammonosulfide |
202-605-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
006-081-00-9 |
zinkbis(dibutyldithiocarbamaat) |
205-232-8 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
|
|
006-082-00-4 |
zinkbis(diëthyldithiocarbamaat) |
238-270-9 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H317 H410 |
|
|
|
|
|
006-083-00-X |
butocarboxim (ISO); 3-(methylthio)-2-butanon-O-[(methylamino)carbonyl]oxim |
252-139-3 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H331 H311 H301 H319 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H226 H331 H311 H301 H319 H410 |
|
|
|
|
|
006-084-00-5 |
carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl[(dibutylamino)thio]methylcarbamaat |
259-565-9 |
Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H317 H410 |
|
|
|
|
|
006-085-00-0 |
fenobucarb (ISO); 2-butylfenylmethylcarbamaat |
223-188-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
006-086-00-6 |
fenoxycarb (ISO); ethyl-[2-(4-fenoxyfenoxy)ethyl]carbamaat |
276-696-7 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 M = 10 000 |
|
|
|
006-087-00-1 |
furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl-2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoaat |
265-974-3 |
Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H373** H319 H315 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H301 H373** H319 H315 H317 H410 |
|
M = 100 |
|
|
|
006-088-00-7 |
benfuracarb (ISO); ethyl-N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninaat |
— |
Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H331 H302 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f*** H331 H302 H410 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
006-090-00-8 |
2-(3-joodprop-2-yn-1-yloxy)ethylfenylcarbamaat |
408-010-0 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H332 H318 H412 |
GHS05 GHS07 Dgr |
H332 H318 H412 |
|
|
|
|
|
006-091-00-3 |
propineb (ISO); polymeer zinkpropyleenbis(dithiocarbamaat) |
— |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 |
H332 H373** H317 H400 |
GHS08 GHS07 GHS09 Wng |
H332 H373** H317 H400 |
|
|
|
|
|
006-092-00-9 |
tert-butyl-(1S)-N-[1-((2S)-2-oxiranyl)-2-fenylethyl]carbamaat |
425-420-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
006-093-00-4 |
2,2'-dithiodi(ethylammonium)-bis(dibenzyldithiocarbamaat) |
427-180-7 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
006-094-00-X |
O-isobutyl-N-ethoxycarbonylthiocarbamaat |
434-350-4 |
Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H226 H350 H340 H302 H373** H317 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H350 H340 H302 H373** H317 H411 |
|
|
|
|
|
006-095-00-5 |
fosetyl-aluminium (ISO); aluminiumtriëthyltrifosfonaat |
254-320-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
006-096-00-0 |
chloorprofam (ISO); isopropyl-3-chloorcarbanilaat |
202-925-7 |
Carc. 2 STOT RE 2 * Aquatic Chronic 2 |
H351 H373** H411 |
GHS08 GHS09 Wng |
H351 H373** H411 |
|
|
|
|
|
006-097-00-6 |
1-fenyl-3-(p-tolueensulfonyl)ureum |
424-620-1 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
|
|
006-098-00-1 |
tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamaat |
429-170-8 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
|
|
006-099-00-7 |
N-(p-tolueensulfonyl)-N'-(3-(p-tolueensulfonyloxy)fenyl)ureum; 3-({[(4-methylfenyl)sulfonyl]carbamoyl}amino)fenyl-4-methylbenzeensulfonaat |
520-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
006-101-00-6 |
reactiemassa van: N, N''-(methyleendi-4,1-fenyleen)bis[N'-fenylureum]; N-(4-[[4-[[(fenylamino)carbonyl]amino]fenylmethyl]fenyl]-N'-cyclohexylureum; N,N''-(methyleendi-4,1-fenyleen)bis[N'-cyclohexylureum] |
423-070-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
006-102-00-1 |
O-hexyl-N-ethoxycarbonylthiocarbamaat |
432-750-3 |
— |
Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H340 H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H302 H373** H317 H411 |
|
|
|
|
006-103-00-7 |
N,N''-(methyleendi-4,1-fenyleen)bis[N'-octyl]ureum |
445-760-8 |
— |
Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H318 H334 H410 |
|
M=100 |
|
|
006-104-00-2 |
meerwandige koolstofbuizen (synthetisch grafiet in buisvorm) met een geometrische buisdiameter ≥ 30 nm tot < 3 μm en een lengte ≥ 5 μm en een dimensieverhouding > 3:1, met inbegrip van meerwandige koolstofnanobuizen, MWC(N)T |
— |
— |
Carc. 1B STOT RE 1 |
H350i H372 (long) (inademing) |
GHS08 Dgr |
H350i H372 (long) (inademing) |
|
STOT RE 1; H372: C ≥ 1 %; STOT RE 2; H373: 0,1 % ≤ C < 1 % |
|
|
007-001-00-5 |
ammoniak, watervrij |
231-635-3 |
Flam. Gas 2 Press. Gas Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H221 H331 H314 H400 |
GHS04 GHS06 GHS05 GHS09 Dgr |
H221 H331 H314 H400 |
|
|
U |
|
|
007-001-01-2 |
ammoniak …. % |
215-647-6 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
STOT SE 3; H335: C ≥ 5 % |
B |
|
|
007-002-00-0 |
stikstofdioxide; [1] distikstoftetraoxide [2] |
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
* STOT SE 3; H335: C ≥0,5 % |
5 |
|
007-003-00-6 |
chloormequat-chloride (ISO); 2-chloorethyltrimethylammoniumchloride |
213-666-4 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
007-004-00-1 |
salpeterzuur … % [C > 70 %] |
231-714-2 |
Ox. Liq. 2 Acute Tox. 1 Skin Corr. 1A |
H272 H330 H314 |
GHS03 GHS06 GHS05 Dgr |
H272 H330 H314 |
EUH071 |
Ox. Liq. 2; H272: C ≥ 99 % Ox. Liq. 3; H272: 70 % ≤ C < 99 % |
B |
|
|
007-006-00-2 |
ethylnitriet |
203-722-6 |
Flam. Gas 1 Press. Gas Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H220 H332 H312 H302 |
GHS02 GHS04 GHS07 Dgr |
H220 H332 H312 H302 |
|
|
U |
|
|
007-007-00-8 |
ethylnitraat |
210-903-3 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
|
007-008-00-3 |
hydrazine |
206-114-9 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H350 H331 H311 H301 H314 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H226 H350 H331 H311 H301 H314 H317 H410 |
|
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 % |
|
|
|
007-009-00-9 |
dicyclohexylammoniumnitriet |
221-515-9 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
|
|
|
007-010-00-4 |
natriumnitriet |
231-555-9 |
Ox. Sol. 3 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
|
|
007-011-00-X |
kaliumnitriet |
231-832-4 |
Ox. Sol. 2 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
|
|
007-012-00-5 |
N,N-dimethylhydrazine |
200-316-0 |
Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H225 H350 H331 H301 H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H331 H301 H314 H411 |
|
|
|
|
|
007-013-00-0 |
1,2-dimethylhydrazine |
— |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H350 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H411 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
007-014-00-6 |
zouten van hydrazine |
— |
— |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H311 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H317 H410 |
|
|
A |
|
007-015-00-1 |
O-ethylhydroxylamine |
402-030-3 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
|
|
|
|
|
007-016-00-7 |
butylnitriet |
208-862-1 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H301 |
GHS02 GHS06 Dgr |
H225 H331 H301 |
|
|
|
|
|
007-017-00-2 |
isobutylnitriet |
208-819-7 |
Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H341 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H341 H332 H302 |
|
|
|
|
|
007-018-00-8 |
sec-butylnitriet |
213-104-8 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
|
007-019-00-3 |
tert-butylnitriet |
208-757-0 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
|
007-020-00-9 |
pentylnitriet; [1] „amylnitriet”, mengsel van isomeren [2] |
207-332-7 [1] 203-770-8 [2] |
463-04-7 [1] 110-46-3 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
|
007-021-00-4 |
hydrazobenzeen; 1,2-difenylhydrazine |
204-563-5 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
|
007-022-00-X |
hydrazinebis(3-carboxy-4-hydroxybenzeensulfonaat) |
405-030-1 |
— |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H350 H302 H314 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H350 H302 H314 H317 H412 |
|
|
|
|
007-023-00-5 |
natrium-3,5-bis(3-(2,4-di-tert-pentylfenoxy)propylcarbamoyl)benzeensulfonaat |
405-510-0 |
— |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
007-024-00-0 |
2-(decylthio)ethylammoniumchloride |
405-640-8 |
STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H315 H318 H410 |
|
|
|
|
|
007-025-00-6 |
(4-hydrazinofenyl)-N-methylmethaansulfonamidehydrochloride |
406-090-1 |
Muta. 2 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H301 H372 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H301 H372 ** H317 H410 |
|
|
|
|
|
007-026-00-1 |
oxo-((2,2,6,6-tetramethylpiperidine-4-yl)amino)carbonylacetohydrazide |
413-230-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
007-027-00-7 |
1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureïdo)hexaan |
420-190-2 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H317 H410 |
|
|
|
|
|
007-028-00-2 |
hydroxylammoniumnitraat |
236-691-2 |
Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
|
|
|
|
|
007-029-00-8 |
diëthyldimethylammoniumhydroxide |
419-400-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
|
007-030-00-3 |
salpeterzuur … % [C ≤ 70 %] |
231-714-2 |
Ox. Liq. 3 Acute Tox. 3 Skin Corr. 1A |
H272 H331 H314 |
GHS03 GHS06 GHS05 Dgr |
H272 H331 H314 |
EUH071 |
Ox. Liq. 3; H272: C ≥ 65 % inademing: ATE = 2,65 mg/l (dampen) Skin Corr. 1A; H314: C ≥ 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % |
B |
|
|
008-001-00-8 |
zuurstof |
231-956-9 |
Ox. Gas 1 Press. Gas |
H270 |
GHS03 GHS04 Dgr |
H270 |
|
|
U |
|
|
008-003-00-9 |
waterstofperoxide in oplossing … % |
231-765-0 |
Ox. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H271 H332 H302 H314 |
GHS03 GHS05 GHS07 Dgr |
H271 H332 H302 H314 |
|
Ox. Liq. 1; H271: C ≥70 %**** Ox. Liq. 2; H272: 50 % ≤ C < 70 % **** * Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % |
B |
|
|
009-001-00-0 |
fluor |
231-954-8 |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1A |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
|
|
|
|
009-002-00-6 |
waterstoffluoride |
231-634-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
|
|
009-003-00-1 |
waterstoffluorideoplossing … % |
231-634-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1 % ≤C < 1 % |
B |
|
|
009-004-00-7 |
natriumfluoride |
231-667-8 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
EUH032 |
|
|
|
|
009-005-00-2 |
kaliumfluoride |
232-151-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
009-006-00-8 |
ammoniumfluoride |
235-185-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
009-007-00-3 |
natriumbifluoride; natriumwaterstofdifluoride; |
215-608-3 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
*Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
|
009-008-00-9 |
natriumbifluoride; kaliumwaterstofdifluoride; |
232-156-2 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
|
009-009-00-4 |
ammoniumbifluoride; ammoniumwaterstofdifluoride; |
215-676-4 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
|
|
009-010-00-X |
tetrafluorboorzuur … % |
240-898-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
|
009-011-00-5 |
hexafluorkiezelzuur … % |
241-034-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
B |
|
|
009-012-00-0 |
alkalihexafluorosilicaten(Na); [1] alkalihexafluorosilicaten(K); [2] alkalihexafluorosilicaten(NH4) [3] |
240-934-8 [1] 240-896-2 [2] 240-968-3 [3] |
16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
* |
A |
|
009-013-00-6 |
fluorosilicaten, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
* |
A |
|
009-014-00-1 |
loodhexafluorosilicaat |
247-278-1 |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
|
009-015-00-7 |
sulfuryldifluoride |
220-281-5 |
Press. Gas Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H373 ** H400 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H331 H373 ** H400 |
|
|
U |
|
|
009-016-00-2 |
trinatriumhexafluoraluminaat [1] trinatriumhexafluoraluminaat (kryoliet) [2] |
237-410-6 [1] 239-148-8 [2] |
13775-53-6 [1] 15096-52-3 [2] |
STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 |
H372 H332 H411 |
GHS07 GHS08 GHS09 Dgr |
H372 H332 H411 |
|
|
|
|
009-017-00-8 |
kalium-μ-fluor-bis(triëthylaluminium) |
400-040-2 |
Flam. Sol. 1 Water-react. 1 Skin Corr. 1A Acute Tox. 4 * |
H228 H270 H314 H332 |
GHS02 GHS05 GHS07 Dgr |
H228 H270 H314 H332 |
EUH014 |
|
T |
|
|
009-018-00-3 |
magnesiumhexafluorosilicaat |
241-022-2 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
* |
|
|
|
011-001-00-0 |
natrium |
231-132-9 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
011-002-00-6 |
natriumhydroxide; bijtende soda |
215-185-5 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit.2; H319: 0,5 % ≤ C < 2 % |
|
|
|
011-003-00-1 |
natriumperoxide |
215-209-4 |
Ox. Sol. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
|
|
|
|
011-004-00-7 |
natriumazide |
247-852-1 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H400 H410 |
EUH032 |
|
|
|
|
011-005-00-2 |
natriumcarbonaat |
207-838-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
011-006-00-8 |
natriumcyanaat |
213-030-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
011-007-00-3 |
propoxycarbazonnatrium |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 10 |
|
|
|
012-001-00-3 |
magnesiumpoeder (pyrofoor) |
231-104-6 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
|
|
012-002-00-9 |
magnesium, poeder of draaisel |
231-104-6 |
— |
Flam. Sol. 1 Water-react. 2 Self-heat. 1 |
H228 H261 H252 |
GHS02 Dgr |
H228 H261 H252 |
|
|
T |
|
012-003-00-4 |
magnesiumalkylen |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
|
012-004-00-X |
aluminium-magnesium-carbonaat-hydroxide-perchloraat-hydraat |
422-150-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
013-001-00-6 |
aluminiumpoeder (pyrofoor) |
231-072-3 |
Water-react. 2 Pyr. Sol. 1 |
H261 H250 |
GHS02 Dgr |
H261 H250 |
|
|
T |
|
|
013-002-00-1 |
aluminiumpoeder (gestabiliseerd) |
231-072-3 |
Water-react. 2 Flam. Sol. 1 |
H261 H228 |
GHS02 Dgr |
H261 H228 |
|
|
T |
|
|
013-003-00-7 |
aluminiumchloride, watervrij |
231-208-1 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
013-004-00-2 |
aluminiumalkylen |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
|
013-005-00-8 |
diëthyl(ethyldimethylsilanolato)aluminium |
401-160-8 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
|
|
013-006-00-3 |
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoëthanolato)(1-methoxy-2-propanolato)aluminium(III), gedimeriseerd |
402-370-2 |
— |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
|
013-007-00-9 |
poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) |
403-430-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
013-008-00-4 |
di-n-octylaluminiumjodide |
408-190-0 |
Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H314 H410 |
EUH014 |
|
|
|
|
013-009-00-X |
natrium((n-butyl)x(ethyl)y-1,5-dihydro)aluminaat) x = 0,5 y = 1,5 |
418-720-2 |
— |
Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 * Skin Corr. 1A |
H228 H260 H250 H332 H314 |
GHS02 GHS05 GHS07 Dgr |
H228 H260 H250 H332 H314 |
EUH014 |
|
T |
|
013-010-00-5 |
hydroxyaluminiumbis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxafosfocine-6-oxide) |
430-650-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-001-00-9 |
trichloorsilaan |
233-042-5 |
Flam. Liq. 1 Water-react. 1 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Eye Dam. 1 |
H224 H260 H331 H302 H314 H318 |
GHS02 GHS06 GHS05 Dgr |
H224 H260 H331 H302 H314 |
EUH014 EUH029 EUH071 |
inademing: ATE = 7,6 mg/l (dampen) oraal: ATE = 1 000 mg/kg lg |
|
|
|
014-002-00-4 |
siliciumtetrachloride |
233-054-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
EUH014 |
|
|
|
|
014-003-00-X |
dimethyldichloorsilaan |
200-901-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
|
|
014-004-00-5 |
methyltrichloorsilaan; methyltrichloorsilaan |
200-902-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
EUH014 |
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
014-005-00-0 |
tetraëthylsilicaat; ethylsilicaat |
201-083-8 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H226 H332 H319 H335 |
GHS02 GHS07 Wng |
H226 H332 H319 H335 |
|
|
|
|
|
014-006-00-6 |
bis(4-fluorfenyl)-methyl-(1,2,4-triazool-4-ylmethyl)silaanhydrochloride |
401-380-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
014-007-00-1 |
triëthoxyisobutylsilaan |
402-810-3 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
|
014-008-00-7 |
(chloormethyl)bis(4-fluorfenyl)methylsilaan |
401-200-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-009-00-2 |
isobutylisopropyldimethoxysilaan |
402-580-4 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H315 |
GHS02 GHS07 Wng |
H226 H332 H315 |
|
|
|
|
|
014-010-00-8 |
dinatriummetasilicaat |
229-912-9 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
|
|
014-011-00-3 |
cyclohexyldimethoxymethylsilaan |
402-140-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
014-012-00-9 |
bis(3-(trimethoxysilyl)propyl)amine |
403-480-3 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
014-013-00-4 |
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidine-4-yloxy)propyl)siloxaan) |
404-920-7 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H312 H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H411 |
|
|
|
|
014-014-00-X |
etacelasil (ISO); 6-(2-chloorethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecaan; |
253-704-7 |
Repr. 1B Acute Tox. 4 * STOT RE 2 * |
H360D *** H302 H373 ** |
GHS08 GHS07 Dgr |
H360D *** H302 H373 ** |
|
|
|
|
|
014-015-00-5 |
α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilaandiyl]-co-oxy(dimethylsilaan)) |
406-420-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
014-016-00-0 |
reactiemassa van: 1,3-dihex-5-een-1-yl-1,1,3,3-tetramethyldisiloxaan; 1,3-dihex-n-een-1-yl-1,1,3,3-tetramethyldisiloxaan |
406-490-6 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-017-00-6 |
flusilazool (ISO); bis(4-fluorfenyl)(methyl)(1H-1,2,4-triazool-1-ylmethyl)silaan |
— |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D *** H302 H411 |
|
|
|
|
|
014-018-00-1 |
octamethylcyclotetrasiloxaan; [D4] |
209-136-7 |
Repr. 2 Aquatic Chronic 1 |
H361f *** H410 |
GHS08 GHS09 Wng |
H361f *** H410 |
|
M = 10 |
|
|
|
014-019-00-7 |
reactiemassa van: 4-[[bis-(4-fluorfenyl)methylsilyl]methyl]-4H-1,2,4-triazool; 1-[[bis-(4-fluorfenyl)methylsilyl]methyl]-1H-1,2,4-triazool |
403-250-2 |
— |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D *** H302 H411 |
|
|
|
|
014-020-00-2 |
bis(1,1-dimethyl-2-propynyloxy)dimethylsilaan |
414-960-7 |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
|
|
|
014-021-00-8 |
tris(isopropenyloxy)fenylsilaan |
411-340-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H400 H410 |
|
|
|
|
|
014-022-00-3 |
reactieproduct van: (2-hydroxy-4-(3-propeenoxy)benzofenon en triëthoxysilaan) met (hydrolyseproduct van silica en methyltrimethoxysilaan) |
401-530-9 |
— |
Flam. Sol. 1 STOT SE 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H228 H370 ** H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H228 H370 ** H332 H312 H302 |
|
|
T |
|
014-023-00-9 |
α, ω-dihydroxypoly(hex-5-een-1-ylmethylsiloxaan) |
408-160-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-024-00-4 |
1-((3-(3-chloor-4-fluorofenyl)propyl)dimethylsilanyl)-4-ethoxybenzeen |
412-620-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
014-025-00-X |
4-[3-(diëthoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]-piperidine |
411-400-3 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H302 H373 ** H315 H318 H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 H412 |
|
|
|
|
|
014-026-00-5 |
dichloor-(3-(3-chloor-4-fluorfenyl)propyl)methylsilaan |
407-180-3 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
014-027-00-0 |
chloor(3-(3-chloor-4-fluorfenyl)propyl)dimethylsilaan |
410-270-5 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
014-028-00-6 |
α-[3-(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyloxy-ω-[3-(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilylpoly(dimethylsiloxaan) |
415-290-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
014-029-00-1 |
O,O'-(ethenylmethylsilyleen)di[(4-methylpentaan-2-on)oxim] |
421-870-1 |
Repr. 2 Acute Tox. 4 * STOT RE 2 * |
H361f *** H302 H373 ** |
GHS08 GHS07 Wng |
H361f *** H302 H373 ** |
|
|
|
|
|
014-030-00-7 |
[(dimethylsilyleen)bis((1,2,3,3a,7a-η)-1H-indeen-1-ylideen)dimethyl]hafnium |
422-060-0 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
|
|
014-031-00-2 |
bis(1-methylethyl)-dimethoxysilaan |
421-540-7 |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H226 H315 H317 H412 |
GHS02 GHS07 Wng |
H226 H315 H317 H412 |
|
|
|
|
|
014-032-00-8 |
dicyclopentyldimethoxysilaan |
404-370-8 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
|
014-033-00-3 |
reactieproducten van 2-methyl-3-(trimethoxysilyl)propyl-2-propenoaat, gehydrolyseerd, en silica |
419-030-4 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
|
|
014-034-00-9 |
3-hexylheptamethyltrisiloxaan |
428-700-5 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
|
014-035-00-4 |
2-(3,4-epoxycyclohexyl)ethyltriëthoxysilaan |
425-050-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
014-036-00-X |
(4-ethoxyfenyl)(3-(3-fenoxy-4-fluorfenyl)propyl)dimethylsilaan |
405-020-7 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360F*** H400 H410 |
GHS08 GHS09 Dgr |
H360F*** H410 |
|
M=1000 |
|
|
|
014-037-00-5 |
butaan-2-on-O,O',O''-(fenylsilylidyn)trioxim |
433-360-6 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373** H317 H412 |
GHS08 GHS07 Wng |
H373** H317 H412 |
|
|
|
|
|
014-038-00-0 |
S-(3-(triëthoxysilyl)propyl)octaanthioaat |
436-690-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
014-039-00-6 |
(2,3-dimethylbut-2-yl)trimethoxysilaan |
439-360-2 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
|
014-041-00-7 |
N, N-bis(trimethylsilyl)aminopropylmethyldiëthoxysilaan |
445-890-5 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
|
014-042-00-2 |
reactiemassa van: O,O',O'',O'''-silaantetrayltetrakis(4-methyl-2-pentanonoxim) (3 stereoisomeren) |
423-010-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
014-043-00-8 |
reactieproduct van amorfe silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraëthylorthosilicaat (5-15 %) en titaantetrachloride (5-20 %) |
432-200-2 |
— |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H335 H315 H318 H412 |
GHS05 GHS07 Dgr |
H335 H315 H318 H412 |
|
|
|
|
014-044-00-3 |
3-[(4'-acetoxy-3'-methoxyfenyl)propyl]trimethoxysilaan |
433-050-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
014-045-00-9 |
magnesiumnatriumfluoridesilicaat |
442-650-1 |
— |
STOT RE 2 * |
H373** |
GHS08 Wng |
H373** |
|
|
|
|
014-046-00-4 |
►C6 E-glasmicrovezels ◄ met een representatieve samenstelling; [Calcium-aluminium-silicaatvezels met willekeurige oriëntatie en de volgende representatieve samenstelling (in massapercentage): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Proces: gewoonlijk met roterende vlamdemping. (Er kunnen nog andere elementen in kleine hoeveelheden aanwezig zijn; de procesbeschrijving sluit geen innovatie uit).] |
— |
— |
Carc. 1B |
H350i |
GHS08 Dgr |
H350i |
|
|
A |
|
014-047-00-X |
►C6 Glasmicrovezels ◄ met een representatieve samenstelling; [Calcium-aluminium-silicaatvezels met willekeurige oriëntatie en de volgende samenstelling (in massapercentage): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Proces: gewoonlijk met roterende vlamdemping. (Er kunnen nog andere elementen in kleine hoeveelheden aanwezig zijn; de procesbeschrijving sluit geen innovatie uit).] |
— |
— |
Carc. 2 |
H351 (inademing) |
GHS08 Wng |
H351 (inademing) |
|
|
A |
|
014-048-00-5 |
vezels bestaande uit siliciumcarbide (met diameter < 3 μm, lengte > 5 μm en dimensieverhouding ≥ 3:1) |
206-991-8 |
Carc. 1B |
H350i |
GHS08 Dgr |
H350i |
|
|
|
|
|
014-049-00-0 |
trimethoxyvinylsilaan; trimethoxy(vinyl)silaan |
220-449-8 |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
014-050-00-6 |
tris(2-methoxyethoxy)vinylsilaan; 6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaündecaan; |
213-934-0 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
014-052-00-7 |
silaanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolyseproducten met silica; pyrogeen, synthetisch amorf, nano siliciumdioxide met behandeld oppervlak |
272-697-1 |
STOT RE 2 |
H373 (longen) (inademing) |
GHS08 Wng |
H373 (longen) (inademing) |
EUH066 |
|
|
|
|
015-001-00-1 |
gele of witte fosfor |
231-768-7 |
Pyr. Sol. 1 Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 |
H250 H330 H300 H314 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H250 H330 H300 H314 H400 |
|
|
|
|
|
015-002-00-7 |
rode fosfor |
231-768-7 |
Flam. Sol. 1 Aquatic Chronic 3 |
H228 H412 |
GHS02 Dgr |
H228 H412 |
|
|
|
|
|
015-003-00-2 |
calciumfosfide; tricalciumdifosfide |
215-142-0 |
Water ontvl. 1 Acute tox. 2 Acute tox. 3 Acute tox. 1 Oogletsel 1 Aquatisch acuut 1 |
H260 H300 H311 H330 H318 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H260 H300 H311 H330 H318 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
015-004-00-8 |
aluminiumfosfide |
244-088-0 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
015-005-00-3 |
magnesiumfosfide; trimagnesiumdifosfide |
235-023-7 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
015-006-00-9 |
trizinkdifosfide; zinkfosfide |
215-244-5 |
Water-react. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H260 H300 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H410 |
EUH029 EUH032 |
M=100 |
T |
|
|
015-007-00-4 |
fosfortrichloride |
231-749-3 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Skin Corr. 1A |
H330 H300 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H300 H373 ** H314 |
EUH014 EUH029 |
|
|
|
|
015-008-00-X |
fosforpentachloride |
233-060-3 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B |
H330 H302 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H302 H373 ** H314 |
EUH014 EUH029 |
|
|
|
|
015-009-00-5 |
fosforyltrichloride |
233-046-7 |
Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1A |
H330 H372 ** H302 H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H372 ** H302 H314 |
EUH014 EUH029 |
|
|
|
|
015-010-00-0 |
fosforpentoxide |
215-236-1 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
015-011-00-6 |
fosforzuur . %, orthofosforzuur . % |
231-633-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
|
015-012-00-1 |
tetrafosfortrisulfide; fosforsesquisulfide |
215-245-0 |
Flam. Sol. 2 Water-react. 1 Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H302 H400 |
|
|
T |
|
|
015-013-00-7 |
triëthylfosfaat |
201-114-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
015-014-00-2 |
tributylfosfaat |
204-800-2 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 |
H351 H302 H315 |
GHS08 GHS07 Wng |
H351 H302 H315 |
|
|
|
|
|
015-015-00-8 |
tricresylfosfaat (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolylfosfaat (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); |
201-103-5 |
STOT SE 1 Aquatic Chronic 2 |
H370 ** H411 |
GHS08 GHS09 Dgr |
H370 ** H411 |
|
STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 % |
C |
|
|
015-016-00-3 |
tricresylfosfaat (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolylfosfaat (m-m-m-, m-m-p-, m-p-p-, p-p-p-); |
201-105-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H312 H302 H411 |
GHS07 GHS09 Wng |
H312 H302 H411 |
|
* |
C |
|
|
015-019-00-X |
dichloorvos (ISO); 2,2-dichloorvinyldimethylfosfaat |
200-547-7 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 |
H330 H311 H301 H317 H400 |
GHS06 GHS09 Dgr |
H330 H311 H301 H317 H400 |
|
M=1000 |
|
|
|
015-020-00-5 |
mevinfos (ISO); 2-methoxycarbonyl-1-methylvinyldimethylfosfaat |
232-095-1 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10000 |
|
|
|
015-021-00-0 |
trichloorfon (ISO); dimethyl-2,2,2-trichloor-1-hydroxyethylfosfonaat |
200-149-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H400 H410 |
|
M = 1000 |
|
|
|
015-022-00-6 |
fosfamidon (ISO); 2-chloor-2-diëthylcarbamoyl-1-methylvinyldimethylfosfaat |
236-116-5 |
Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H300 H311 H410 |
|
|
|
|
|
015-023-00-1 |
pyrazoxon; diëthyl-3-methylpyrazool-5-ylfosfaat |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
|
015-024-00-7 |
triamifos (ISO); 5-amino-3-fenyl-1,2,4-triazool-1-yl-N,N,N',N'-tetramethylfosfondiamide |
— |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-025-00-2 |
TEPP (ISO); tetraëthylpyrofosfaat |
203-495-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
015-026-00-8 |
schradan (ISO); octamethylpyrofosforamide |
205-801-0 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-027-00-3 |
sulfotep (ISO); O,O,O,O-tetraëthyldithiopyrofosfaat |
222-995-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
|
015-028-00-9 |
demeton-O (ISO); O,O-diëthyl-O-2-ethylthioëthylthiofosfaat |
206-053-8 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
015-029-00-4 |
demeton-S (ISO); diëthyl-S-2-ethylthioëthylthiofosfaat |
204-801-8 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-030-00-X |
demeton-O-methyl (ISO); O-2-ethylthioëthyl-O,O-dimethylthiofosfaat |
212-758-1 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
015-031-00-5 |
demeton-S-methyl (ISO); S-2-ethylthioëthyldimethylthiofosfaat |
213-052-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H311 H301 H411 |
GHS06 GHS09 Dgr |
H311 H301 H411 |
|
|
|
|
|
015-032-00-0 |
prothoaat (ISO); O,O-diëthylisopropylcarbamoylmethyldithiofosfaat |
218-893-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 3 |
H310 H300 H412 |
GHS06 Dgr |
H310 H300 H412 |
|
|
|
|
|
015-033-00-6 |
foraat (ISO); O,O-diëthylethylthiomethyldithiofosfaat |
206-052-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
|
015-034-00-1 |
parathion (ISO); O,O-diëthyl-O-4-nitrofenylthiofosfaat |
200-271-7 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H311 H372 ** H410 |
|
M = 100 |
|
|
|
015-035-00-7 |
parathion — methyl (ISO); O,O-dimethyl-O-4-nitrofenylthiofosfaat |
206-050-1 |
Flam. Liq. 3 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H330 H300 H311 H373 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H330 H300 H311 H373 ** H410 |
|
M = 100 |
|
|
|
015-036-00-2 |
O-ethyl-O-4-nitrofenylfenylthiofosfonaat; EPN |
218-276-8 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-037-00-8 |
fenkapton (ISO); S-(2,5-dichloorfenylthiomethyl)-O, O-diëthyldithiofosfaat |
218-892-7 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
|
015-038-00-3 |
cumafos (ISO); O-3-chloor-4-methylcumarine-7-yl-O,O-diëthylthiofosfaat |
200-285-3 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
|
015-039-00-9 |
azinfos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazine-3-ylmethyldithiofosfaat |
201-676-1 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H317 H410 |
|
|
|
|
|
015-040-00-4 |
diazinon (ISO); O,O-diëthyl-O-2-isopropyl-6-methylpyrimidine-4-ylthiofosfaat |
206-373-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
|
015-041-00-X |
malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl-O,O-dimethyldithiofosfaat; [met ≤ 0,03 % isomalathion] |
204-497-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=1000 |
|
|
|
015-042-00-5 |
chloorthion; O-(3-chloor-4-nitrofenyl)-O,O-dimethylthiofosfaat |
207-902-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 100 |
|
|
|
015-043-00-0 |
fosnichloor (ISO); O-(4-chloor-3-nitrofenyl)-O,O-dimethylthiofosfaat |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
|
|
015-044-00-6 |
carbofenothion (ISO); 4-chloorfenylthiomethyl-O,O-diëthyldithiofosfaat |
212-324-1 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
015-045-00-1 |
mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl-O,O-diëthyldithiofosfaat |
219-993-9 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H400 H410 |
|
|
|
|
|
015-046-00-7 |
oxydemeton-methyl; S-2-(ethylsulfinyl)ethyl-O,O-dimethylthiofosfaat |
206-110-7 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H311 H301 H400 |
GHS06 GHS09 Dgr |
H311 H301 H400 |
|
|
|
|
|
015-047-00-2 |
ethion (ISO); O,O,O',O'-tetraëthyl-S,S'-methyleendi(dithiofosfaat); diëthion |
209-242-3 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 10000 |
|
|
|
015-048-00-8 |
fenthion (ISO); O,O-dimethyl-O-(4-methylthio-m-tolyl)thiofosfaat |
200-231-9 |
Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H312 H302 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H331 H312 H302 H372** H410 |
|
M=100 |
|
|
|
015-049-00-3 |
endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyldimethylthiofosfaat |
220-472-3 |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
|
|
015-050-00-9 |
thiometon (ISO); S-2-ethylthioëthyl-O,O-dimethyldithiofosfaat |
211-362-6 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
|
|
015-051-00-4 |
dimethoaat (ISO); O,O-dimethylmethylcarbamoylmethyldithiofosfaat |
200-480-3 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
015-052-00-X |
fenchloorfos (ISO); O, O-dimethyl-O-2,4,5-trichloorfenylthiofosfaat |
206-082-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-053-00-5 |
menazon (ISO); S-[(4,6-diamino-1,3,5-triazine-2-yl)methyl]-O, O-dimethyldithiofosfaat |
201-123-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
015-054-00-0 |
fenitrothion (ISO); O,O-dimethyl-O-4-nitro-m-tolylthiofosfaat |
204-524-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
015-055-00-6 |
naled (ISO); 1,2-dibroom-2,2-dichloorethyldimethylfosfaat |
206-098-3 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H312 H302 H319 H315 H400 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H400 |
|
M = 1000 |
|
|
|
015-056-00-1 |
azinfos-ethyl (ISO); O,O-diëthyl-4-oxobenzotriazine-3-ylmethyldithiofosfaat |
220-147-6 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M=100 |
|
|
|
015-057-00-7 |
formothion (ISO); N-formyl-N-methylcarbamoylmethyl-O,O-dimethyldithiofosfaat |
219-818-6 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
015-058-00-2 |
morfothion (ISO); O,O-dimethyl-S-[(morfolino-carbonyl)-methyl]-dithiofosfaat |
205-628-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
|
|
015-059-00-8 |
vamidothion (ISO); O,O-dimethyl-S-2-(1-methylcarbamoylethylthio)-ethylthiofosfaat |
218-894-8 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
|
|
015-060-00-3 |
disulfoton (ISO); O,O-diëthyl-2-ethylthioëthyldithiofosfaat |
206-054-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-061-00-9 |
dimefox (ISO); tetramethylfosforodiamidefluoride |
204-076-8 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-062-00-4 |
mipafox (ISO); N,N'-diisopropyldiamidofosforzuur-fluoride |
206-742-3 |
STOT SE 1 |
H370 ** |
GHS08 Dgr |
H370 ** |
|
|
|
|
|
015-063-00-X |
dioxathion (ISO); 1,4-dioxaan-2,3-diyl-O,O,O',O'-tetraëthyldi(dithiofosfaat) |
201-107-7 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
M = 1000 |
|
|
|
015-064-00-5 |
bromofos-ethyl (ISO); O-4-broom-2,5-dichloorfenyl-O,O-diëthylthiofosfaat |
225-399-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
|
|
015-065-00-0 |
S-[2-(ethylsulfinyl)ethyl]-O,O-dimethyldithiofosfaat |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H330 H310 H300 H411 |
GHS06 GHS09 Dgr |
H330 H310 H300 H411 |
|
|
|
|
|
015-066-00-6 |
omethoaat (ISO); O,O-dimethyl-S-methylcarbamoylmethylthiofosfaat |
214-197-8 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
|
|
015-067-00-1 |
fosalone (ISO); O,O-diëthyl-S-[(6-chloor-2-oxobenzoxazoline-3-yl)methyl)]-dithiofosfaat |
218-996-2 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H301 H332 H312 H317 H410 |
|
M=1000 |
|
|
|
015-068-00-7 |
dichlofenthion (ISO); O-2,4-dichloorfenyl-O,O-diëthylthiofosfaat |
202-564-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
|
015-069-00-2 |
methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazool-3-ylmethyl-O,O-dimethyldithiofosfaat |
213-449-4 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
|
|
015-070-00-8 |
cyaanthoaat (ISO); S-(N-(1-cyaan-1-methylethyl)carbamoylmethyl)-O,O-diëthylthiofosfaat |
223-099-4 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
|
015-071-00-3 |
chloorfenvinfos (ISO); 2-chloor-1-(2,4-dichloorfenyl)vinyldiëthylfosfaat |
207-432-0 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
015-072-00-9 |
monocrotofos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinylfosfaat |
230-042-7 |
Muta. 2 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H330 H300 H311 H410 |
|
|
|
|
|
015-073-00-4 |
dicrotofos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyldimethylfosfaat |
205-494-3 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
015-074-00-X |
crufomaat (ISO); 4-tert-butyl-2-chloorfenylmethylmethylfosforamidaat |
206-083-1 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-075-00-5 |
S-2-ethyl-sulfinylisopropyl-O,O-dimethylthiofosfaat |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
015-076-00-0 |
potasan; O,O-diëthyl-O-(4-methylcumarine-7-yl)-thiofosfaat |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M = 1000 |
|
|
|
015-077-00-6 |
O-(2,2-dichloorvinyl)-O-methyl-O-(2-ethylsulfinyl-ethyl)-fosfaat |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
|
|
015-078-00-1 |
demeton-S-methylsulfon (ISO); S-2-ethylsulfonylethyldimethylthiofosfaat |
241-109-5 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H301 H312 H411 |
GHS06 GHS09 Dgr |
H301 H312 H411 |
|
|
|
|
|
015-079-00-7 |
acefaat (ISO); O,S-dimethylacetylthiofosforamidaat |
250-241-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
015-080-00-2 |
amidithion (ISO); 2-methoxyethylcarbamoylethyl-O,O-dimethyldithiofosfaat |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
015-081-00-8 |
O,O,O',O'-tetrapropyl-dithiopyrofosfaat |
221-817-0 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-082-00-3 |
azothoaat (ISO); O-4(4-chloor-fenylazo)fenyl-O,O-dimethylthiofosfaat |
227-419-3 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
|
015-083-00-9 |
bensulide (ISO); 2-fenylsulfonylaminoëthyl-O,O-diisopropyldithiofosfaat |
212-010-4 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
015-084-00-4 |
chloorpyrifos (ISO); O,O-diëthyl-O-3,5,6-trichloor-2-pyridylthiofosfaat |
220-864-4 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H400 H410 |
|
M = 10000 |
|
|
|
015-085-00-X |
chloorfonium-chloride (ISO); tributyl (2,4-dichloorbenzyl)-fosfoniumchloride |
204-105-4 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H312 H319 H315 |
GHS06 Dgr |
H301 H312 H319 H315 |
|
|
|
|
|
015-086-00-5 |
cumithoaat (ISO); O,O-diëthyl-O-7,8,9,10-tetrahydro-6-oxo-benzo[c]chromeen-3-ylthiofosfaat |
— |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
015-087-00-0 |
cyanofos (ISO); O-4-cyaanfenyl-O,O-dimethylthiofosfaat |
220-130-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
015-088-00-6 |
dialifos (ISO); 2-chloor-1-ftaalimidoëthyl-O,O-diëthyldithiofosfaat |
233-689-3 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H400 H410 |
|
|
|
|
|
015-089-00-1 |
ethoaat-methyl (ISO); ethylcarbamoylmethyl-O,O-dimethyldithiofosfaat |
204-121-1 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
015-090-00-7 |
fensulfothion (ISO); O,O-diëthyl-O-4-methylsulfinylfenylthiofosfaat |
204-114-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-091-00-2 |
fonofos (ISO); O-ethylfenylethyldithiofosfonaat |
213-408-0 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-092-00-8 |
fosacetim (ISO); O,O-bis(4-chloorfenyl)-N-acetimidoylthiofosforamidaat |
223-874-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
|
|
015-093-00-3 |
leptofos (ISO); O-4-broom-2,5-dichloorfenyl-O-methylfenylthiofosfonaat |
244-472-8 |
Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H370 ** H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H370 ** H312 H410 |
|
|
|
|
|
015-094-00-9 |
mefosfolan (ISO); diëthyl-4-methyl-1,3-dithiolaan-2-ylideenfosforamidaat |
213-447-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H310 H300 H411 |
GHS06 GHS09 Dgr |
H310 H300 H411 |
|
|
|
|
|
015-095-00-4 |
methamidofos (ISO); O,S-dimethylthiofosforamidaat |
233-606-0 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 |
H330 H300 H311 H400 |
GHS06 GHS09 Dgr |
H330 H300 H311 H400 |
|
|
|
|
|
015-096-00-X |
oxydisulfoton (ISO); O,O-diëthyl-S-[2-(ethylsulfinyl)-ethyl]dithiofosfaat |
219-679-1 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 10 |
|
|
|
015-097-00-5 |
fenthoaat (ISO); ethyl-2-(dimethoxyfosfinothioylthio)-2-fenylacetaat |
219-997-0 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
M = 100 |
|
|
|
015-098-00-0 |
trichloronaat (ISO); O-ethyl-O-2,4,5-trichloorfenylethylthiofosfonaat |
206-326-1 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
015-099-00-6 |
pirimifos-ethyl (ISO); O,O-diëthyl-O-2-diëthylamino-6-methylpyrimidine-4-ylthiofosfaat |
245-704-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
|
|
015-100-00-X |
foxim (ISO); α-(diëthoxyfosfinothioylimino)fenylacetonitril |
238-887-3 |
Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f*** H302 H317 H410 |
|
M=1000 |
|
|
|
015-101-00-5 |
fosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H-isoïndool-2-yl)methyl]-O,O-dimethyldithiofosfaat; O,O-dimethyl-S-ftaalimidomethyldithiofosfaat |
211-987-4 |
Repr. 2 Acute Tox. 4 Acute Tox. 3 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H332 H301 H370 (zenuwstelsel) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H361f H332 H301 H370 (zenuwstelsel) H410 |
|
M = 100 M = 100 |
|
|
|
015-102-00-0 |
tris(2-chloorethyl)fosfaat |
204-118-5 |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360F*** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H302 H411 |
|
|
|
|
|
015-103-00-6 |
fosfortribromide |
232-178-2 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
|
015-104-00-1 |
difosforpentasulfide; fosforpentasulfide |
215-242-4 |
Flam. Sol. 1 Water-react. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H332 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H332 H302 H400 |
EUH029 |
|
T |
|
|
015-105-00-7 |
trifenylfosfiet |
202-908-4 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |
|
|
|
015-106-00-2 |
hexamethylfosforzuurtriamide; hexamethylfosforamide |
211-653-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
015-107-00-8 |
ethoprofos (ISO); ethyl-S,S-dipropyldithiofosfaat |
236-152-1 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H301 H317 H410 |
|
|
|
|
|
015-108-00-3 |
bromofos (ISO); O-4-broom-2,5-dichloorfenyl-O,O-dimethylthiofosfaat |
218-277-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 100 |
|
|
|
015-109-00-9 |
crotoxyfos (ISO); 1-fenylethyl-3-(dimethoxyfosfinyloxy)-isocrotonaat |
231-720-5 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 10 |
|
|
|
015-110-00-4 |
cyanofenfos (ISO); O-4-cyaanfenyl-O-ethylfenylthiofosfonaat |
— |
Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H301 H370 ** H312 H319 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H370 ** H312 H319 H411 |
|
|
|
|
|
015-111-00-X |
fosfolan (ISO); diëthyl-1,3-dithiolaan-2-ylideenfosforamidaat |
213-423-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-112-00-5 |
thionazin (ISO); O,O-diethyl-O-pyrazine-2-ylthiofosfaat; |
206-049-6 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-113-00-0 |
tolclofos-methyl (ISO); O-(2,6-dichloor-p-tolyl) O,O-dimethylthiofosfaat |
260-515-3 |
Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 1 M = 1 |
|
|
|
015-114-00-6 |
chloormefos (ISO); S-chloormethyl-O,O-diëthyldithiofosfaat |
246-538-1 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10 |
|
|
|
015-115-00-1 |
chloorthiofos (ISO); [isomere reactiemassa met overwegend O-2,5-dichloorfenyl-4-methylthiofenyl-O,O-diëthylthiofosfaat] |
244-663-6 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 1000 |
|
|
|
015-116-00-7 |
demefion-O (ISO); O,O-dimethyl-O-2-methylthioëthylthiofosfaat |
211-666-9 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
|
015-117-00-2 |
demefion-S (ISO); O,O-dimethyl-S-2-methylthioëthylthiofosfaat |
219-971-9 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
|
|
015-118-00-8 |
demeton |
— |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
015-119-00-3 |
dimethyl-4-(methylthio)fenylfosfaat |
— |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-120-00-9 |
ditalimfos (ISO); O, O-diëthylftaalimidothiofosfonaat; |
225-875-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
015-121-00-4 |
edifenfos (ISO); O-ethyl-S,S-difenyldithiofosfaat |
241-178-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
|
|
|
|
|
015-122-00-X |
etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidine-4-yl-O, O-dimethylthiofosfaat |
253-855-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
|
|
015-123-00-5 |
fenamifos (ISO); ethyl-4-methylthio-m-tolyl-N-isopropylfosforamidaat |
244-848-1 |
Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H300 H310 H330 H319 H400 H410 |
GHS06 GHS09 Dgr |
H300 H310 H330 H319 H410 |
|
M = 100 M = 100 |
|
|
|
015-124-00-0 |
fosthiëtaan (ISO); diëthyl-1,3-dithiëtaan-2-ylideenfosforamidaat |
244-437-7 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
015-125-00-6 |
glyfosine (ISO); N,N-bis(fosfonomethyl)glycine |
219-468-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
015-126-00-1 |
heptenofos (ISO); 7-chloorbicyclo[3.2.0]hepta-2,6-dieen-6-yldimethylfosfaat |
245-737-0 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
|
|
015-127-00-7 |
iprobenfos (ISO); S-benzyldi-isopropylthiofosfaat |
247-449-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
015-128-00-2 |
IPSP; S-ethylsulfinylmethyl-O,O-diisopropyldithiofosfaat |
— |
Acute Tox. 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H301 H400 H410 |
GHS06 GHS09 Dgr |
H310 H301 H410 |
|
M = 100 |
|
|
|
015-129-00-8 |
isofenfos (ISO); O-ethyl-O-2-isopropoxycarbonylfenyl-N-isopropylthiofosforamidaat |
246-814-1 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 100 |
|
|
|
015-130-00-3 |
isothioaat (ISO); S-2-isopropylthioëthyl-O,O-dimethyldithiofosfaat; |
— |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
|
|
015-131-00-9 |
isoxathion (ISO); O,O-diëthyl-O-5-fenylisoxazool-3-ylthiofosfaat |
242-624-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
015-132-00-4 |
S-(chloorfenylthiomethyl)-O,O-dimethyldithiofosfaat; methylcarbofenothion |
— |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 1000 |
|
|
|
015-133-00-X |
piperofos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyldithiofosfaat |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
|
|
015-134-00-5 |
pirimifos-methyl (ISO); O-(2-diëthylamino-6-methylpyrimidine-4-yl)-O,O-dimethylthiofosfaat |
249-528-5 |
Acute Tox. 4 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H372 (zenuwstelsel) H400 H410 |
GHS07 GHS08 GHS09 Dgr |
H302 H372 (zenuwstelsel) H410 |
|
oraal: ATE = 1414 mg/kg lichaamsgewicht M = 1000 M = 1000 |
|
|
|
015-135-00-0 |
profenofos (ISO); O-(4-broom-2-chloorfenyl)-O-ethyl-S-propylthiofosfaat |
255-255-2 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 1000 |
|
|
|
015-136-00-6 |
trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonaat; isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]isocrotonaat; propetamfos (ISO) |
250-517-2 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
|
|
015-137-00-1 |
pyrazofos (ISO); O,O-diëthyl-O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidine-2-yl)thiofosfaat |
236-656-1 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
|
|
|
015-138-00-7 |
quinalfos (ISO); O,O-diëthyl-O-chinoxaline-2-ylthiofosfaat |
237-031-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 1000 |
|
|
|
015-139-00-2 |
terbufos (ISO); S-tert-butylthiomethyl-O,O-diëthyldithiofosfaat |
235-963-8 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
|
|
015-140-00-8 |
triazofos (ISO); O,O-diëthyl-O-1-fenyl-1H-1,2,4-triazool-3-ylthiofosfaat |
245-986-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H410 |
|
M=100 |
|
|
|
015-141-00-3 |
ethyleendiammonium-O,O-bis(octyl)dithiofosfaat, mengsel van isomeren |
400-520-1 |
— |
Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H410 |
|
|
|
|
015-142-00-9 |
butyl(dialkyloxy(dibutoxyfosforyloxy)titaan)(trialkyloxytitaan)fosfaat |
401-100-0 |
— |
Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 |
H225 H319 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H319 H411 |
|
|
T |
|
015-143-00-4 |
reactiemassa van 2-chloorethyl-chloorpropyl-2-chloorethylfosfonaat, reactiemassa van isomeren en 2-chloorethyl-chloorpropyl-2-chloorpropylfosfonaat, reactiemassa van isomeren |
401-740-0 |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
015-144-00-X |
reactiemassa van pentylmethylfosfinaat en 2-methylbutylmethylfosfinaat |
402-090-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
015-145-00-5 |
reactiemassa van koper(I)-O,O-diisopropyldithiofosfaat en koper(I)-O-isopropyl-O-(4-methylpent-2-yl)dithiofosfaat en koper(I)-O,O-bis(4-methylpent-2-yl)dithiofosfaat |
401-520-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-146-00-0 |
S-(tricyclo(5.2.1.0 2,6)deca-3-een-8(of 9)-yl O-(isopropyl of isobutyl of 2-ethylhexyl) O-(isopropyl of isobutyl of 2-ethylhexyl)dithiofosfaat |
401-850-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
015-147-00-6 |
reactiemassa van C12-14-tert-alkylammoniumdifenylthiofosfaat en dinonylsulfide (of -disulfide) |
400-930-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
015-148-00-1 |
2-(difosfonomethyl)barnsteenzuur |
403-070-4 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
|
015-149-00-7 |
reactiemassa van: hexyldioctylfosfineoxide; dihexyloctylfosfineoxide; trioctylfosfineoxide |
403-470-9 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
015-150-00-2 |
(2-(1,3-dioxolaan-2-yl)ethyl)trifenylfosfoniumbromide |
404-940-6 |
Acute Tox. 4 * Eye Dam. 1 STOT RE 2 * Aquatic Chronic 3 |
H302 H318 H373 ** H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H318 H373 ** H412 |
|
|
|
|
|
015-151-00-8 |
tris(isopropyl/tert-butylfenyl)fosfaat |
405-010-2 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
015-152-00-3 |
dioxabenzofos (ISO); 2-methoxy-4H-1,3,2-benzodioxafosforinine-2-sulfide |
223-292-3 |
Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 Aquatic Chronic 2 |
H311 H301 H370 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H311 H301 H370 ** H411 |
|
|
|
|
|
015-153-00-9 |
isazofos (ISO); O-(5-chloor-1-isopropyl-1,2,4-triazool-3-yl)-O, O-diëthylthiofosfaat |
255-863-8 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H311 H301 H373 ** H317 H410 |
|
|
|
|
|
015-154-00-4 |
ethefon; 2-chloorethylfosfonzuur |
240-718-3 |
Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 |
H311 H332 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H332 H302 H314 H411 |
EUH071 |
|
|
|
|
015-155-00-X |
glufosinaat-ammonium (ISO); ammonium-2-amino-4-(hydroxymethylfosfinyl)butyraat |
278-636-5 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H360Fd H332 H312 H302 H373** |
GHS08 GHS07 Dgr |
H360Fd H332 H312 H302 H373** |
|
|
|
|
|
015-156-00-5 |
methyl-3-[(dimethoxyfosfinothioyl)oxy]methacrylaat; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyfosfinothioyl)oxy]methacrylaat; |
250-366-9 [1]-[2] |
30864-28-9 [1] 62610-77-9 [2] |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
015-157-00-0 |
fosfonzuur; [1] fosforigzuur [2] |
237-066-7 [1] 233-663-1 [2] |
13598-36-2 [1] 10294-56-1 [2] |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
015-158-00-6 |
(η-cyclopentadiënyl)(η-cumenyl)ijzer(1+)hexafluorofosfaat(1–) |
402-340-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
015-159-00-1 |
hydroxyfosfonoazijnzuur |
405-710-8 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 |
H302 H373 ** H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H314 H317 |
|
|
|
|
|
015-160-00-7 |
vanadylpyrofosfaat |
406-260-5 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
|
015-161-00-2 |
divanadylpyrofosfaat |
407-130-0 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
|
015-162-00-8 |
vanadium(IV)oxidewaterstoffosfaat-hemihydraat, gedoopt met lithium, zink, molybdeen, ijzer en chloor |
407-350-7 |
— |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H373 ** H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H332 H373 ** H318 H411 |
|
|
|
|
015-163-00-3 |
bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylfosfinoxide |
412-010-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
015-164-00-9 |
calcium-P,P'-(1-hydroxyethyleen)bis(waterstoffosfonaat)-dihydraat |
400-480-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
015-165-00-4 |
reactiemassa van: thiobis(4,1-fenyleen)-S,S,S',S'-tetrafenyldisulfoniumbishexafluorofosfaat; difenyl-(4-fenylthiofenyl)sulfoniumhexafluorofosfaat |
404-986-7 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
015-166-00-X |
3,9-bis(2,6-di-tert-butyl-4-methylfenoxy)-2,4,8,10-tetraoxa-3,9-difosfaspiro[5.5]undecaan |
410-290-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
015-167-00-5 |
3-(hydroxyfenylfosfinyl)propaanzuur |
411-200-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
015-168-00-0 |
fosthiazaat (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidine-3-ylthiofosfonaat |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
EUH070 |
|
|
|
|
015-169-00-6 |
tributyltetradecylfosfonium-tetrafluorboraat |
413-520-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H317 H410 |
|
|
|
|
015-170-00-1 |
reactiemassa van: di-(1-octaan-N,N,N-trimethylammonium)-octylfosfaat; 1-octaan-N,N,N-trimethylammonium-dioctylfosfaat; 1-octaan-N,N,N-trimethylammonium-octylphosphaat |
407-490-9 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
015-171-00-7 |
O, O,O-tris(2(of 4)-C9-10-isoalkylfenyl)-thiofosfaat |
406-940-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
015-172-00-2 |
reactiemassa van: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiofosforothionylisopropyl)fosfaat; isotridecylammonium-bis(di-(4-methylpent-2-yloxy)thiofosforothionylisopropyl)fosfaat |
406-240-6 |
— |
Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 |
H226 H314 H411 |
GHS02 GHS05 GHS09 Dgr |
H226 H314 H411 |
|
|
|
|
015-173-00-8 |
methyl-[2-(1,1-dimethylethyl)-6-methoxypirimidine-4-yl]ethylthiofosfonaat |
414-080-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
015-174-00-3 |
1-chloor-N,N-diëthyl-1,1-difenyl-1-(fenylmethyl)fosforamine |
411-370-1 |
Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 2 |
H301 H318 H411 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H411 |
|
|
|
|
|
015-175-00-9 |
tert-butyl-(trifenylfosforanylideen)acetaat |
412-880-7 |
Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H301 H373 ** H319 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H319 H317 H411 |
|
|
|
|
|
015-176-00-4 |
P,P,P',P'-tetrakis-(o-methoxyfenyl)propaan-1,3-difosfine |
413-430-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
015-177-00-X |
((4-fenylbutyl)hydroxyfosforyl)azijnzuur |
412-170-7 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373 ** H318 H317 |
GHS08 GHS05 Dgr |
H373 ** H318 H317 |
|
|
|
|
|
015-178-00-5 |
(R)-α-fenylethylammonium(–)-(1R, 2S)-(1,2-epoxypropyl)fosfonaat-monohydraat |
418-570-8 |
Repr. 2 Aquatic Chronic 2 |
H361f *** H411 |
GHS08 GHS09 Wng |
H361f *** H411 |
|
|
|
|
|
015-179-00-0 |
UVCB-condensatieproduct van: tetrakis-hydroxymethylfosfoniumchloride, ureum en gedestilleerde gehydrogeneerde C16-18-talk-alkylamine |
422-720-8 |
Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H302 H373 ** H314 H317 H410 |
|
|
|
|
|
015-180-00-6 |
[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-fenylbutyl)fosfinyl]-azijnzuur, (–)-cinchonidinezout (1:1) |
415-820-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
015-181-00-1 |
fosfine |
232-260-8 |
Flam. Gas 1 Press. Gas Acute Tox. 1 Skin Corr. 1B Aquatic Acute 1 |
H220 H330 H314 H400 |
GHS02 GHS04 GHS06 GHS05 GHS09 Dgr |
H220 H330 H314 H400 |
|
inademing: ATE = 10 ppmV (gassen) |
U |
|
|
015-182-00-7 |
tetrapropaan-2-yl-(dichloormethaandiyl)bis(fosfonaat) |
430-630-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
015-183-00-2 |
(1-hydroxydodecylideen)difosfonzuur |
425-230-2 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
|
015-184-00-8 |
zouten van glyfosaat, tenzij elders in deze bijlage vermeld |
— |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
A |
|
015-186-00-9 |
chloorpyrifos-methyl (ISO); O, O-dimethyl-O-3,5,6-trichloor-2-pyridylthiofosfaat |
227-011-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 10000 |
|
|
|
015-187-00-4 |
reactiemassa van: tetranatrium(((2-hydroxyethyl)imino)bis(methyleen))bisfosfonaat, N-oxide; trinatrium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazafosforine-4-yl)-methyl)fosfonaat, N-oxide, P-oxide |
417-540-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
▼M8 ————— |
||||||||||
|
015-189-00-5 |
fenylbis(2,4,6-trimethylbenzoyl)-fosfineoxide |
423-340-5 |
Skin Sens. 1A Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
015-190-00-0 |
bis(2,4-dicumylfenyl)neopentyldifosfiet; 3,9-bis[2,4-bis(1-fenyl-1-methylethyl)fenoxy]-2,4,8,10-tetraoxa-3,9-difosfaspiro[5.5]undecaan |
421-920-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
015-191-00-6 |
dodecyldifenylfosfaat |
431-760-5 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
▼M29 ————— |
||||||||||
|
015-193-00-7 |
trifenyl(fenylmethyl)fosfonium-1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butaansulfonamide (1:1) |
442-960-7 |
Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H400 H410 |
GHS05 GHS06 GHS09 Dgr |
H301 H318 H410 |
|
|
|
|
|
015-194-00-2 |
tetrabutylfosfoniumnonafluor-1-butaansulfonaat |
444-440-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
015-195-00-8 |
reactiemassa van: kalium-o-tolueenfosfonaat; kalium-m-tolueenfosfonaat; kalium-p-tolueenfosfonaat |
433-860-4 |
— |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
015-196-00-3 |
reactiemassa van: dimethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat; diëthyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat; methylethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat |
435-960-3 |
— |
Carc. 1B Muta. 1B Skin Sens. 1 |
H350 H340 H317 |
GHS08 GHS07 Dgr |
H350 H340 H317 |
|
|
|
|
015-197-00-9 |
bis(2,4,4-trimethylpentyl)dithiofosfonzuur |
420-160-9 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H302 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H302 H314 H411 |
|
|
|
|
|
015-198-00-4 |
(4-fenylbutyl)fosfinezuur |
420-450-5 |
Carc. 2 Eye Dam. 1 |
H351 H318 |
GHS05 GHS08 Dgr |
H351 H318 |
|
|
|
|
|
015-199-00-X |
tris[2-chloor-1-(chloormethyl)ethyl]fosfaat |
237-159-2 |
Carc. 2 |
H351 |
GSH08 Wng |
H351 |
|
|
|
|
|
015-200-00-3 |
indiumfosfide |
244-959-5 |
Carc. 1B Repr. 2 STOT RE 1 |
H350 H361f H372 (longen) |
GHS08 Dgr |
H350 H361f H372 (longen) |
|
STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % |
|
|
|
015-201-00-9 |
trixylylfosfaat |
246-677-8 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
015-202-00-4 |
tris(nonylfenyl)fosfiet |
247-759-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
015-203-00-X |
difenyl(2,4,6-trimethylbenzoyl)fosfineoxide |
278-355-8 |
Repr. 1B Skin Sens. 1B |
H360Fd H317 |
GHS08 GHS07 Dgr |
H360Fd H317 |
|
|
|
|
|
015-204-00-5 |
benzyl(diëthylamino)difenylfosfonium 4-[1,1,1,3,3,3-hexafluor-2-(4-hydroxyfenyl)propaan-2-yl]fenolaat |
479-100-5 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
015-205-00-0 |
benzyltrifenylfosfonium, zout met 4,4'-[2,2,2-trifluor-1-(trifluormethyl)ethylideen]bis[fenol] (1:1) |
278-305-5 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
015-206-00-6 |
reactiemassa van 4,4'-[2,2,2-trifluor-1-(trifluormethyl)ethylideen]difenol en benzyl(diëthylamino)difenylfosfonium 4-[1,1,1,3,3,3-hexafluor-2-(4-hydroxyfenyl)propaan-2-yl]fenolaat (1:1) |
— |
— |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
015-207-00-1 |
reactiemassa van 4,4'-[2,2,2-trifluor-1-(trifluormethyl)ethylideen]difenol en benzyltrifenylfosfonium, zout met 4,4'-[2,2,2-trifluor-1-(trifluormethyl)ethylideen]difenol (1:1) |
— |
— |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
015-208-00-7 |
dimethylpropylfosfonaat |
242-555-3 |
Muta. 1B Repr. 1B |
H340 H360Df |
GHS08 Dgr |
H340 H360Df |
|
|
|
|
|
016-001-00-4 |
waterstofsulfide |
231-977-3 |
Flam. Gas 1A Press. Gas Acute Tox. 2 Aquatic Acute 1 |
H220 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H220 H330 H400 |
|
inademing: ATE = 440 ppmV (gassen) |
U |
|
|
016-002-00-X |
bariumsulfide |
244-214-4 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
EUH031 |
|
|
|
|
016-003-00-5 |
bariumpolysulfiden |
256-814-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
|
016-004-00-0 |
calciumsulfide |
243-873-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
|
016-005-00-6 |
calciumpolysulfiden |
215-709-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
|
|
016-006-00-1 |
dikaliumsulfide; kaliumsulfide |
215-197-0 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
|
|
016-007-00-7 |
kaliumpolysulfiden |
253-390-1 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
|
|
016-008-00-2 |
ammoniumpolysulfiden |
232-989-1 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
EUH031: C ≥1 % |
|
|
|
016-009-00-8 |
dinatriumsulfide; natriumsulfide |
215-211-5 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H311 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H400 |
|
|
|
|
|
016-010-00-3 |
natriumpolysulfiden |
215-686-9 |
Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
EUH031 |
|
|
|
|
016-011-00-9 |
zwaveldioxide |
231-195-2 |
Press. Gas Acute Tox. 3 STOT SE 1 Skin. Corr. 1B |
H331 H370 (luchtwegen) (inademing) H314 |
GHS04 GHS06 GHS08 GHS05 Dgr |
H331 H370 (luchtwegen) (inademing) H314 |
|
inademing: ATE = 1 000 ppmV (gassen) |
U, 5 |
|
|
016-012-00-4 |
dizwaveldichloride; zwavelmonochloride |
233-036-2 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H301 H332 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H332 H314 H400 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % |
|
|
|
016-013-00-X |
zwaveldichloride |
234-129-0 |
Skin Corr. 1B STOT SE 3 Aquatic Acute 1 |
H314 H335 H400 |
GHS05 GHS07 GHS09 Dgr |
H314 H335 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
|
|
016-014-00-5 |
zwaveltetrachloride |
— |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
|
|
016-015-00-0 |
thionyldichloride; thionylchloride |
231-748-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H332 H302 H314 |
GHS05 GHS07 Dgr |
H332 H302 H314 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % |
|
|
|
016-016-00-6 |
sulfurylchloride |
232-245-6 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
|
016-017-00-1 |
chloorsulfonzuur |
232-234-6 |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
|
|
016-018-00-7 |
fluorsulfonzuur |
232-149-4 |
Acute Tox. 4 * Skin Corr. 1A |
H332 H314 |
GHS05 GHS07 Dgr |
H332 H314 |
|
|
|
|
|
016-019-00-2 |
oleum (rokend zwavelzuur) … % SO3 |
— |
— |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
B |
|
016-020-00-8 |
zwavelzuur … % |
231-639-5 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % |
B |
|
|
016-021-00-3 |
methaanthiol; methylmercaptaan |
200-822-1 |
Flam. Gas. 1 Press. Gas Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H331 H410 |
|
|
U |
|
|
016-022-00-9 |
ethaanthiol; ethylmercaptaan |
200-837-3 |
Flam. Liq. 1 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H224 H331 H302 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H331 H302 H410 |
|
inademing: ATE = 7,1 mg/l (dampen) oraal: ATE = 680 mg/kg lg |
|
|
|
016-023-00-4 |
dimethylsulfaat |
201-058-1 |
Carc. 1B Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H350 H341 H330 H301 H314 H317 |
GHS06 GHS08 GHS05 Dgr |
H350 H341 H330 H301 H314 H317 |
|
Carc. 1B; H350: C ≥ 0,01 % Muta. 2 H341: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 % |
|
|
|
016-024-00-X |
dimexano (ISO); bis(methoxythiocarbonyl)disulfide |
215-993-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
016-025-00-5 |
disul (ISO); 2-(2,4-dichloorfenoxy)ethylwaterstofsulfaat; 2,4-DES |
205-259-5 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H302 H315 H318 |
GHS05 GHS07 Dgr |
H302 H315 H318 |
|
|
|
|
|
016-026-00-0 |
sulfamidezuur; sulfaminezuur; amidosulfonzuur |
226-218-8 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
|
016-027-00-6 |
diëthylsulfaat |
200-589-6 |
Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H340 H332 H312 H302 H314 |
GHS05 GHS08 GHS07 Dgr |
H350 H340 H332 H312 H302 H314 |
|
|
|
|
|
016-028-00-1 |
natriumdithioniet; natriumhydrosulfiet |
231-890-0 |
Self-heat. 1 Acute Tox. 4 * |
H251 H302 |
GHS02 GHS07 Dgr |
H251 H302 |
EUH031 |
|
|
|
|
016-029-00-7 |
p-tolueensulfonzuur, (met meer dan 5 % H2SO4) |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
|
|
016-030-00-2 |
p-tolueensulfonzuur (met ten hoogste 5 % H2SO4) |
203-180-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 20 % |
|
|
|
016-031-00-8 |
tetrahydrothiofeen-1,1-dioxide; sulfolaan |
204-783-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
016-032-00-3 |
1,3-propaansulton; 1,2-oxathiolaan-2,2-dioxide |
214-317-9 |
Carc. 1B Acute Tox. 4 * Acute Tox. 4 * |
H350 H312 H302 |
GHS08 GHS07 Dgr |
H350 H312 H302 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
016-033-00-9 |
dimethylsulfamoylchloride |
236-412-4 |
Carc. 1B Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H330 H312 H302 H314 |
GHS06 GHS05 GHS08 Dgr |
H350 H330 H312 H302 H314 |
|
|
|
|
|
016-034-00-4 |
tetranatrium-3,3'-(piperazine-1,4-diylbis((6-chloor-1,3,5-triazine-4,2-diyl)imino(2-aceetamido)-4,1-fenyleenazo))bis(naftaleen-1,5- disulfonaat) |
400-010-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-035-00-X |
pentanatrium-5-anilino-3-(4-(4-(6-chloor-4-(3-sulfonatoanilino)-1,3,5-triazine-2-ylamino)-2,5-dimethylfenylazo)-2,5-disulfonatofenylazo)-4-hydroxynaftaleen-2,7-disulfonaat |
400-120-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
016-036-00-5 |
tetranatrium-5-(4,6-dichloor-5-cyaanpyrimidine-2-ylamino)-4-hydroxy-2,3-azodinaftaleen-1,2,5,7-disulfonaat |
400-130-1 |
— |
Resp. Sens. 1 Aquatic Chronic 2 |
H334 H411 |
GHS08 GHS09 Dgr |
H334 H411 |
|
|
|
|
016-037-00-0 |
dinatrium-1-amino-4-(4-benzeensulfonamido-3-sulfonatoanilino)antrachinon-2-sulfonaat |
400-350-8 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
016-038-00-6 |
dinatrium-6-((4-chloor-6-(N-methyl)-2-toluïdino)-1,3,5-triazine-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulfonatofenylazo)naftaleen-3-sulfonaat |
400-380-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-039-00-1 |
tetranatrium-2-(6-chloor-4-(4-(2,5-dimethyl-4-(2,5-disulfonatofenylazo)fenylazo)-3-ureïdoanilino)-1,3,5-triazine-2-ylamino)benzeen-1,4-disulfonaat |
400-430-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-040-00-7 |
reactiemassa van dinatrium-6-(2,4-dihydroxyfenylazo)-3-(4-(4-(2,4-dihydroxyfenylazo)anilino)-3-sulfonatofenylazo)-4-hydroxynaftaleen-2-sulfonaat en dinatrium-6-(2,4-diaminofenylazo)-3-(4-(4-(2,4-diaminofenylazo)anilino)-3-sulfonatofenylazo)-4-hydroxynaftaleen-2-sulfonaat en trinatrium-6-(2,4-dihydroxyfenylazo)-3-(4-(4-(7-(2,4-dihydroxyfenylazo)-1-hydroxy-3-sulfonato-2-naftylazo)anilino)-3-sulfonatofenylazo)-4-hydroxynaftaleen-2-sulfonaat |
400-570-4 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
016-041-00-2 |
calcium-2,5-dichloor-4-(4-((5-chloor-4-methyl-2-sulfonatofenyl)azo)-5-hydroxy-3-methylpyrazool-1-yl)benzeensulfonaat |
400-710-4 |
— |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
|
|
016-042-00-8 |
tetranatrium-5-benzamido-3-(5-(4-fluor-6-(1-sulfonato-2-naftylamino)-1,3,5-triazine-2-ylamino)-2-sulfonatofenylazo)-4-hydroxynaftaleen-2,7- disulfonaat |
400-790-0 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
|
016-043-00-3 |
dilithium-6-aceetamido-4-hydroxy-3-(4-((2-sulfonatoöxy)ethylsulfonyl)fenylazo)naftaleen-2-sulfonaat |
401-010-1 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
016-044-00-9 |
dinatrium-S,S-hexaan-1,6-diyldi(thiosulfaat)-dihydraat |
401-320-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
016-045-00-4 |
lithium-natrium-waterstof-4-amino-6-(5-(5-chloor-2,6-difluorpyrimidine-4-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(2-(sulfonatoöxy)ethylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat |
401-560-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-046-00-X |
natriumwaterstofsulfaat |
231-665-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
016-047-00-5 |
hexanatrium-7-(4-(4-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazine-2-ylamino)-2-methylfenylazo)-7-sulfonatonaftylazo)naftaleen-1,3,5- trisulfonaat |
401-650-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-048-00-0 |
natrium-3,5-dichloor-2-(5-cyaan-2,6-bis(3-hydroxypropylamino)-4-methylpyridine-3-ylazo)benzeensulfonaat |
401-870-8 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
016-049-00-6 |
calciumoctadecylxyleensulfonaat |
402-040-8 |
— |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
|
016-050-00-1 |
kaliumnatrium-5-(4-chloor-6-(N-(4-(4-chloor-6-(5-hydroxy-2,7-disulfonato-6-(2-sulfonatofenylazo)-4-naftylamino)-1,3,5-triazine-2-ylamino)fenyl-N-methyl)amino)-1,3,5-triazine-2-ylamino)-4-hydroxy-3-(2-sulfonatofenylazo)naftaleen-2,7-disulfonaat |
402-150-6 |
— |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
016-051-00-7 |
trinatrium-7-(4-(6-fluor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-2-ureïdofenylazo)naftaleen-1,3,6- trisulfonaat |
402-170-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-052-00-2 |
benzyltributylammonium-4-hydroxynaftaleen-1-sulfonaat |
402-240-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
|
016-053-00-8 |
(C16 of C18-n-alkyl)(C16 of C18-n-alkyl)ammonium-2-((C16 of C18-n-alkyl)(C16 of C18-n-alkyl)carbamoyl)benzeensulfonaat |
402-460-1 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
016-054-00-3 |
natrium-4-(2,4,4-trimethylpentylcarbonyloxy)benzeensulfonaat |
400-030-8 |
— |
Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Sens. 1 |
H331 H372 ** H302 H319 H335 H317 |
GHS06 GHS08 Dgr |
H331 H372 ** H302 H319 H335 H317 |
|
|
|
|
016-055-00-9 |
tetranatrium-4-amino-3,6-bis(5-(6-chloor-4-(2-hydroxyethylamino)-1,3,5-triazine-2-ylamino)-2-sulfonatofenylazo)-5-hydroxynaftaleen-2,7-sulfonaat (met > 35 % natriumchloride en natriumacetaat) |
400-510-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
016-056-00-4 |
kaliumwaterstofsulfaat |
231-594-1 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
|
|
016-057-00-X |
styreen-4-sulfonylchloride |
404-770-2 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
|
016-058-00-5 |
thionylchloride, reactieprodukten met 1,3,4-thiadiazool-2,5-dithiol, tert-nonaanthiol en C12-14-tert-alkylamine |
404-820-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
|
016-059-00-0 |
N,N,N',N'-tetramethyldithiobis(ethyleen)diaminedihydrochloride |
405-300-9 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H317 H410 |
|
|
|
|
|
016-060-00-6 |
diammoniumperoxodisulfaat; ammoniumpersulfaat |
231-786-5 |
Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
|
|
016-061-00-1 |
dikaliumperoxodisulfaat; kaliumpersulfaat |
231-781-8 |
Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
|
|
016-062-00-7 |
bensultap (ISO); 1,3-bis(fenylsulfonylthio)-2-(N,N-dimethylamino)propaan |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
016-063-00-2 |
natriummetabisulfiet |
231-673-0 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
EUH031 |
|
|
|
|
016-064-00-8 |
natriumwaterstofsulfiet … %; natriumbisulfiet . . . % |
231-548-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
EUH031 |
|
B |
|
|
016-065-00-3 |
natrium-1-amino-4-[2-methyl-5-(4-methylfenylsulfonylamino)fenylamino]antrachinon-2-sulfonaat |
400-100-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
016-066-00-9 |
tetranatrium-[5-((4-amino-6-chloor-1,3,5-triazine-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatofenylazo)-2-sulfonatobenzylideenhydrazino)benzoaat]koper(II) |
404-070-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
016-067-00-4 |
(4-methylfenyl)mesityleen-sulfonaat |
407-530-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
016-068-00-X |
natrium-3,5-bis(tetradecyloxycarbonyl)benzeensulfinaat |
407-720-8 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
016-069-00-5 |
3,5-bis(tetradecyloxycarbonyl)benzeensulfienzuur |
407-990-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
016-070-00-0 |
4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)difenylsulfon |
408-220-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
016-071-00-6 |
trinatrium-3-amino-6,13-dichloor-10-((3-((4-chloor-6-(2-sulfofenylamino)-1,3,5-triazine-2-yl)amino)propyl)-amino)-4,11-trifenoxydioxazinedisulfonaat |
410-130-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
016-072-00-1 |
3-amino-4-hydroxy-N-(2-methoxyethyl)-benzeensulfonamide |
411-520-6 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
|
016-073-00-7 |
tetrakis(fenylmethyl)thioperoxydi(carbothioamide) |
404-310-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
016-074-00-2 |
6-fluor-2-methyl-3-(4-methylthiobenzyl)indeen |
405-410-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
016-075-00-8 |
2,2'-diallyl-4,4'-sulfonyldifenol |
411-570-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
016-076-00-3 |
2,3-bis((2-mercapto-ethyl)thio)-1-propaanthiol |
411-290-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H410 |
|
|
|
|
|
016-077-00-9 |
2-chloor-p-tolueensulfochloride |
412-890-1 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H314 H317 H412 |
GHS05 GHS07 Dgr |
H314 H317 H412 |
|
|
|
|
|
016-078-00-4 |
4-methyl-N,N-bis(2-(((4-methylfenyl)sulfonyl)amino)ethyl)-benzeensulfonamide |
413-300-5 |
Aquatic Chronic 4 |
H413 |
— |
|
|
|
|
|
|
016-079-00-X |
N,N-bis(2-(p-tolueensulfonyloxy)ethyl)-p-tolueensulfonamide |
412-920-3 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
016-080-00-5 |
natrium-2-anilino-5-(2-nitro-4-(N-fenylsulfamoyl))anilinobenzeensulfonaat |
412-320-1 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
016-081-00-0 |
hexahydrocyclopenta[c]pyrrool-1-(1H)-ammonium-N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide |
418-350-1 |
— |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H302 H319 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H319 H317 H411 |
|
|
|
|
016-082-00-6 |
ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidine-2-yl)-3-(2-ethoxyfenoxysulfonyl)ureum |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
016-083-00-1 |
acibenzolar-S-methyl; benzo[1,2,3]thiadiazool-7-carbothioaat, S-methylester |
420-050-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
|
|
016-084-00-7 |
prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)-3-[2-(3,3,3-trifluorpropyl)fenylsulfonyl]ureum |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=100 |
|
|
|
016-085-00-2 |
flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidine-2-yl)-3-(3-trifluormethyl-2-pyridylsulfonyl)ureum |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
016-086-00-8 |
tetranatrium-10-amino-6,13-dichloor-3-(3-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazine-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentaceen-4,11-disulfonaat |
402-590-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
016-087-00-3 |
reactiemassa van: thiobis(4,1-fenyleen)-S,S,S',S'-tetrafenyldisulfoniumbishexafluorofosfaat; difenyl-(4-fenylthiofenyl)sulfoniumhexafluorofosfaat; propyleencarbonaat |
403-490-8 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H317 H410 |
|
|
|
|
|
016-088-00-9 |
4-(bis(4-(diëthylamino)fenyl)methyl)benzeen-1,2-dimethaansulfonzuur |
407-280-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
016-089-00-4 |
reactiemassa van esters van 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindaan en 2-diazo-1,2-dihydro-1-oxo-5-sulfonaftaleen |
413-840-1 |
— |
Self-react. C **** Aquatic Chronic 4 |
H242 H413 |
GHS02 Dgr |
H242 H413 |
|
|
|
|
016-090-00-X |
4-methyl-N-(methylsulfonyl)benzeensulfonamide |
415-040-8 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
|
|
|
|
016-091-00-5 |
C12-14-tert-alkylammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthraceen-2-sulfonaat |
414-110-5 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
016-092-00-0 |
reactiemassa van: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecaandithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecaandithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecaandithiol |
427-050-1 |
— |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f H315 H317 H410 |
|
|
|
|
016-093-00-6 |
reactiemassa van: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonaat); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonaat) |
414-770-4 |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
|
016-094-00-1 |
zwavel |
231-722-6 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
|
016-095-00-7 |
reactiemassa van: reactieproduct van 4,4'-methyleenbis[2-(4-hydroxybenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxo-naftaleensulfonaat (1:2); reactieproduct van 4,4'-methyleenbis[2-(4-hydroxybenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxo-naftaleensulfonaat (1:3) |
417-980-4 |
— |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
|
016-096-00-2 |
thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazine-2-ylcarbamoylsulfamoyl)thiofeen-2-carboxylaat |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 M = 100 |
|
|
|
016-097-00-8 |
1-amino-2-methyl-2-propaanthiol-hydrochloride |
434-480-1 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H302 H314 H317 H412 |
|
|
|
|
|
016-098-00-3 |
dimethyldisulfide |
210-871-0 |
Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 STOT SE 3 STOT SE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H331 H301 H336 H370 (bovenste luchtwegen, inademing) H319 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H331 H301 H336 H370 (bovenste luchtwegen, inademing) H319 H317 H410 |
|
inademing: ATE = 5 mg/l (dampen) oraal: ATE = 190 mg/kg lichaamsgewicht M = 1 M = 10 |
|
|
|
017-001-00-7 |
chloor |
231-959-5 |
Ox. Gas 1 Press. Gas Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H270 H331 H319 H335 H315 H400 |
GHS03 GHS04 GHS06 GHS09 Dgr |
H270 H331 H319 H335 H315 H400 |
|
M = 100 |
U |
|
|
017-002-00-2 |
waterstofchloride |
231-595-7 |
Press. Gas Acute Tox. 3 * Skin Corr. 1A |
H331 H314 |
GHS04 GHS06 GHS05 Dgr |
H331 H314 |
|
|
U5 |
|
|
017-002-01-X |
zoutzuur … % |
231-595-7 |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % EyeIrrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B |
|
017-003-00-8 |
bariumchloraat |
236-760-7 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H332 H302 H411 |
|
|
|
|
|
017-004-00-3 |
kaliumchloraat |
223-289-7 |
Ox. Sol. 1 Acute Tox. 3 |
H271 H301 |
GHS03 GHS06 Dgr |
H271 H301 |
|
oraal: ATE = 100 mg/kg lg |
|
|
|
017-005-00-9 |
natriumchloraat |
231-887-4 |
Ox. Sol. 1 Acute Tox. 3 |
H271 H301 |
GHS03 GHS06 Dgr |
H271 H301 |
|
oraal: ATE = 100 mg/kg lg |
|
|
|
017-006-00-4 |
perchloorzuur … % |
231-512-4 |
Ox. Liq. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % Skin Irrit. 2; H315: 1 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 10 % Ox. Liq. 1; H271: C > 50 %: Ox. Liq. 2; H272: C ≤ 50 %: |
B |
|
|
017-007-00-X |
bariumperchloraat |
236-710-4 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * |
H271 H332 H302 |
GHS03 GHS07 Dgr |
H271 H332 H302 |
|
|
|
|
|
017-008-00-5 |
kaliumperchloraat |
231-912-9 |
Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
|
|
017-009-00-0 |
ammoniumperchloraat |
232-235-1 |
Expl. 1.1 Ox. Sol. 1 |
H201 H271 |
GHS01 Dgr |
H201 H271 |
|
|
T |
|
|
017-010-00-6 |
natriumperchloraat |
231-511-9 |
Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
|
|
017-011-00-1 |
natriumhypochloriet, oplossing … % actief Cl |
231-668-3 |
Skin Corr. 1B Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H318 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
EUH031 |
M = 10 M = 1 EUH031: C ≥ 5 % |
B |
|
|
017-012-00-7 |
calciumhypochloriet |
231-908-7 |
Ox. Sol. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H272 H302 H314 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H400 |
EUH031 |
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3 % M = 10 |
T |
|
|
017-013-00-2 |
calciumchloride |
233-140-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
017-014-00-8 |
ammoniumchloride |
235-186-4 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
017-015-00-3 |
(2-(aminomethyl)fenyl)acetylchloride-hydrochloride |
417-410-4 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
|
017-016-00-9 |
methyltrifenylfosfoniumchloride |
418-400-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H411 |
|
|
|
|
|
017-017-00-4 |
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methylammoniumchloride |
426-210-6 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
|
017-018-00-X |
N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammoniumchloride |
405-660-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
017-019-00-5 |
(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisochinolinehydrochloride |
415-110-8 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
017-020-00-0 |
ethylpropoxyaluminiumchloride |
421-790-7 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
017-021-00-6 |
beheenamidopropyl-dimethyl-(dihydroxypropyl) ammoniumchloride |
423-420-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
|
017-023-00-7 |
[fosfinylidyntris(oxy)]-tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl]-trichloriden |
425-520-9 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
017-026-00-3 |
chloordioxide |
233-162-8 |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H270 H330 H314 H400 |
GHS04 GHS03 GHS06 GHS05 GHS09 Dgr |
H270 H330 H314 H400 |
|
M = 10 |
5 |
|
|
017-026-01-0 |
chloordioxide … % |
233-162-8 |
Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
|
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3 % STOT SE 3; H335: C ≥ 3 % M = 10 |
B |
|
|
019-001-00-2 |
kalium |
231-119-8 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
|
|
019-002-00-8 |
kaliumhydroxide; bijtende potas |
215-181-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % |
|
|
|
019-003-00-3 |
kalium-(E,E)-hexa-2,4-dienoaat |
246-376-1 |
Oogirrit. 2 |
H319 |
GSH07 Wng |
H319 |
|
|
|
|
|
020-001-00-X |
calcium |
231-179-5 |
Water-react. 2 |
H261 |
GHS02 Dgr |
H261 |
|
|
|
|
|
020-002-00-5 |
calciumcyanide |
209-740-0 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
EUH032 |
|
|
|
|
020-003-00-0 |
reactiemassa van: dicalcium-(bis(2-hydroxy-5-tetrapropenylfenylmethyl)methylamine)dihydroxide; tricalcium-(tris(2-hydroxy-5-tetrapropenylfenylmethyl)methylamine)trihydroxide; poly[calcium-((2-hydroxy-5-tetrapropenylfenylmethyl)methylamine)hydroxide] |
420-470-4 |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
022-001-00-5 |
titaantetrachloride |
231-441-9 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
EUH014 |
|
|
|
|
022-002-00-0 |
titaan(4+)oxalaat |
403-260-7 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
022-003-00-6 |
bis(η5-cyclopentadiënyl)-bis(2,6-difluor-3-[pyrrool-1-yl]-phenyl)titaan |
412-000-1 |
Flam. Sol. 1 Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H228 H361f *** H373 ** H411 |
GHS02 GHS08 GHS09 Dgr |
H228 H361f *** H373 ** H411 |
|
|
T |
|
|
022-004-00-1 |
kaliumtitaanoxide (K2Ti6O13) |
432-240-0 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
022-005-00-7 |
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadieen-1-yl]silanaminato(2–)-κN][1,2,3,4-η)-1,3-pentadieen]-titaan |
419-840-8 |
Flam. Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H228 H314 H317 H413 |
GHS02 GHS05 GHS07 Dgr |
H228 H314 H317 H413 |
|
|
|
|
|
►C12 022-006-00-2 ◄ |
titaniumdioxide; [in poedervorm, bevattend: 1 % of meer deeltjes met een aërodynamische diameter ≤ 10 μm] |
236-675-5 |
Carc. 2 |
H351 (inademing) |
GHS08 Wng |
H351 (inademing) |
|
|
V, W, 10 |
|
|
023-001-00-8 |
divanadiumpentaoxide; vanadiumpentaoxide |
215-239-8 |
Muta. 2 Carc. 1B Repr. 2 Lact. Acute Tox. 3 Acute Tox. 2 STOT SE 3 STOT RE 1 Aquatic Chronic 2 |
H341 H350 H361fd H362 H301 H330 H335 H372 (ademhalingswegen, inademing) H411 |
GHS06 GHS08 GHS09 Dgr |
H341 H350 H361fd H362 H301 H330 H335 H372 (ademhalingswegen, inademing) H411 |
|
inademing: ATE = 0,05 mg/L (stofdeeltjes of nevels) oraal: ATE = 220 mg/kg lg |
|
|
|
024-001-00-0 |
chroom(VI)oxide |
215-607-8 |
Ox. Sol. 1 Carc. 1A Muta. 1B Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 1 % |
|
|
|
024-002-00-6 |
kaliumdichromaat |
231-906-6 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
3 |
|
|
024-003-00-1 |
ammoniumdichromaat |
232-143-1 |
Ox. Sol. 2 **** Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5 % Resp. Sens.; H334: C ≥0,2 % Skin Sens.; H317:C ≥0,2 % |
G3 |
|
|
024-004-00-7 |
natriumdichromaat |
234-190-3 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS05 GHS08 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H410 |
|
Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317:C ≥0,2 % STOT SE 3; H335: C ≥ 5 % |
3 |
|
|
▼M1 ————— |
||||||||||
|
024-005-00-2 |
chromyldichloride; chroomoxychloride |
239-056-8 |
Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350i H340 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350i H340 H314 H317 H410 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: 0,5 % ≤ C < 5 % Skin Sens. 1; H317: C ≥ 0,5 % |
T3 |
|
|
024-006-00-8 |
kaliumchromaat |
232-140-5 |
Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H340 H319 H335 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H340 H319 H335 H315 H317 H410 |
|
Skin Sens. 1; H317:C ≥ 0,5 % |
3 |
|
|
024-007-00-3 |
zinkchromaat met inbegrip van zinkkaliumchromaat |
— |
— |
Carc. 1A Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H410 |
|
|
A |
|
024-008-00-9 |
calciumchromaat |
237-366-8 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
|
|
024-009-00-4 |
strontiumchromaat |
232-142-6 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H400 H410 |
|
|
|
|
|
024-010-00-X |
dichroomtris(chromaat); chroom(III)chromaat; chromichromaat |
246-356-2 |
Ox. Sol. 1 Carc. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350 H314 H317 H410 |
|
|
T |
|
|
024-011-00-5 |
ammoniumbis(1-(3,5-dinitro-2-oxidofenylazo)-3-(N-fenylcarbamoyl)-2-naftolato)chromaat(1–) |
400-110-2 |
Self-react. C **** Aquatic Acute 1 Aquatic Chronic 1 |
H242 H400 H410 |
GHS02 GHS09 Dgr |
H242 H410 |
|
|
|
|
|
024-012-00-0 |
trinatriumbis(7-aceetamido-2-(4-nitro-2-oxidofenylazo)-3-sulfonato-1-naftolato)chromaat(1–) |
400-810-8 |
— |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
|
024-013-00-6 |
trinatrium-(6-anilino-2-(5-nitro-2-oxidofenylazo)-3-sulfonato-1-naftolato)(4-sulfonato-1,1'-azodi-2,2'naftolato)chromaat(1–) |
402-500-8 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
024-014-00-1 |
trinatriumbis(2-(5-chloor-4-nitro-2-oxidofenylazo)-5-sulfonato-1-naftolato)chromaat(1–) |
402-870-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
024-015-00-7 |
dinatrium(3-methyl-4-(5-nitro-2-oxidofenylazo)-1-fenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatofenylazo)-2-naftolato)chromaat(1–) |
404-930-1 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H318 H411 |
|
|
|
|
024-016-00-2 |
tetradecylammoniumbis(1-(5-chloor-2-oxidofenylazo)-2-naftolato)chromaat(1–) |
405-110-6 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
|
|
024-017-00-8 |
chroom(VI)verbindingen met uitzondering van bariumchromaat en van elders in deze bijlage vermelde verbindingen |
— |
— |
Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H317 H410 |
|
|
A |
|
024-018-00-3 |
natriumchromaat |
231-889-5 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317:C ≥ 0,2 % |
3 |
|
|
024-019-00-9 |
hoofdbestanddeel: acetoazijnzuuranilide / 3-amino-1-hydroxybenzeen (ATAN-MAP): trinatrium {6-[(2 of 3 of 4)-amino-(4 of 5 of 6)-hydroxyfenylazo]-5'-(fenylsulfamoyl)-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato}-{6''-[1-(fenylcarbamoyl)ethylazo]-5'-(fenylsulfamoyl)-3-sulfonatonaftaleen-2-azobenzeen-1'',2'''-diolato}chromaat(III); bijproduct 1: acetoazijnzuuranilide / acetoazijnzuuranilide (ATAN-ATAN): trinatrium-bis{6-[1-(fenylcarbamoyl)ethylazo]-5'''-(fenylsulfonyl)-3''-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato}chromaat(III); bijproduct 2: 3-amino-1-hydroxybenzeen / 3-amino-1-hydroxybenzeen (MAP-MAP): trinatrium-bis{6-[(2 of 3 of 4)-amino-(4 of 5 of 6)-hydroxyfenylazo]-5'-(fenylsulfamoyl)-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato}chromaat (III) |
419-230-1 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
024-020-00-4 |
trinatrium-bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naftylazo)fenylsulfonylamino]pyrimidine-5-azo)benzeen-2',4-diolato)]chromaat(III) |
418-220-4 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
024-021-00-X |
kaliumtetranatriumbis[(N,N'-n)-1'-(fenylcarbamoyl)-3,5-disulfonatobenzeenazo-1'-prop-1'-een-2,2'-diolato]chromaat(III) |
425-830-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
025-001-00-3 |
mangaandioxide |
215-202-6 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
|
|
025-002-00-9 |
kaliumpermanganaat |
231-760-3 |
Ox. Sol. 2 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H272 H361d H302 H400 H410 |
GHS03 GHS08 GHS07 GHS09 Dgr |
H272 H361d H302 H410 |
|
|
|
|
|
025-003-00-4 |
mangaansulfaat |
232-089-9 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
|
|
025-004-00-X |
bis(N,N',N''-trimethyl-1,4,7-triazacyclononaan)-trioxo-dimangaan(IV)di(hexafluorofosfaat)-monohydraat |
411-760-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
025-005-00-5 |
reactiemassa van: trinatrium[29H,31H-ftalocyanine-C, C,C-trisulfonato(6–)-N 29,N 30,N 31,N 32]manganaat(3–); tetranatrium[29H,31H-ftalocyanine-C, C,C, C-tetrasulfonato(6–)-N 29,N 30,N 31,N 32]manganaat(3–); pentanatrium[29H,31H-ftalocyanine-C, C,C, C,C-pentasulfonato(6–)-N 29,N 30,N 31,N 32]manganaat(3–) |
417-660-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
026-001-00-6 |
(η-cumeen)-(η-cyclopentadiënyl)ijzer(II)-hexafluorantimonaat |
407-840-0 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
026-002-00-1 |
(η-cumeen)-(η-cyclopentadiënyl)ijzer(II)-trifluormethaan-sulfonaat |
407-880-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
026-003-00-7 |
ijzer(II)sulfaat |
231-753-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
026-003-01-4 |
ijzer(II)sulfaat (1:1)-heptahydraat; zwavelzuur, ijzer(II)zout (1:1), heptahydraat; ijzersulfaat-heptahydraat |
231-753-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
Skin Irrit.2; H315: C ≥ 25 % |
|
|
|
026-004-00-2 |
kaliumferriet |
430-010-4 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
|
027-001-00-9 |
kobalt |
231-158-0 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 |
H350 H341 H360F H334 H317 H413 |
GHS08 Dgr |
H350 H341 H360F H334 H317 H413 |
|
|
|
|
|
027-002-00-4 |
kobaltoxide |
215-154-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=10 |
|
|
|
027-003-00-X |
kobaltsulfide |
215-273-3 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
|
|
027-004-00-5 |
kobaltdichloride |
231-589-4 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
|
027-005-00-0 |
kobaltsulfaat |
233-334-2 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
|
027-006-00-6 |
kobaltdi(acetaat) |
200-755-8 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
|
|
027-007-00-1 |
zinkhexacyaankobaltaat(III), complex met tert-butylalcohol/polypropyleenglycol |
425-240-7 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
027-008-00-7 |
complex van kobalt(III)-bis(N-fenyl-4-(5-ethylsulfonyl-2-hydroxyfenylazo)-3-hydroxynaftylamide), gehydrateerd (n H2O, 2 <n <3) |
427-390-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
027-009-00-2 |
kobaltdinitraat |
233-402-1 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
|
|
027-010-00-8 |
kobaltcarbonaat |
208-169-4 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
|
|
028-001-00-1 |
tetracarbonylnikkel; nikkeltetracarbonyl |
236-669-2 |
Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H351 H360D *** H330 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H351 H360D *** H330 H410 |
|
|
|
|
|
028-002-00-7 |
nikkel |
231-111-4 |
Carc. 2 STOT RE 1 Skin Sens. 1 |
H351 H372** H317 |
GHS08 GHS07 Dgr |
H351 H372** H317 |
|
|
S7 |
|
|
028-002-01-4 |
nikkelpoeder; [deeltjes met diameter < 1 mm] |
231-111-4 |
Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H351 H372** H317 H412 |
GHS08 GHS07 Dgr |
H351 H372** H317 H412 |
|
|
|
|
|
028-003-00-2 |
nikkelmonoxide; [1] nikkeloxide; [2] bunseniet [3] |
215-215-7[1] 234-323-5[2]-[3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
028-004-00-8 |
nikkeldioxide |
234-823-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
|
028-005-00-3 |
dinikkeltrioxide |
215-217-8 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
|
|
028-006-00-9 |
nikkel(II)sulfide; [1] nikkelsulfide; [2] milleriet [3] |
240-841-2[1] 234-349-7[2]-[3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H372** H317 H410 |
|
|
|
|
028-007-00-4 |
trinikkeldisulfide; nikkelsubsulfide; [1] heazlewoodiet [2] |
234-829-6 [1] — [2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. 1A Muta. 2 Acute Tox. 3 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H331 H372** H317 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H350i H341 H331 H372** H317 H410 |
|
inademing: ATE = 0,92 mg/l (stofdeeltjes of nevels) |
|
|
028-008-00-X |
nikkeldihydroxide; [1] nikkelhydroxide [2] |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. 1A Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H410 |
|
|
|
|
028-009-00-5 |
nikkelsulfaat |
232-104-9 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
|
028-010-00-0 |
nikkelcarbonaat; basisch nikkelcarbonaat; koolzuur, nikkel(2+)zout; [1] koolzuur, nikkelzout; [2] [μ-[carbonato(2–)-O:O']]dihydroxytrinikkel; [3] [carbonato(2–)] tetrahydroxytrinikkel [4] |
222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] |
3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
|
|
|
028-011-00-6 |
nikkeldichloride |
231-743-0 |
Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
|
028-012-00-1 |
nikkeldinitraat; [1] salpeterzuur, nikkelzout [2] |
236-068-5 [1] 238-076-4 [2] |
13138-45-9 [1] 14216-75-2 [2] |
Ox. Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H400 H410 |
GHS03 GHS05 GHS08 GHS07 GHS09 Dgr |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317 C ≥0,01 % M = 1 |
|
|
028-013-00-7 |
nikkelmatte |
273-749-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-014-00-2 |
afvalslik en bezinksel, elektrolytische koperzuivering, ontkoperd, nikkelsulfaat |
295-859-3 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
|
028-015-00-8 |
afvalslik en bezinksel, elektrolytische koperzuivering, ontkoperd |
305-433-1 |
Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
|
|
|
|
028-016-00-3 |
nikkeldiperchloraat; perchloorzuur, nikkel(II)zout |
237-124-1 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
|
028-017-00-9 |
dikaliumnikkelbis(sulfaat); [1] diammoniumnikkelbis(sulfaat) [2] |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
028-018-00-4 |
nikkelbis(sulfamidaat); nikkelsulfamaat |
237-396-1 |
Carc. 1A Muta. 2 Repr. 1B Acute Tox. 4 STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H302 H372** H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H302 H372** H334 H317 H410 |
|
oraal: ATE = 853 mg/kg lichaamsgewicht (anhydraat) oraal: ATE = 1 098 mg/kg lichaamsgewicht (tetrahydraat) STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
|
|
028-019-00-X |
nikkelbis(tetrafluorboraat) |
238-753-4 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
|
|
028-021-00-0 |
nikkeldiformiaat; [1] mierenzuur, nikkelzout; [2] mierenzuur, kopernikkelzout [3] |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
|
028-022-00-6 |
nikkeldi(acetaat); [1] nikkelacetaat [2] |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M = 1 |
|
|
028-024-00-7 |
nikkeldibenzoaat |
209-046-8 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M=1 |
|
|
|
028-025-00-2 |
nikkelbis(4-cyclohexylbutyraat) |
223-463-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
|
|
028-026-00-8 |
nikkel(II)stearaat; nikkel(II)octadecanoaat |
218-744-1 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C;≥0,01 % M=1 |
|
|
|
028-027-00-3 |
nikkeldilactaat |
— |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
|
028-028-00-9 |
nikkel(II)octanoaat |
225-656-7 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
|
028-029-00-4 |
nikkeldifluoride; [1] nikkeldibromide; [2] nikkeldijodide; [3] nikkelkaliumfluoride [4] |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] -[4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
|
028-030-00-X |
nikkelhexafluorosilicaat |
247-430-7 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
|
|
028-031-00-5 |
nikkelselenaat |
239-125-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
|
028-032-00-0 |
nikkelwaterstoffosfaat; [1] nikkelbis(diwaterstoffosfaat); [2] trinikkelbis(orthofosfaat); [3] dinikkeldifosfaat; [4] nikkelbis(fosfinaat); [5] nikkelfosfinaat; [6] fosforzuur, calciumnikkelzout; [7] difosforzuur, nikkel(II)zout [8] |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] -[7] -[8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-033-00-6 |
diammoniumnikkelhexacyanoferraat |
— |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
|
028-034-00-1 |
nikkeldicyanide |
209-160-8 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
EUH032 |
|
|
|
|
028-035-00-7 |
nikkelchromaat |
238-766-5 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
|
028-036-00-2 |
nikkel(II)silicaat; [1] dinikkelorthosilicaat; [2] nikkelsilicaat(3:4); [3] kiezelzuur, nikkelzout; [4] triwaterstofhydroxybis[orthosilicato(4–)]trinikkelaat(3–) [5] |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-037-00-8 |
dinikkelhexacyanoferraat |
238-946-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-038-00-3 |
trinikkelbis(arsenaat); nikkel(II)arsenaat |
236-771-7 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H372** H317 H410 |
|
|
|
|
|
028-039-00-9 |
nikkeloxalaat; [1] oxaalzuur, nikkelzout [2] |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-040-00-4 |
nikkeltelluride |
235-260-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-041-00-X |
trinikkeltetrasulfide |
— |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-042-00-5 |
trinikkelbis(arseniet) |
— |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-043-00-0 |
kobaltnikkel grijze periklaas; C.I. Pigment Black 25; C.I. 77332; [1] kobaltnikkeldioxide; [2] kobaltnikkeloxide [3] |
269-051-6 [1] 261-346-8 [2] -[3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-044-00-6 |
nikkeltintrioxide; nikkelstannaat |
234-824-9 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
|
028-045-00-1 |
nikkeltriuraandecaoxide |
239-876-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
|
028-046-00-7 |
nikkeldithiocyanaat |
237-205-1 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
EUH032 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
|
028-047-00-2 |
nikkeldichromaat |
239-646-5 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
|
|
028-048-00-8 |
nikkel(II)seleniet |
233-263-7 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
|
028-049-00-3 |
nikkelselenide |
215-216-2 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
|
028-050-00-9 |
kiezelzuur, loodnikkelzout |
— |
Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360Df H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360Df H372** H317 H410 |
|
|
|
|
|
028-051-00-4 |
nikkeldiarsenide; [1] nikkelarsenide [2] |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-052-00-X |
nikkelbariumtitaan lichtgeel prideriet; C.I. Pigment Yellow 157; C.I. 77900 |
271-853-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
|
028-053-00-5 |
nikkeldichloraat; [1] nikkeldibromaat; [2] ethylwaterstofsulfaat, nikkel(II)zout [3] |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < % Skin Sens. 1; H317:C≥0,01 %1 M=1 |
|
|
028-054-00-0 |
nikkel(II)trifluoracetaat; [1] nikkel(II)propionaat; [2] nikkelbis(benzeensulfonaat); [3] nikkel(II)hydrogeencitraat; [4] citroenzuur, ammoniumnikkelzout; [5] citroenzuur, nikkelzout; [6] nikkelbis(2-ethylhexanoaat); [7] 2-ethylhexaanzuur, nikkelzout; [8] dimethylhexaanzuur, nikkelzout; [9] nikkel(II)isoöctanoaat; [10] nikkelisoöctanoaat; [11] nikkelbis(isononanoaat); [12] nikkel(II)neononanoaat; [13] nikkel(II)isodecanoaat; [14] nikkel(II)neodecanoaat; [15] neodecaanzuur, nikkelzout; [16] nikkel(II)neoündecanoaat; [17] bis(D-gluconato-O 1,O 2)nikkel; [18] nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoaat (1:2); [19] nikkel(II)palmitaat; [20] (2-ethylhexanoato-O)(isononanoato-O)nikkel; [21] (isononanoato-O)(isoöctanoato-O)nikkel; [22] (isoöctanoato-O)(neodecanoato-O)nikkel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24] 2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25] (isodecanoato-O)(isoöctanoato-O)nikkel; [26] (isodecanoato-O)(isononanoato-O)nikkel; [27] (isononanoato-O)(neodecanoato-O)nikkel; [28] vetzuren, C6-19-vertakte, nikkelzouten; [29] vetzuren, C8-18- en C18-onverzadigd, nikkelzouten; [30] 2,7-naftaleendisulfonzuur, nikkel(II)zout; [31] |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 294-302-1 [29] 283-972-0 [30] -[31] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
|
028-055-00-6 |
nikkel(II)sulfiet; [1] nikkeltelluurtrioxide; [2] nikkeltelluurtetraoxide; [3] molybdeennikkelhydroxideoxidefosfaat [4] |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
|
028-056-00-1 |
nikkelboride (NiB); [1] dinikkelboride; [2] trinikkelboride; [3] nikkelboride; [4] dinikkelsilicide; [5] nikkeldisilicide; [6] dinikkelfosfide; [7] nikkelboorfosfide [8] |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] -[8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
|
028-057-00-7 |
dialuminiumnikkeltetraoxide; [1] nikkeltitaantrioxide; [2] nikkeltitaanoxide; [3] nikkeldivanadiumhexaoxide; [4] kobaltdimolybdeennikkeloctaoxide; [5] nikkelzirkoniumtrioxide; [6] molybdeennikkeltetraoxide; [7] nikkelwolfraamtetraoxide; [8] olivijn, nikkelgroen; [9] lithiumnikkeldioxide; [10] molybdeennikkeloxide; [11] |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] -[10] -[11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
|
028-058-00-2 |
kobaltlithiumnikkeloxide |
442-750-5 |
— |
Carc. 1A Acute Tox. 2 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H330 H372** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H372** H317 H410 |
|
|
|
|
029-001-00-4 |
koperchloride; koper(I)chloride; kopermonochloride |
231-842-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
|
|
029-002-00-X |
dikoperoxide; koper(I)oxide |
215-270-7 |
Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H332 H302 H318 H410 |
|
inademing: ATE = 3,34 mg/l (stofdeeltjes of nevels) oraal: ATE = 500 mg/kg lichaamsgewicht M = 100 M = 10 |
|
|
|
029-003-00-5 |
nafteenzuur, koperzouten; kopernaftenaat |
215-657-0 |
Flam. Liq. 3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H302 H410 |
|
|
|
|
|
029-004-00-0 |
kopersulfaat |
231-847-6 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
|
029-005-00-6 |
(tris(chloormetil)ftalocyaninato)koper(II), reactieprodukten met N-methylpiperazine en methoxyazijnzuur |
401-260-1 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
029-006-00-1 |
tris(octadec-9-enylammonium)-(trisulfonatoftalocyaninato)koper(II) |
403-210-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
029-007-00-7 |
(trinatrium-(2-((3-(6-(2-chloor-5-sulfonato)anilino-4-(3-carboxypyridinio)-1,3,5-triazine-2-ylamino)-2-oxido-5-sulfonatofenylazo)fenylmethylazo)-4-sulfonatobenzoato)koper(3–))hydroxide |
404-670-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
G |
|
|
029-008-00-2 |
koper(II)methaansulfonaat |
405-400-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
|
|
029-009-00-8 |
ftalocyanine-N-[3-(diëthylamino)propyl]sulfonamide-kopercomplex |
413-650-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
029-010-00-3 |
reactiemassa van verbindingen van (dodecakis(p-tolylthio)ftalocyaninato)koper(II) tot en met (hexadecakis(p-tolylthio)ftalocyaninato)koper(II) |
407-700-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
029-011-00-9 |
natrium[29H,31H-ftalocyaninato-(2–)-N 29,N 30,N 31,N 32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonaat, kopercomplex |
412-730-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
029-012-00-4 |
natrium-((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatoftalocyaninato)koper(II) |
407-340-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
029-013-00-X |
trinatrium-(2-(α-(3-(4-chloor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-2-oxido-5-sulfonatofenylazo)benzylideenhydrazino)-4-sulfonatobenzoato)koper(II) |
407-580-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
029-014-00-5 |
reactiemassa van: 2,2'-[[cis-1,2-cyclohexaandiylbis(nitrilomethylideen)]bis[fenolaat]](2–)N,N',O,O'-kopercomplex; 2,2'-[[trans-1,2-cyclohexaandiylbis(nitrilomethylidyn)]bis[fenolaat]](2–)N,N',O,O'-kopercomplex |
419-610-7 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
|
029-015-00-0 |
koperthiocyanaat |
214-183-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
EUH032 |
M = 10 M = 10 |
|
|
|
029-016-00-6 |
koper(II)oxide |
215-269-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 M = 10 |
|
|
|
029-017-00-1 |
dikoperchloridetrihydroxide |
215-572-9 |
Acute Tox. 4 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H301 H400 H410 |
GHS06 GHS09 Dgr |
H332 H301 H410 |
|
inademing: ATE = 2,83 mg/l (stofdeeltjes of nevels) oraal: ATE = 299 mg/kg lichaamsgewicht M = 10 M = 10 |
|
|
|
029-018-00-7 |
tetrakoperhexahydroxidesulfaat; [1] tetrakoperhexahydroxidesulfaathydraat [2] |
215-582-3 [1] 215-582-3 [2] |
1333-22-8 [1] 12527-76-3 [2] |
Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
oraal: ATE = 500 mg/kg lichaamsgewicht M = 10 M = 10 |
|
|
029-019-01-X |
koperschilfers (gecoat met alifatisch zuur) |
|
|
Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H319 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H319 H410 |
|
inademing: ATE = 0,733 mg/l (stofdeeltjes of nevels) oraal: ATE = 500 mg/kg lg M = 10 M = 1 |
|
|
029-020-00-8 |
koper(II)carbonaat--koper(II)hydroxide (1:1) |
235-113-6 |
Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H319 H410 |
|
inademing: ATE = 1,2 mg/l (stofdeeltjes of nevels) oraal: ATE = 500 mg/kg lichaamsgewicht M = 10 M = 10 |
|
|
|
029-021-00-3 |
koperdihydroxide; koper(II)hydroxide |
243-815-9 |
Acute Tox. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H302 H318 H410 |
|
inademing: ATE = 0,47 mg/l (stofdeeltjes of nevels) oraal: ATE = 500 mg/kg lichaamsgewicht M = 10 M = 10 |
|
|
|
029-022-00-9 |
Bordeauxse pap; reactieproducten van kopersulfaat met calciumdihydroxide |
— |
Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H332 H318 H410 |
|
inademing: ATE = 1,97 mg/l (stofdeeltjes of nevels) M = 10 M = 1 |
|
|
|
029-023-00-4 |
kopersulfaat-pentahydraat |
231-847-6 |
Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H302 H318 H410 |
|
oraal: ATE = 481 mg/kg lichaamsgewicht M = 10 M = 1 |
|
|
|
▼M36 ————— |
||||||||||
|
029-025-00-5 |
bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O’)koper; bis(N-cyclohexyldiazeniumdioxy)koper; [Cu-HDO] |
239-703-4 |
Flam. Sol. 1 Acute Tox. 4 STOT RE 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H373 (lever) H318 H400 H410 |
GHS02 GHS07 GHS08 GHS05 GHS09 Dgr |
H228 H302 H373 (lever) H318 H410 |
|
oraal: ATE = 360 mg/kg lichaamsgewicht M = 1 M = 1 |
|
|
|
029-026-00-0 |
koper; [specifieke oppervlakte > 0,67 mm2/mg] |
231-159-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 10 M = 1 |
|
|
|
030-001-00-1 |
zinkpoeder — zinkstof (pyrofoor) |
231-175-3 |
Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H400 H410 |
GHS02 GHS09 Dgr |
H260 H250 H410 |
|
|
T |
|
|
030-001-01-9 |
zinkpoeder — zinkstof (gestabiliseerd) |
231-175-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
030-003-00-2 |
zinkchloride |
231-592-0 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
030-004-00-8 |
dimethylzink; [1] diëthylzink [2] |
208-884-1 [1] 209-161-3 [2] |
544-97-8 [1] 557-20-0 [2] |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H260 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H260 H314 H410 |
EUH014 |
|
|
|
030-005-00-3 |
diamminediisocyanatozink |
401-610-3 |
— |
Acute Tox. 4 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 |
H302 H318 H334 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H318 H334 H317 H400 |
|
|
|
|
030-006-00-9 |
zinksulfaat (gehydrateerd) (mono-, hexa- en heptahydraat); [1] zinksulfaat (watervrij) [2] |
231-793-3 [1] 231-793-3 [2] |
7446-19-7 [1] 7733-02-0 [2] |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
|
030-007-00-4 |
bis(3,5-di-tert-butylsalicylato-O 1,O 2)zink |
403-360-0 |
Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
|
|
030-008-00-X |
hydroxo(2-(benzeensulfonamido)benzoato)zink(II) |
403-750-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
|
030-009-00-5 |
zink-bis(4-(n-octyloxycarbonylamino)salicylaat)-dihydraat |
417-130-2 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
030-010-00-0 |
2-dodec-1-enylbutaandizuur, 4-methylester zinkzout |
430-740-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
030-011-00-6 |
trizinkbis(orthofosfaat) |
231-944-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
030-012-00-1 |
aluminium-magnesium-zink-carbonaat-hydroxide |
423-570-6 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
|
030-013-00-7 |
zinkoxide |
215-222-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
030-015-00-8 |
tetrazink(2+)bis(hexacyanokobalt(3+))diacetaat |
440-060-9 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
031-001-00-4 |
galliumarsenide |
215-114-8 |
Repr. 1B Carc. 1B STOT RE 1 |
H360F H350 H372 (ademhalingssysteem en hematopoëtisch systeem) |
GHS08 Dgr |
H360F H350 H372 (ademhalingssysteem en hematopoëtisch systeem) |
|
|
|
|
|
033-001-00-X |
arseen |
231-148-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
|
|
033-002-00-5 |
arseenverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
* |
A1 |
|
033-003-00-0 |
diarseentrioxide; arseentrioxide |
215-481-4 |
Carc. 1A Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H300 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H300 H314 H410 |
|
|
|
|
|
033-004-00-6 |
diarseenpentaoxide; arseenpentaoxide; arseenoxide |
215-116-9 |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
|
|
033-005-00-1 |
arseenzuur en zouten daarvan, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
A |
|
033-006-00-7 |
arsine |
232-066-3 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H330 H373 ** H400 H410 |
GHS02 GHS04 GHS06 GHS08 GHS09 Dgr |
H220 H330 H373 ** H410 |
|
|
U |
|
|
033-007-00-2 |
tert-butylarsine |
423-320-6 |
Pyr. Liq. 1 Acute Tox. 2 * |
H250 H330 |
GHS02 GHS06 Dgr |
H250 H330 |
|
|
|
|
|
034-001-00-2 |
seleen |
231-957-4 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 4 |
H331 H301 H373 ** H413 |
GHS06 GHS08 Dgr |
H331 H301 H373 ** H413 |
|
|
|
|
|
034-002-00-8 |
seleenverbindingen met uitzondering van cadmiumsulfoselenide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H373** H410 |
|
|
A |
|
034-003-00-3 |
natriumseleniet |
233-267-9 |
Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 2 |
H300 H331 H317 H411 |
GHS06 GHS09 Dgr |
H300 H331 H317 H411 |
EUH031 |
|
|
|
|
035-001-00-5 |
broom |
231-778-1 |
Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 |
H330 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H314 H400 |
|
|
|
|
|
035-002-00-0 |
waterstofbromide |
233-113-0 |
Press. Gas Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS04 GHS05 GHS07 Dgr |
H314 H335 |
|
|
U |
|
|
035-002-01-8 |
waterstofbromideoplossing … % |
— |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40 % STOT SE 3; H335: C ≥ 10 % |
B |
|
035-003-00-6 |
kaliumbromaat |
231-829-8 |
Ox. Sol. 1 Carc. 1B Acute Tox. 3 * |
H271 H350 H301 |
GHS03 GHS06 GHS08 Dgr |
H271 H350 H301 |
|
|
|
|
|
035-004-00-1 |
2-hydroxyethylammoniumperbromide |
407-440-6 |
— |
Ox. Sol. 2 **** Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H272 H302 H314 H317 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H317 H400 |
|
|
|
|
035-005-00-7 |
ammoniumbromide |
235-183-8 |
Repr. 1B Lact. STOT SE 3 STOT RE 1 Eye Irrit. 2 |
H360FD H362 H336 H372 (zenuwstelsel) H319 |
GHS08 GHS07 Dgr |
H360FD H362 H336 H372 (zenuwstelsel) H319 |
|
|
|
|
|
040-001-00-3 |
zirkoniumpoeder (pyrofoor) |
231-176-9 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
|
|
040-002-00-9 |
zirkoniumpoeder, droog (niet-pyrofoor) |
— |
— |
Self-heat. 1 |
H251 |
GHS02 Dgr |
H251 |
|
|
T |
|
040-003-00-4 |
reactieproduct van 3,5-di-tert-butylsalicylzuur en zirkoniumoxychloride, gedehydreerd, basisch Zr: DTBS = 1,0: 1,0 tot en met 1.0: 1,5 |
430-610-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
042-001-00-9 |
molybdeentrioxide |
215-204-7 |
Carc. 2 Eye Irrit. 2 STOT SE 3 |
H351 H319 H335 |
GHS08 GHS07 Wng |
H351 H319 H335 |
|
|
|
|
|
042-002-00-4 |
tetrakis(dimethylditetradecylammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxoöctamolybdaat(4–) |
404-760-8 |
Acute Tox. 3 * Eye Dam. 1 |
H331 H318 |
GHS06 GHS05 Dgr |
H331 H318 |
|
|
|
|
|
042-003-00-X |
tetrakis(trimethylhexadecylammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxoöctamolybdaat(4–) |
404-860-1 |
Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H318 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H228 H318 H410 |
|
|
T |
|
|
042-004-00-5 |
reactieproduct van ammoniummolybdaat en C12-C24-gediëthoxyleerd alkylamine (1:5-1:3) |
412-780-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
042-005-00-0 |
reactiemassa van: mono- en diglycerolen van canolaolie; canolaoliezuuramide van N-[3-(tridecyloxy)propyl]-1,3-propaandiamine, vertakt N,N-diorganodithiocarbamaatmolybdeencomplex |
434-240-6 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
046-001-00-X |
tetraämminepalladium(II)waterstofcarbonaat |
425-270-0 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H318 H317 H410 |
|
|
|
|
|
047-001-00-2 |
zilvernitraat |
231-853-9 |
Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H272 H314 H400 H410 |
GHS03 GHS05 GHS09 Dgr |
H272 H314 H410 |
|
|
|
|
|
047-002-00-8 |
polyfosforzuur, koper-, natrium-, magnesium-, calcium-, zilver- en zinkzout |
416-850-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
047-003-00-3 |
zilverzinkzeoliet (zeoliet, type LTA, oppervlakte gewijzigd met zilver- en zinkionen) [Deze rubriek betreft zeoliet van het type LTA (Linde-type A) waarvan de oppervlakte is gewijzigd met zowel zilver- als zinkionen met de gehalten Ag+ 0,5 % — 6 %, Zn2 + 5 % — 16 %, en eventueel met fosfor, NH4+, mg2+ en/of Ca2+, telkens < 3 %] |
— |
Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H361d H315 H318 H410 |
|
M = 100 M = 100 |
|
|
|
047-004-00-9 |
massief zilver: [deeltjesdiameter ≥ 1 mm] |
231-131-3 |
Repr. 2 STOT RE 2 |
H361f H373 (zenuwstelsel) |
GHS08 Wng |
H361f H373 (zenuwstelsel) |
|
|
|
|
|
047-005-00-4 |
zilverpoeder: [deeltjesdiameter > 100 nm < 1 mm] |
231-131-3 |
Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H373 (zenuwstelsel) H400 H410 |
GHS08 GHS09 Wng |
H361f H373 (zenuwstelsel) H410 |
|
M = 10 M = 10 |
|
|
|
047-006-00-X |
nanozilver: [deeltjesdiameter > 1 nm ≤ 100 nm] |
231-131-3 |
Repr. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H373 (zenuwstelsel) H400 H410 |
GHS08 GHS09 Wng |
H361f H373 (zenuwstelsel) H410 |
|
M = 1 000 M = 1 000 |
|
|
|
048-001-00-5 |
cadmiumverbindingen met uitzondering van cadmiumsulfoselenide (xCdS.yCdSe), van reactiemassa van cadmiumsulfide met zinksulfide (xCdS.yZnS) en van reactiemassa van cadmiumsulfide met kwiksulfide (xCdS.yHgS), tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
|
048-002-00-0 |
cadmium (niet-pyrofoor); [1] cadmiumoxide (niet-pyrofoor) [2] |
231-152-8 [1] 215-146-2 [2] |
7440-43-9 [1] 1306-19-0 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361fd H330 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361fd H330 H372 ** H410 |
|
|
|
|
048-003-00-6 |
cadmiumdiformiaat; cadmiumformiaat |
224-729-0 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,25 % |
|
|
|
048-004-00-1 |
cadmiumcyanide |
208-829-1 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H351 H373 ** H410 |
EUH032 |
STOT RE 2; H373: C ≥0,1 % EUH032:C≥1 % |
|
|
|
048-005-00-7 |
cadmiumhexafluorosilicaat(2–); cadmiumfluorosilica |
241-084-0 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
|
|
|
048-006-00-2 |
cadmiumfluoride |
232-222-0 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C <7 % |
|
|
|
048-007-00-8 |
cadmiumjodide |
232-223-6 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
|
|
|
048-008-00-3 |
cadmiumchloride |
233-296-7 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % |
|
|
|
048-009-00-9 |
cadmiumsulfaat |
233-331-6 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1 % ≤ C < 7 % |
|
|
|
048-010-00-4 |
cadmiumsulfide |
215-147-8 |
Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Aquatic Chronic 4 |
H350 H341 H361fd H372 ** H302 H413 |
GHS08 GHS07 Dgr |
H350 H341 H361fd H372 ** H302 H413 |
|
* STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 % |
1 |
|
|
048-011-00-X |
cadmium (pyrofoor) |
231-152-8 |
Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H250 H350 H341 H361fd H330 H372 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H250 H350 H341 H361fd H330 H372 ** H410 |
|
|
|
|
|
048-012-00-5 |
cadmiumcarbonaat |
208-168-9 |
Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H332 H312 H302 H372 (nier, bot) H410 |
|
|
A1 |
|
|
048-013-00-0 |
cadmiumhydroxide; cadmiumdihydroxide |
244-168-5 |
Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H332 H312 H302 H372 (nier, bot) H410 |
|
|
A1 |
|
|
048-014-00-6 |
cadmiumnitraat; cadmiumdinitraat |
233-710-6 |
Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H332 H312 H302 H372 (nier, bot) H410 |
|
Carc. 1B; H350: C ≥ 0,01 % |
A1 |
|
|
050-001-00-5 |
tintetrachloride; tin(IV)chloride |
231-588-9 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
STOT SE 3; H335:C≥5 % |
|
|
|
050-002-00-0 |
cyhexatin (ISO); hydroxytricyclohexylstannaan; tri(cyclohexyl)tinhydroxide |
236-049-1 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M=1000 |
|
|
|
050-003-00-6 |
fentin-acetaat (ISO); trifenyltinacetaat |
212-984-0 |
Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
|
|
050-004-00-1 |
fentin-hydroxide (ISO); trifenyltinhydroxide |
200-990-6 |
Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
|
|
050-005-00-7 |
trimethyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
|
050-006-00-2 |
triëthyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
|
050-007-00-8 |
tripropyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* |
A1 |
|
050-008-00-3 |
tributyltinverbindingen, met uitzondering van de elders in deze bijlage met name genoemde |
— |
— |
Repr. 1B Acute tox. 3 Acute tox. 4* STOT RE 1 Huidirrit. 2 Oogirrit. 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H360FD H301 H312 H372** H315 H319 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360FD H301 H312 H372** H315 H319 H410 |
|
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Huidirrit. 2; H315: C ≥ 1 % Oogirrit. 2; H319: C ≥ 1 % M = 10 |
A 1 |
|
050-009-00-9 |
fluortripentylstannaan; [1] hexapentyldistannoxaan [2] |
243-546-7 [1] 247-143-7 [2] |
20153-49-5 [1] 25637-27-8 [2] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
|
050-010-00-4 |
fluortrihexylstannaan |
243-547-2 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
|
|
050-011-00-X |
trifenyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* M=100 |
A1 |
|
050-012-00-5 |
tetracyclohexylstannaan; [1] chloortricyclohexylstannaan; [2] butyltricyclohexylstannaan [3] |
215-910-5 [1] 221-437-5 [2] 230-358-5 [3] |
1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
|
050-013-00-0 |
trioctyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 |
H319 H335 H315 H413 |
GHS07 Wng |
H319 H335 H315 H413 |
|
Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
A1 |
|
050-017-00-2 |
fenbutatin-oxide (ISO); bis(tris(2-fenyl-2-methylpropyl)tin)oxide |
236-407-7 |
Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H330 H319 H315 H410 |
|
|
|
|
|
050-018-00-8 |
tin(II)methaansulfonaat |
401-640-7 |
Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H317 H411 |
|
|
|
|
|
050-019-00-3 |
azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H-1,2,4-triazool; |
255-209-1 |
Acute Tox. 2 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H301 H335 H315 H318 H410 |
|
|
|
|
|
050-020-00-9 |
trioctylstannaan |
413-320-4 |
STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 |
H372 ** H315 H413 |
GHS08 GHS07 Dgr |
H372 ** H315 H413 |
|
|
|
|
|
050-021-00-4 |
dichloordioctylstannaan |
222-583-2 |
Repr. 1B Acute Tox. 2 STOT RE 1 Aquatic Chronic 3 |
H360D H330 H372 ** H412 |
GHS08 GHS06 Dgr |
H360D H330 H372 ** H412 |
|
Repr. 1B; H360 D: C ≥ 0,03 % inademing: ATE = 0,098 mg/l (stofdeeltjes of nevels) |
|
|
|
050-022-00-X |
dibutyltindichloride; (DBTC) |
211-670-0 |
Muta. 2 Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360FD H330 H301 H312 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H360FD H330 H301 H312 H372** H314 H410 |
|
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10 |
|
|
|
050-023-00-5 |
reactiemassa van: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannaan; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-fenyl-1,3-decaandionyl)dioctylstannaan; ((2-ethyl-1-oxohexyl)oxy)-(1-fenyl-1,3-decaandionyl)dioctylstannaan |
422-920-5 |
— |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
M=10 |
|
|
050-024-00-0 |
reactiemassa van: tri-p-tolyltinhydroxide; hexa-p-tolyldistannoxaan |
432-230-6 |
— |
STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H372** H302 H315 H318 H317 H410 |
|
|
|
|
050-025-00-6 |
trichloormethylstannaan |
213-608-8 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
|
050-026-00-1 |
2-ethylhexyl-10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat |
260-828-5 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
|
050-027-00-7 |
2-ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat; [DOTE] |
239-622-4 |
Repr. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H372 (immuunsysteem) H400 H410 |
GHS08 GHS09 Dgr |
H360D H372 (immuunsysteem) H410 |
|
|
|
|
|
050-028-00-2 |
2-ethylhexyl-10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat |
260-829-0 |
Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A |
H361d H302 H372 (zenuwstelsel, immuunsysteem) H317 |
GHS08 GHS07 Dgr |
H361d H302 H372 (zenuwstelsel, immuunsysteem) H317 |
|
|
|
|
|
050-029-00-8 |
dimethyltindichloride |
212-039-2 |
Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B |
H361d H330 H301 H311 H372 (zenuwstelsel, immuunsysteem) H314 |
GHS08 GHS06 GHS05 Dgr |
H361d H330 H301 H311 H372 (zenuwstelsel, immuunsysteem) H314 |
EUH071 |
|
|
|
|
050-030-00-3 |
dibutyltindilauraat; dibutyl[bis(dodecanoyloxy)]stannaan |
201-039-8 |
Muta. 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (immuunsysteem) |
GHS08 Dgr |
H341 H360FD H372 (immuunsysteem) |
|
|
|
|
|
050-031-00-9 |
dioctyltindilauraat; [1] stannaan, dioctyl-, bis(kokos-acyloxy)derivaten [2] |
222-883-3 [1] 293-901-5 [2] |
3648-18-8 [1] 91648-39-4 [2] |
Repr. 1B STOT RE 1 |
H360D H372 (immuunsysteem) |
GHS08 Dgr |
H360D H372 (immuunsysteem) |
|
|
|
|
050-032-00-4 |
dibutyltinbis(2-ethylhexanoaat) |
220-481-2 |
Muta. 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (immuunsysteem) |
GHS08 Dgr |
H341 H360FD H372 (immuunsysteem) |
|
|
|
|
|
050-033-00-X |
dibutyltindi(acetaat) |
213-928-8 |
Muta. 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (immuunsysteem) |
GHS08 Dgr |
H341 H360FD H372 (immuunsysteem) |
|
|
|
|
|
050-034-00-5 |
dibutyltinmaleaat |
201-077-5 |
Muta. 2 Repr. 1B Acute Tox. 2 Acute Tox. 4 STOT RE 1 Skin Corr. 1 Eye Dam. 1 |
H341 H360FD H330 H302 H372 (immuunsysteem) H314 H318 |
GHS08 GHS06 GHS05 Dgr |
H341 H360FD H330 H302 H372 (immuunsysteem) H314 |
|
inademing: ATE = 0,317 mg/l (stofdeeltjes of nevels) oraal: ATE = 510 mg/kg lg |
|
|
|
050-035-00-0 |
dibutyltinoxide |
212-449-1 |
Muta. 2 Repr. 1B Acute Tox. 3 STOT RE 1 Skin Irrit. 2 Eye Dam. 1 |
H341 H360FD H301 H372 (immuunsysteem) H315 H318 |
GHS08 GHS06 GHS05 Dgr |
H341 H360FD H301 H372 (immuunsysteem) H315 H318 |
|
oraal: ATE = 170 mg/kg lg |
|
|
|
051-001-00-8 |
antimoontrichloride |
233-047-2 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE3; H335: C ≥ 5 % |
|
|
|
051-002-00-3 |
antimoonpentachloride |
231-601-8 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
051-003-00-9 |
antimoonverbindingen met uitzondering van het tetroxide (Sb2O4), van het pentoxide (Sb2O5), van het trisulfide (Sb2S3) en van het pentasulfide (Sb2S5), tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Wng |
H332 H302 H411 |
|
* |
A1 |
|
051-004-00-4 |
antimoontrifluoride |
232-009-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
|
|
051-005-00-X |
diantimoontrioxide |
215-175-0 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
051-006-00-5 |
difenyl(4-fenylthiofenyl)sulfoniumhexafluoroantimonaat |
403-500-0 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
051-007-00-0 |
bis(4-dodecylfenyl)jodoniumhexafluoroantimonaat |
404-420-9 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
052-001-00-0 |
telluur |
236-813-4 |
Repr. 1B Lact. |
H360Df H362 |
GHS08 Dgr |
H360Df H362 |
|
|
|
|
|
052-002-00-6 |
telluurdioxide |
231-193-1 |
Repr. 1B Lact. |
H360Df H362 |
GHS08 Dgr |
H360Df H362 |
|
|
|
|
|
053-001-00-3 |
jood |
231-442-4 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H312 H400 |
GHS07 GHS09 Wng |
H332 H312 H400 |
|
|
|
|
|
053-002-00-9 |
waterstofjodide |
233-109-9 |
Press. Gas Skin Corr. 1A |
H314 |
GHS04 GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥0,02 % |
U5 |
|
|
053-002-01-6 |
waterstofjodideoplossing … % |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
|
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
053-003-00-4 |
jodylbenzeen |
— |
Expl. **** |
**** |
**** |
**** |
|
|
|
|
|
053-004-00-X |
calciumjodylbenzoaat |
— |
— |
Expl. **** |
**** |
**** |
**** |
|
|
C |
|
053-005-00-5 |
(4-(1-methylethyl)fenyl)-(4-methylfenyl)jodonium-tetrakis(pentafluorfenyl)boraat(1–) |
422-960-3 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373 ** H410 |
|
|
|
|
|
056-001-00-1 |
bariumperoxide |
215-128-4 |
Ox. Sol. 2 Acute Tox. 4 * Acute Tox. 4 * |
H272 H332 H302 |
GHS03 GHS07 Dgr |
H272 H332 H302 |
|
|
|
|
|
056-002-00-7 |
bariumzouten met uitzondering van bariumsulfaat, van zouten van 1-azo-2-hydroxynaftalenyl-arylsulfonzuur en van elders in deze bijlage vermelde zouten |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
A1 |
|
056-003-00-2 |
bariumcarbonaat |
208-167-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
056-004-00-8 |
bariumchloride |
233-788-1 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H332 |
GHS06 Dgr |
H301 H332 |
|
|
|
|
|
056-005-00-3 |
bariumdiboortetraoxide |
237-222-4 |
Repr. 1B Acute Tox. 4 Acute Tox. 3 |
H360FD H332 H301 |
GHS08 GHS06 Dgr |
H360FD H332 H301 |
|
inademing: ATE = 1,5 mg/L (stofdeeltjes of nevels) oraal: ATE = 100 mg/kg lg |
|
|
|
064-001-00-8 |
gadolinium(III)sulfiet-trihydraat |
456-900-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
072-001-00-4 |
hafnium-tetra-n-butoxide |
411-740-2 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
074-001-00-X |
hexanatrium-diwaterstof-dodecawolframaat |
412-770-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
074-002-00-5 |
reactieproducten van wolfraamhexachloride met 2-methylpropaan-2-ol, nonylfenol en pentaan-2,4-dion |
408-250-6 |
— |
Flam. Liq. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H314 H317 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H314 H317 H410 |
|
|
|
|
076-001-00-5 |
osmiumtetraoxide; osmiumzuur |
244-058-7 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1B |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
|
|
078-001-00-0 |
tetrachloroplatinaten, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
|
078-002-00-6 |
diammoniumtetrachloroplatinaat |
237-499-1 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
|
078-003-00-1 |
dinatriumtetrachloroplatinaat |
233-051-4 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
|
078-004-00-7 |
dikaliumtetrachloroplatinaat |
233-050-9 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
|
|
078-005-00-2 |
hexachloroplatinaten, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
|
078-006-00-8 |
dinatriumhexachloroplatinaat |
240-983-5 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
|
078-007-00-3 |
dikaliumhexachloroplatinaat |
240-979-3 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
|
078-008-00-9 |
diammoniumhexachloroplatinaat |
240-973-0 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
|
|
078-009-00-4 |
hexachloroplatinazuur |
241-010-7 |
Acute Tox. 3 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H301 H314 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H314 H334 H317 |
|
|
|
|
|
078-010-00-X |
tetraämmineplatina(II)- waterstofcarbonaat |
426-730-3 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
078-011-00-5 |
hydroxydisulfitoplatina(II)zuur |
423-310-1 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 H314 H334 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H302 H373 H314 H334 H317 H412 |
|
|
|
|
|
078-012-00-0 |
platina(IV)nitraat/salpeterzuuroplossing |
432-400-1 |
— |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
080-001-00-0 |
kwik |
231-106-7 |
Repr. 1B Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H330 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D*** H330 H372** H410 |
|
|
|
|
|
080-002-00-6 |
anorganische kwikverbindingen met uitzondering van kwik(II)sulfide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
A1 |
|
080-003-00-1 |
dikwikdichloride; kwik(I)chloride; calomel |
233-307-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
|
|
080-004-00-7 |
organische kwikverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
A1 |
|
080-005-00-2 |
kwikdifulminaat; kwik(II)fulminaat; kwikfulminaat; knalkwik; slagkwik |
211-057-8 |
Unst. Expl. Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H331 H311 H301 H373 ** H400 H410 |
|
|
|
|
|
080-005-01-X |
kwikdifulminaat; kwik(II)fulminaat; kwikfulminaat; knalkwik; slagkwik [≥ 20 % flegmatisator] |
211-057-8 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373 ** H400 H410 |
|
|
|
|
|
080-006-00-8 |
dikwikdicyanideoxide; kwikoxycyanide |
215-629-8 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373** H410 |
|
|
|
|
|
080-007-00-3 |
dimethylkwik; [1] diëthylkwik [2] |
209-805-3 [1] 211-000-7 [2] |
593-74-8 [1] 627-44-1 [2] |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,05 % |
1 |
|
080-008-00-9 |
fenylkwiknitraat; [1] fenylkwikhydroxide; [2] basisch fenylkwiknitraat [3] |
200-242-9 [1] 202-866-7 [2] -[3] |
55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
|
080-009-00-4 |
2-methoxyethylkwikchloride |
204-659-7 |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
|
|
080-010-00-X |
kwikdichloride; kwik(II)chloride |
231-299-8 |
Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H361f*** H300 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H361f*** H300 H372** H314 H410 |
|
|
|
|
|
080-011-00-5 |
fenylkwikacetaat |
200-532-5 |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
|
|
080-012-00-0 |
methylkwikchloride |
204-064-2 |
Carc. 2 Repr. 1A Lact. Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H362 H330 H310 H300 H372 (zenuwstelsel, nieren) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H351 H360Df H362 H330 H310 H300 H372 (zenuwstelsel, nieren) H410 |
|
inademing: ATE = 0,05 mg/l (stofdeeltjes of nevel) via de huid: ATE = 50 mg/kg lichaamsgewicht oraal: ATE = 5 mg/kg lichaamsgewicht |
1 |
|
|
081-001-00-3 |
thallium |
231-138-1 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373 ** H413 |
|
|
|
|
|
081-002-00-9 |
thalliumverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373 ** H411 |
|
|
A |
|
081-003-00-4 |
dithalliumsulfaat; thalliumsulfaat |
231-201-3 |
Acute Tox. 2 * STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H300 H372 ** H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H300 H372 ** H315 H411 |
|
|
|
|
|
082-001-00-6 |
loodverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373 ** H410 |
|
Repr.2 H361f: C ≥ 2,5 % * STOT RE 2; H373: C ≥0,5 % |
A1 |
|
082-002-00-1 |
loodalkylen |
— |
— |
Repr. 1A Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H330 H310 H300 H373 ** H410 |
|
Repr.1A; H360D: C≥ 0,1 % * STOT RE 2; H373: C ≥0,05 % |
A1 |
|
082-003-00-7 |
looddiazide; loodazide |
236-542-1 |
Unst. Expl. Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H200 H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
|
082-003-01-4 |
looddiazide; loodazide [≥ 20 % flegmatisator] |
236-542-1 |
Expl. 1.1 Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H360Df H332 H302 H373 ** H410 |
|
|
1 |
|
|
082-004-00-2 |
loodchromaat |
231-846-0 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
|
082-005-00-8 |
looddi(acetaat) |
206-104-4 |
Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
|
1 |
|
|
082-006-00-3 |
triloodbis(orthofosfaat) |
231-205-5 |
Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
|
1 |
|
|
082-007-00-9 |
loodacetaat, basisch |
215-630-3 |
Carc. 2 Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H351 H360Df H373 ** H410 |
|
|
1 |
|
|
082-008-00-4 |
lood(II)methaansulfonaat |
401-750-5 |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H360Df H332 H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H360Df H332 H302 H373 ** H315 H318 |
|
|
1 |
|
|
082-009-00-X |
loodsulfochromaat geel; C.I. Pigment Yellow 34; [Deze stof staat beschreven in de Colour Index onder het Colour Index Constitution Number, C.I. 77603.] |
215-693-7 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
|
082-010-00-5 |
loodchromaatmolybdaatsulfaat rood; C.I. Pigment Red 104; [Deze stof staat beschreven in de Colour Index onder het Colour Index Constitution Number, C.I. 77605.] |
235-759-9 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
|
|
082-011-00-0 |
lood(II)waterstofarsenaat |
232-064-2 |
Carc. 1A Repr. 1A Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H331 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H360Df H331 H301 H373 ** H410 |
|
|
1 |
|
|
082-012-00-6 |
bromide/chloride/fluoride/jodide van barium/calcium/cesium/lood/samarium/strontium, europium-gedoteerd |
431-780-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H411 |
|
|
|
|
|
082-013-00-1 |
loodpoeder; [deeltjesdiameter < 1 mm] |
231-100-4 |
Repr. 1A Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H362 H400 H410 |
GHS08 GHS09 Dgr |
H360FD H362 H410 |
|
Repr. 1A; H360D: C ≥ 0,03 % M = 10 M = 100 |
|
|
|
082-014-00-7 |
massief lood: [deeltjesdiameter ≥ 1 mm] |
231-100-4 |
Repr. 1A Lact. Aquatic Chronic 1 |
H360FD H362 H410 |
GHS08 GHS09 Dgr |
H360FD H362 H410 |
|
M = 10 |
|
|
|
092-001-00-8 |
uraan |
231-170-6 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373 ** H413 |
|
|
|
|
|
092-002-00-3 |
uraanverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 |
H330 H300 H373** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373** H411 |
|
|
A |
|
601-001-00-4 |
methaan |
200-812-7 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-002-00-X |
ethaan |
200-814-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-003-00-5 |
propaan |
200-827-9 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-004-00-0 |
butaan; [1] en isobutaan [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
|
601-004-01-8 |
butaan (met ≥ 0,1 % butadieen (203-450-8)); [1] isobutaan (met ≥ 0,1 % butadieen (203-450-8)) [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
C S U |
|
601-005-00-6 |
2,2-dimethylpropaan; neopentaan |
207-343-7 |
Flam. Gas 1 Press. Gas Aquatic Chronic 2 |
H220 H411 |
GHS02 GHS04 GHS09 Dgr |
H220 H411 |
|
|
U |
|
|
601-006-00-1 |
pentaan |
203-692-4 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H336 H411 |
EUH066 |
|
C |
|
|
601-007-00-7 |
hexaan (met < 5 % n-hexaan (203-777-6)); 2-methylpentaan; [1] 3-methylpentaan; [2] 2,2-dimethylbutaan; [3] 2,3-dimethylbutaan [4] |
203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] |
107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
C |
|
601-008-00-2 |
heptaan; n-heptaan; [1] 2,4-dimethylpentaan; [2] 2,2,3-trimethylbutaan; [3] 3,3-dimethylpentaan; [4] 2,3-dimethylpentaan; [5] 3-methylhexaan; [6] 2,2-dimethylpentaan; [7] 2-methylhexaan; [8] 3-ethylpentaan; [9] isoheptaan; [10] |
205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] |
142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
|
601-009-00-8 |
octaan; n-octaan; [1] 2,2,4-trimethylpentaan; [2] 2,3,3-trimethylpentaan; [3] 3,3-dimethylhexaan; [4] 2,2,3-trimethylpentaan; [5] 2,3,4-trimethylpentaan; [6] 3,4-dimethylhexaan; [7] 2,3-dimethylhexaan; [8] 2,4-dimethylhexaan; [9] 4-methylheptaan; [10] 3-methylheptaan; [11] 2,2-dimethylhexaan; [12] 2,5-dimethylhexaan; [13] 2-methylheptaan; [14] 2,2,3,3-tetramethylbutaan; [15] 3-ethyl-2-methylpentaan; [16] 3-ethylhexaan; [17] 3-ethyl-3-methylpentaan; [18] isoöctaan; [19] |
203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] |
111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
|
601-010-00-3 |
etheen |
200-815-3 |
Flam. Gas 1 Press. Gas STOT SE 3 |
H220 H336 |
GHS02 GHS04 GHS07 Dgr |
H220 H336 |
|
|
U |
|
|
601-011-00-9 |
propeen; propyleen |
204-062-1 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-012-00-4 |
but-1-een; [1] buteen, mengsel van 1- en 2-isomeren; [2] 2-methylpropeen; [3] (Z)-but-2-een; [4] (E)-but-2-een [5] |
203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] |
106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
|
601-013-00-X |
1,3-butadieen; buta-1,3-dieen |
203-450-8 |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
D U |
|
|
601-014-00-5 |
isopreen (gestabiliseerd) 2-methyl-1,3-butadieen |
201-143-3 |
Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 |
H224 H350 H341 H412 |
GHS02 GHS08 Dgr |
H224 H350 H341 H412 |
|
|
D |
|
|
601-015-00-0 |
acetylene; ethyne |
200-816-9 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
►M4 — ◄ |
|
U |
|
|
601-016-00-6 |
cyclopropaan |
200-847-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
601-017-00-1 |
cyclohexaan |
203-806-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
|
|
|
601-018-00-7 |
methylcyclohexaan |
203-624-3 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
|
|
601-019-00-2 |
1,4-dimethylcyclohexaan |
209-663-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
|
|
601-020-00-8 |
benzeen |
200-753-7 |
Flam. Liq. 2 Carc. 1a Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H350 H340 H372 ** H304 H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H340 H372 ** H304 H319 H315 |
|
|
E |
|
|
601-021-00-3 |
tolueen |
203-625-9 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 |
H225 H361d *** H304 H373 ** H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H361d *** H304 H373 ** H315 H336 |
|
|
|
|
|
601-022-00-9 |
o-xyleen; [1] p-xyleen; [2] m-xyleen; [3] xyleen [4] |
202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] |
95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H312 H315 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 |
|
* |
C |
|
601-023-00-4 |
ethylbenzeen |
202-849-4 |
Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1 |
H225 H332 H373 (gehoororganen) H304 |
GHS02 GHS07 GHS08 Dgr |
H225 H332 H373 (gehoororganen) H304 |
|
|
|
|
|
601-024-00-X |
cumeen |
202-704-5 |
Flam. Liq. 3 Carc. 1B Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H350 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H350 H304 H335 H411 |
|
|
|
|
|
601-025-00-5 |
mesityleen; 1,3,5-trimethylbenzeen |
203-604-4 |
Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 |
H226 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H335 H411 |
|
STOT SE 3; H335: C ≥ 25 % |
|
|
|
601-026-00-0 |
styreen |
202-851-5 |
Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 |
H226 H361d H332 H372 (gehoororganen) H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H226 H361d H332 H372 (gehoororganen) H315 H319 |
|
* |
D |
|
|
601-027-00-6 |
2-fenylpropeen; α-methylstyreen |
202-705-0 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H226 H319 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H319 H335 H411 |
|
STOT SE 3; H335: C ≥ 25 % |
|
|
|
601-028-00-1 |
2-methylstyreen; 2-vinyltolueen |
210-256-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
|
|
601-029-00-7 |
dipenteen; limoneen [1] (S)-p-mentha-1,8-dieen; l-limoneen [2] trans-1-methyl-4-(1-methylvinyl)cyclohexeen; [3] (±)-1-methyl-4-(1-methylvinyl)cyclohexeen [4] |
205-341-0 [1] 227-815-6 [2] 229-977-3 [3] 231-732-0 [4] |
138-86-3 [1] 5989-54-8 [2] 6876-12-6 [3] 7705-14-8 [4] |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H315 H317 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H317 H410 |
|
|
C |
|
601-030-00-2 |
cyclopentaan |
206-016-6 |
Flam. Liq. 2 Aquatic Chronic 3 |
H225 H412 |
GHS02 Dgr |
H225 H412 |
|
|
|
|
|
601-031-00-8 |
2,4,4-trimethylpent-1-een |
203-486-4 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
|
|
601-032-00-3 |
benzo[a]pyreen; benzo[def]chryseen |
200-028-5 |
Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H360FD H317 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
|
|
601-033-00-9 |
benzo[a]antraceen |
200-280-6 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
M=100 |
|
|
|
601-034-00-4 |
benzo[e]acefenantryleen |
205-911-9 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-035-00-X |
benzo[j]fluorantheen |
205-910-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-036-00-5 |
benzo[k]fluorantheen |
205-916-6 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-037-00-0 |
n-hexaan |
203-777-6 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT SE 3 STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H361f*** H304 H336 H372 (zenuwstelsel) H315 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H361f*** H304 H336 H372 (zenuwstelsel) H315 H411 |
|
|
|
|
|
601-041-00-2 |
dibenzo[a,h]antraceen |
200-181-8 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % M=100 |
|
|
|
601-042-00-8 |
bifenyl; difenyl |
202-163-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
|
|
601-043-00-3 |
1,2,4-trimethylbenzeen |
202-436-9 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H319 H335 H315 H411 |
|
|
|
|
|
601-044-00-9 |
3a,4,7,7a-tetrahydro-4,7-methanoïndeen |
201-052-9 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H332 H302 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H302 H319 H335 H315 H411 |
|
|
|
|
|
601-045-00-4 |
1,2,3,4-tetrahydronaftaleen |
204-340-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
EUH019 |
|
|
|
|
601-046-00-X |
7-methylocta-1,6-dieen |
404-210-7 |
Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H400 H410 |
GHS02 GHS09 Wng |
H226 H410 |
|
|
|
|
|
601-047-00-5 |
m-mentha-1,3(8)-dieen |
404-150-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
601-048-00-0 |
chryseen |
205-923-4 |
Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H400 H410 |
GHS08 GHS09 Dgr |
H350 H341 H410 |
|
|
|
|
|
601-049-00-6 |
benzo[e]pyreen |
205-892-7 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
|
|
601-051-00-7 |
4-fenylbut-1-een |
405-980-7 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
601-052-00-2 |
naftaleen |
202-049-5 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS07 GHS08 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
601-053-00-8 |
nonylfenol; [1] 4-nonylfenol, vertakt [2] |
246-672-0 [1] 284-325-5 [2] |
25154-52-3 [1] 84852-15-3 [2] |
Repr. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361fd H302 H314 H410 |
|
|
|
|
601-054-00-3 |
reactiemassa van isomeren van: dibenzylbenzeen; dibenzyl(methyl)benzeen; dibenzyl(dimethyl)benzeen; dibenzyl(trimethyl)benzeen |
405-570-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-055-00-9 |
reactiemassa van isomeren van: mono-(2-tetradecyl)naftalenen; di-(2-tetradecyl)naftalenen; tri-(2-tetradecyl)naftalenen |
410-190-0 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
|
|
601-056-00-4 |
reactiemassa van isomeren van: methyldifenylmethaan; dimethyldifenylmethaan |
405-470-4 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
601-057-00-X |
N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammoniumtosylaat |
421-130-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
|
601-058-00-5 |
di-L-paramentheen |
417-870-6 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
601-059-00-0 |
methyl-2-benzylideen-3-oxobutyraat |
420-940-9 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
|
601-060-00-6 |
1,2-bis[4-fluor-6-{4-sulfo-5-(2-(4-sulfonaftaleen-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaftaleen-7-ylazo)fenylamino}-1,3,5-triazine-2-ylamino]ethaan; x-natrium-y-kaliumzouten x = 7,755 y =0,245 |
417-610-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
601-061-00-1 |
(ethyl-1,2-ethaandiyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylfenoxy)poly]oxy-(methyl-1,2-ethaandiyl) |
418-960-8 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
601-062-00-7 |
reactiemassa van: vertakt triacontaan; vertakt dotriacontaan; vertakt tetratriacontaan; vertakt hexatriacontaan |
417-030-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
601-063-00-2 |
reactiemassa van isomeren van vertakt tetracosan |
417-060-2 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
|
▼M23 ————— |
||||||||||
|
601-065-00-3 |
reactiemassa van: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxaan-5,2'-norcaraan); (1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxaan-5,2'-norcaraan) |
416-930-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
601-066-00-9 |
1-(4-(trans-4-heptylcyclohexyl)fenyl)ethanon |
426-820-2 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
601-067-00-4 |
triëthylarsenaat |
427-700-2 |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
|
|
601-068-00-X |
1,2-diacetoxybut-3-een |
421-720-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
601-069-00-5 |
2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridiniumbromide |
422-680-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
601-070-00-0 |
reactiemassa van: vertakt icosaan; vertakt docosaan; vertakt tetracosaan |
417-050-8 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
|
|
601-071-00-6 |
1-dimethoxymethyl-2-nitrobenzeen |
423-830-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
601-072-00-1 |
reactiemassa van: 1-(4-isopropylfenyl)-1-fenylethaan; 1-(3-isopropylfenyl)-1-fenylethaan; 1-(2-isopropylfenyl)-1-fenylethaan |
430-690-2 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
601-073-00-7 |
1-broom-3,5-difluorbenzeen |
416-710-2 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373 ** H315 H317 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Wng |
H226 H302 H373 ** H315 H317 H410 |
|
|
|
|
|
601-074-00-2 |
reactiemassa van: 4-(2,2,3-trimethylcyclopent-3-een-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octaan; 1-(2,2,3-trimethylcyclopent-3-een-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octaan; spiro[cyclohex-3-een-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-een-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] |
422-040-1 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
601-075-00-8 |
4,4'-bis(N-carbamoyl-4-methylbenzeensulfonamide)difenylmethaan |
418-770-5 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
601-076-00-3 |
ethynylcyclopropaan |
425-430-1 |
Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H315 H318 H412 |
GHS02 GHS05 Dgr |
H225 H315 H318 H412 |
|
|
|
|
|
601-077-00-9 |
reactiemassa van: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octaan; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octaan |
426-510-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
601-078-00-4 |
reactiemassa van: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptaan; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptaan |
427-040-5 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
601-079-00-X |
reactiemassa van: trans-trans-cyclohexadeca-1,9-dieen; cis-trans-cyclohexadeca-1,9-dieen |
429-620-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
601-080-00-5 |
reactiemassa van: sec-butylfenyl(fenyl)methaan, mengsel van isomeren; 1-(sec-butylfenyl(fenyl)-2-fenylethaan, mengsel van isomeren; 1-(sec-butylfenyl-1-fenylethaan, mengsel van isomeren |
431-100-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
601-081-00-0 |
cyclohexadeca-1,9-dieen |
431-730-1 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
|
601-082-00-6 |
reactiemassa van: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptaan; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptaan |
434-420-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
601-083-00-1 |
5-endo-hexylbicyclo[2.2.1]hept-2-een |
435-000-3 |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 |
H304 H315 H413 |
GHS08 GHS07 Dgr |
H304 H315 H413 |
|
|
|
|
|
601-084-00-7 |
reactiemassa van: 5-endo-butylbicyclo[2.2.1]hept-2-een; 5-exo-butylbicyclo[2.2.1]hept-2-een (80:20) |
435-180-3 |
— |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H315 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H304 H315 H410 |
|
|
|
|
601-085-00-2 |
isopentaan; 2-methylbutaan |
201-142-8 |
Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H224 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H224 H304 H336 H411 |
EUH066 |
|
|
|
|
601-087-00-3 |
2,4,4-trimethylpenteen |
246-690-9 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 |
H225 H304 H336 |
GHS02 GHS07 GHS08 Dgr |
H225 H304 H336 |
|
|
D |
|
|
601-088-00-9 |
4-vinylcyclohexeen |
202-848-9 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
601-089-00-4 |
muscalure; cis-tricos-9-een |
248-505-7 |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
601-090-00-X |
benzo[rst]pentafeen |
205-877-5 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
|
|
601-091-00-5 |
dibenzo[b,def]chryseen; dibenzo[a,h]pyreen |
205-878-0 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
|
|
601-092-00-0 |
dibenzo[def,p]chryseen; dibenzo[a,l]pyreen |
205-886-4 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
|
|
601-093-00-6 |
1,4-dimethylnaftaleen |
209-335-9 |
Acute Tox. 4 Asp. Tox. 1 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 3 |
H302 H304 H319 H400 H412 |
GHS07 GHS08 GHS09 Dgr |
H302 H304 H319 H410 |
|
oraal: ATE = 1 300 mg/kg lichaamsgewicht M = 1 |
|
|
|
601-094-00-1 |
1-isopropyl-4-methylbenzeen; p-cymeen |
202-796-7 |
Flam. Liq. 3 Acute Tox. 3 Asp. Tox. 1 Aquatic Chronic 2 |
H226 H331 H304 H411 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H331 H304 H411 |
|
inademing: ATE = 3 mg/l (dampen) |
|
|
|
601-095-00-7 |
p-menta-1,3-dieen; 1-isopropyl-4-methylcyclohexa-1,3-dieen; alfa-terpineen |
202-795-1 |
Flam. Liq. 3 Acute Tox. 4 Skin Sens. 1 Asp. Tox. 1 Aquatic Chronic 2 |
H226 H302 H317 H304 H411 |
GHS02 GHS07 GHS08 GHS09 Dgr |
H226 H302 H317 H304 H411 |
|
oraal: ATE = 1 680 mg/kg lichaamsgewicht |
|
|
|
601-096-00-2 |
(R)-p-mentha-1,8-diene; d-limonene |
227-813-5 |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1B Asp. Tox. 1 Aquatic Acute 1 Aquatic Chronic 3 |
H226 H315 H317 H304 H400 H412 |
GHS02 GHS07 GHS08 GHS09 Dgr |
H226 H315 H317 H304 H410 |
|
M = 1 |
|
|
|
601-097-00-8 |
propylbenzeen |
203-132-9 |
Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H304 H335 H411 |
|
|
|
|
|
602-001-00-7 |
chloormethaan; methylchloride |
200-817-4 |
Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2 * |
H220 H351 H373 ** |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H373 ** |
|
|
U |
|
|
602-002-00-2 |
broommethaan; methylbromide |
200-813-2 |
Press. Gas Muta. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 |
H341 H331 H301 H373** H319 H335 H315 H400 H420 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H341 H331 H301 H373 ** H319 H335 H315 H400 H420 |
|
|
U |
|
|
602-003-00-8 |
dibroommethaan |
200-824-2 |
Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
* |
|
|
|
602-004-00-3 |
dichloormethaan; methyleenchloride |
200-838-9 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
|
602-005-00-9 |
methyljodide; joodmethaan |
200-819-5 |
Carc. 2 Acute Tox. 4 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 |
H351 H312 H331 H301 H335 H315 |
GHS06 GHS08 Dgr |
H351 H312 H331 H301 H335 H315 |
|
|
|
|
|
602-006-00-4 |
chloroform; trichloormethaan |
200-663-8 |
Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H351 H361d H331 H302 H372 H319 H315 |
GHS06 GHS08 Dgr |
H351 H361d H331 H302 H372 H319 H315 |
|
|
|
|
|
602-007-00-X |
bromoform; tribroommethaan |
200-854-6 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H331 H302 H319 H315 H411 |
GHS06 GHS09 Dgr |
H331 H302 H319 H315 H411 |
|
|
|
|
|
602-008-00-5 |
koolstoftetrachloride; tetrachloormethaan |
200-262-8 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 Ozone 1 |
H351 H331 H311 H301 H372** H412 H420 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 H372 ** H412 H420 |
|
* STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2 % ≤C < 1 % |
|
|
|
602-009-00-0 |
chloorethaan |
200-830-5 |
Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3 |
H220 H351 H412 |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H412 |
|
|
U |
|
|
602-010-00-6 |
1,2-dibroomethaan |
203-444-5 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H331 H311 H301 H319 H335 H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H319 H335 H315 H411 |
|
* |
|
|
|
602-011-00-1 |
1,1-dichloorethaan |
200-863-5 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H225 H302 H319 H335 H412 |
GHS02 GHS07 Dgr |
H225 H302 H319 H335 H412 |
|
* |
|
|
|
602-012-00-7 |
1,2-dichloorethaan; ethyleendichloride |
203-458-1 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H302 H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H302 H319 H335 H315 |
|
|
|
|
|
602-013-00-2 |
1,1,1-trichloorethaan; methylchloroform |
200-756-3 |
Acute Tox. 4 * Ozone 1 |
H332 H420 |
GHS07 Wng |
H332 H420 |
|
|
F |
|
|
602-014-00-8 |
1,1,2-trichloorethaan |
201-166-9 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H351 H332 H312 H302 |
GHS08 GHS07 Wng |
H351 H332 H312 H302 |
EUH066 |
* |
|
|
|
602-015-00-3 |
1,1,2,2-tetrachloorethaan |
201-197-8 |
Acute Tox. 2 * Acute Tox. 1 Aquatic Chronic 2 |
H330 H310 H411 |
GHS06 GHS09 Dgr |
H330 H310 H411 |
|
|
|
|
|
602-016-00-9 |
1,1,2,2-tetrabroomethaan |
201-191-5 |
Acute Tox. 2 * Eye Irrit. 2 Aquatic Chronic 3 |
H330 H319 H412 |
GHS06 Dgr |
H330 H319 H412 |
|
|
|
|
|
602-017-00-4 |
pentachloorethaan |
200-925-1 |
Carc. 2 STOT RE 1 Aquatic Chronic 2 |
H351 H372 ** H411 |
GHS08 GHS09 Dgr |
H351 H372 ** H411 |
|
STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
|
|
602-018-00-X |
1-chloorpropaan; [1] 2-chloorpropaan [2] |
208-749-7 [1] 200-858-8 [2] |
540-54-5 [1] 75-29-6 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
|
602-019-00-5 |
1-broompropaan; n-propylbromide; |
203-445-0 |
Flam. Liq. 2 Repr. 1B STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 |
H225 H360FD H373 ** H319 H335 H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H373 ** H319 H335 H315 H336 |
|
|
|
|
|
602-020-00-0 |
1,2-dichloorpropaan; propyleendichloride |
201-152-2 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* |
H225 H350 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H302 |
|
|
|
|
|
602-021-00-6 |
1,2-dibroom-3-chloorpropaan |
202-479-3 |
Carc. 1B Muta. 1B Repr. 1A Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H340 H360F *** H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H340 H360F *** H301 H373 ** H412 |
|
|
|
|
|
602-022-00-1 |
1-chloorpentaan; [1] 2-chloorpentaan; [2] 3-chloorpentaan [3] |
208-846-4 [1] 210-885-7 [2] 210-467-4 [3] |
543-59-9 [1] 625-29-6 [2] 616-20-6 [3] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
|
602-023-00-7 |
vinylchloride; chloorethyleen |
200-831-0 |
Press. Gas Flam. Gas 1 Carc. 1A |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
D U |
|
|
602-024-00-2 |
broomethyleen |
209-800-6 |
Press. Gas Flam. Gas 1 Carc. 1B |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
U |
|
|
602-025-00-8 |
1,1-dichloorethyleen; vinylideenchloride |
200-864-0 |
Flam. Liq. 1 Carc. 2 Acute Tox. 4 * |
H224 H351 H332 |
GHS02 GHS08 GHS07 Dgr |
H224 H351 H332 |
|
* |
D |
|
|
602-026-00-3 |
1,2-dichloorethyleen; [1] cis-dichloorethyleen; [2] trans-dichloorethyleen [3] |
208-750-2 [1] 205-859-7 [2] 205-860-2 [3] |
540-59-0 [1] 156-59-2 [2] 156-60-5 [3] |
Flam. Liq. 2 Acute Tox. 4 * Aquatic Chronic 3 |
H225 H332 H412 |
GHS02 GHS07 Dgr |
H225 H332 H412 |
|
* |
C |
|
602-027-00-9 |
trichloorethyleen; trichlooretheen |
201-167-4 |
Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H350 H341 H319 H315 H336 H412 |
GHS08 GHS07 Dgr |
H350 H341 H319 H315 H336 H412 |
|
|
|
|
|
602-028-00-4 |
tetrachloorethyleen |
204-825-9 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
|
|
602-029-00-X |
3-chloorpropeen; allylchloride |
203-457-6 |
Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
|
|
D |
|
|
602-030-00-5 |
1,3-dichloorpropeen; [1] (Z)-1,3-dichloorpropeen [2] |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 |
|
|
C D |
|
602-031-00-0 |
1,1-dichloorpropeen |
209-253-3 |
Flam. Liq. 2 Acute Tox. 3 * Aquatic Chronic 3 |
H225 H301 H412 |
GHS02 GHS06 Dgr |
H225 H301 H412 |
|
|
|
|
|
602-032-00-6 |
3-chloor-2-methylpropeen |
209-251-2 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H302 H314 H317 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H302 H314 H317 H411 |
|
|
|
|
|
602-033-00-1 |
chloorbenzeen |
203-628-5 |
Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H315 H411 |
|
|
|
|
|
602-034-00-7 |
1,2-dichloorbenzeen; o-dichloorbenzeen |
202-425-9 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
* |
|
|
|
602-035-00-2 |
1,4-dichloorbenzeen; p-dichloorbenzeen |
203-400-5 |
Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H400 H410 |
GHS08 GHS09 Wng |
H351 H319 H410 |
|
|
|
|
|
602-036-00-8 |
chloropreen (gestabiliseerd); 2-chloorbuta-1,3-dieen (gestabiliseerd) |
204-818-0 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
|
|
D |
|
|
602-037-00-3 |
α-chloortolueen; benzylchloride |
202-853-6 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H373 ** H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H373 ** H335 H315 H318 |
|
|
|
|
|
602-038-00-9 |
α, α,α-trichloortolueen; benzotrichloride |
202-634-5 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H335 H315 H318 |
|
|
|
|
|
602-039-00-4 |
polychloorbifenylen; pcb |
215-648-1 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Wng |
H373 ** H410 |
|
STOT RE 2; H373: C ≥ 0,005 % |
C |
|
|
602-040-00-X |
2-chloortolueen; [1] 3-chloortolueen; [2] 4-chloortolueen; [3] chloortolueen [4] |
202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] |
95-49-8 [1] 108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
C |
|
602-041-00-5 |
pentachloornaftaleen |
215-320-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H410 |
|
|
C |
|
|
602-042-00-0 |
1,2,3,4,5,6-hexachloorcyclohexanen, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H410 |
|
|
A C |
|
602-043-00-6 |
lindaan (ISO); γ-HCH of γ-BHC; γ-1,2,3,4,5,6-hexachloorcyclohexaan |
200-401-2 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H373 ** H362 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H312 H373 ** H362 H410 |
|
M=10 |
|
|
|
602-044-00-1 |
camfechloor (ISO); toxafeen; |
232-283-3 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H335 H315 H410 |
|
|
|
|
|
602-045-00-7 |
DDT (ISO); clofenotaan (INN); dicofaan; 1,1,1-trichloor-2,2-bis(4-chloorfenyl)ethaan; dichloordifenyltrichloorethaan |
200-024-3 |
Carc. 2 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H372 ** H410 |
|
|
|
|
|
602-046-00-2 |
heptachloor (ISO); 1,4,5,6,7,8,8-heptachloor-3a,4,7,7a-tetrahydro-4,7-methanoïndeen |
200-962-3 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H373 ** H410 |
|
|
|
|
|
602-047-00-8 |
chloordaan (ISO); 1,2,4,5,6,7,8,8-octachloor-3a,4,7,7a-tetrahydro-4,7-methanoïndaan |
200-349-0 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H312 H302 H410 |
|
|
|
|
|
602-048-00-3 |
aldrin (ISO) |
206-215-8 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H372 ** H410 |
|
|
|
|
|
602-049-00-9 |
dieldrin (ISO) |
200-484-5 |
Carc. 2 Acute Tox. 1 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H310 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H310 H301 H372 ** H410 |
|
|
|
|
|
602-050-00-4 |
isodrin; (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaftaleen |
207-366-2 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M=100 |
|
|
|
602-051-00-X |
endrin (ISO); 1,2,3,4,10,10-hexachloor-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaftaleen |
200-775-7 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
|
|
602-052-00-5 |
endosulfan (ISO); 1,2,3,4,7,7-hexachloor-8,9,10-trinorborn-2-een-5,6-yleendimethylsulfiet; (1,4,5,6,7,7-hexachloor-8,9,10-trinorborn-5-een-2,3-yleendimethyleen)sulfiet |
204-079-4 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H312 H410 |
|
|
|
|
|
602-053-00-0 |
isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloor-1,3,3a,4,7,7a-hexahydro-4,7-methanoïsobenzofuran |
206-045-4 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
|
|
602-054-00-6 |
3-joodpropeen; allyljodide |
209-130-4 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
|
602-055-00-1 |
broomethaan; ethylbromide |
200-825-8 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H351 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H302 |
|
|
|
|
|
602-056-00-7 |
α, α,α-trifluortolueen; benzotrifluoride |
202-635-0 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
|
|
602-057-00-2 |
α-broomtolueen; benzylbromide |
202-847-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
|
|
|
|
602-058-00-8 |
α, α-dichloortolueen; benzylideenchloride; benzalchloride |
202-709-2 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H351 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H351 H331 H302 H335 H315 H318 |
|
|
|
|
|
602-059-00-3 |
1-chloorbutaan; butylchloride |
203-696-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
602-060-00-9 |
broombenzeen |
203-623-8 |
Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H411 |
|
|
|
|
|
602-061-00-4 |
perfluorpropeen; hexafluorpropeen |
204-127-4 |
Press. Gas Acute Tox. 4 * STOT SE 3 |
H332 H335 |
GHS07 Wng |
H332 H335 |
|
|
U |
|
|
602-062-00-X |
1,2,3-trichloorpropaan |
202-486-1 |
Carc. 1B Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H350 H360F *** H332 H312 H302 |
GHS08 GHS07 Dgr |
H350 H360F *** H332 H312 H302 |
|
|
D |
|
|
602-063-00-5 |
heptachloorepoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloor-3a,4,7,7a-tetrahydro-4,7-methanoïndaan |
213-831-0 |
Carc. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H373 ** H410 |
|
|
|
|
|
602-064-00-0 |
1,3-dichloor-2-propanol |
202-491-9 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * |
H350 H301 H312 |
GHS06 GHS08 Dgr |
H350 H301 H312 |
|
|
|
|
|
602-065-00-6 |
hexachloorbenzeen |
204-273-9 |
Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372 ** H400 H410 |
GHS08 GHS09 Dgr |
H350 H372 ** H410 |
|
|
|
|
|
602-066-00-1 |
tetrachloor-p-benzochinon |
204-274-4 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
|
602-067-00-7 |
1,3-dichloorbenzeen |
208-792-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
602-068-00-2 |
ethyleenbis(trichlooracetaat) |
219-732-9 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
|
602-069-00-8 |
dichloroacetyleen |
— |
Unst. Expl. Carc. 2 STOT RE 2 * |
H200 H351 H373 ** |
GHS01 GHS08 Wng |
H200 H351 H373 ** |
|
|
|
|
|
602-070-00-3 |
3-chloor-4,5,α, α,α-pentafluortolueen |
401-930-3 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H226 H332 H302 H400 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H302 H400 |
|
|
|
|
|
602-071-00-9 |
broombenzylbroomtolueen, reactiemassa van isomeren |
402-210-1 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H317 H410 |
|
|
|
|
|
602-072-00-4 |
dichloor[(dichloorfenyl)methyl]methylbenzeen, reactiemassa van isomeren; (dichloorfenyl)(dichloortolyl)methaan, reactiemassa van isomeren (IUPAC) |
278-404-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
602-073-00-X |
1,4-dichloorbut-2-een |
212-121-8 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H330 H311 H301 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H330 H311 H301 H314 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5 % |
|
|
|
602-074-00-5 |
pentachloorbenzeen |
210-172-0 |
Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
|
|
602-075-00-0 |
4,4,5,5-tetrachloor-1,3-dioxolaan-2-on |
404-060-2 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS05 Dgr |
H330 H302 H314 |
|
|
|
|
|
602-076-00-6 |
2,3,4-trichloorbut-1-een |
219-397-9 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H302 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H302 H319 H335 H315 H410 |
|
Carc. 2; H351: C ≥ 0,1 % |
|
|
|
602-077-00-1 |
dodecachloorpentacyclo[5.2.1.02,6.03,9.05,8]decaan; mirex |
219-196-6 |
Carc. 2 Repr. 2 Lact. Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H362 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361fd H362 H312 H302 H410 |
|
|
|
|
|
602-078-00-7 |
hexachloorcyclopentadieen |
201-029-3 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H302 H314 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H311 H302 H314 H410 |
|
|
|
|
|
602-079-00-2 |
2,3-dichloorpropeen; 2,3-dichloorpropyleen |
201-153-8 |
Flam. Liq. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
|
|
|
|
|
602-080-00-8 |
alkanen, C10-13, chloor; chloorparaffines, C10-13 |
287-476-5 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
EUH066 |
|
|
|
|
602-081-00-3 |
2-chloor-4,5-difluorbenzoëzuur |
405-380-5 |
— |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H312 H302 H318 H317 |
GHS05 GHS07 Dgr |
H312 H302 H318 H317 |
|
|
|
|
602-082-00-9 |
2,2,6,6-tetrakis(broommethyl)-4-oxaheptaan-1,7-diol |
408-020-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
602-083-00-4 |
difenylether, pentabroomderivaat; pentabroomdifenylether |
251-084-2 |
STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H362 H400 H410 |
GHS08 GHS09 Wng |
H373 ** H362 H410 |
|
|
|
|
|
602-084-00-X |
1,1-dichloor-1-fluorethaan |
404-080-1 |
Aquatic Chronic 3 Ozone 1 |
H412 H420 |
GHS07 Wng |
H412 H420 |
|
|
|
|
|
602-085-00-5 |
2-broompropaan |
200-855-1 |
Flam. Liq. 2 Repr. 1a STOT RE 2 * |
H225 H360F *** H373 ** |
GHS02 GHS08 Dgr |
H225 H360F *** H373 ** |
EUH066 |
|
|
|
|
602-086-00-0 |
trifluorjoodmethaan; trifluormethyljodide |
219-014-5 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
|
|
602-087-00-6 |
1,2,4-trichloorbenzeen |
204-428-0 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
602-088-00-1 |
2,3-dibroompropaan-1-ol; 2,3-dibroom-1-propanol |
202-480-9 |
Carc. 1B Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H350 H361f *** H311 H332 H302 H412 |
GHS08 GHS07 Dgr |
H350 H361f *** H311 H332 H302 H412 |
|
|
|
|
|
602-089-00-7 |
4-broom-2-chloorfluorbenzeen |
405-580-2 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
602-090-00-2 |
1-allyl-3-chloor-4-fluorbenzeen |
406-630-6 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
602-091-00-8 |
1,3-dichloor-4-fluorbenzeen |
406-160-1 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 |
H302 H373 ** H315 H411 |
GHS08 GHS07 Wng |
H302 H373 ** H315 H411 |
|
|
|
|
|
602-092-00-3 |
1-broom-3,4,5-trifluorbenzeen |
418-480-9 |
Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H351 H315 H318 H411 |
GHS02 GHS08 GHS05 GHS09 Dgr |
H226 H351 H315 H318 H411 |
|
|
|
|
|
602-093-00-9 |
α, α,α,4-tetrachloortolueen; p-chloorbenzotrichloride |
226-009-1 |
Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H350 H361f *** H372 ** H312 H302 H335 H315 |
GHS08 GHS07 Dgr |
H350 H361f *** H372 ** H312 H302 H335 H315 |
|
|
|
|
|
602-094-00-4 |
difenylether, octabroomderivaat |
251-087-9 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
|
602-095-00-X |
alkanen, C14-17, chloor; chloorparaffines, C14-17 |
287-477-0 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
EUH066 |
|
|
|
|
602-096-00-5 |
malachietgroen, hydrochloride [1]; malachietgroen, oxalaat [2] |
209-322-8 [1] 219-441-7 [2] |
569-64-2 [1] 2437-29-8 [2] |
Repr. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361d *** H302 H318 H410 |
|
|
|
|
602-097-00-0 |
1-broom-9-(4,4,5,5,5-pentafluorpentylthio)nonaan |
422-850-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
602-098-00-6 |
2-(3-broomfenoxy)tetrahydro-2H-pyran |
429-030-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
602-099-00-1 |
3-(4-fluorfenyl)-2-methylpropionylchloride |
426-370-7 |
— |
Skin Corr. 1A Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Dgr |
H314 H302 H412 |
EUH014 EUH029 |
|
|
|
602-100-00-5 |
reactiemassa van: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluorpentaan; (S,S)-1,1,1,2,2,3,4,5,5,5-decafluorpentaan |
420-640-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
602-101-00-0 |
2-chloor-4-fluor-5-nitrofenyl(isobutyl)carbonaat |
427-020-6 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373** H317 H410 |
|
|
|
|
|
602-102-00-6 |
1,1,1,3,3-pentafluorbutaan |
430-250-1 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
602-103-00-1 |
1-(chloorfenylmethyl)-2-methylbenzeen |
431-450-1 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
602-104-00-7 |
1,1,2,2,3,3,4-heptafluorcyclopentaan |
430-710-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
602-105-00-2 |
natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butaansulfinaat |
422-100-7 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
602-106-00-8 |
2-broom-4,6-difluoraniline |
429-430-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
602-107-00-3 |
3,3,4,4-tetrafluor-4-joodbut-1-een |
439-500-2 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
|
|
602-108-00-9 |
(2,3,5,6-tetrafluorfenyl)methanol |
443-840-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
602-109-00-4 |
hexabroomcyclododecaan [1] 1,2,5,6,9,10-hexabroomcyclododecaan [2] |
247-148-4 [1] 221-695-9[2] |
25637-99-4[1] 3194-55-6[2] |
Repr. 2 Lact. |
H361 H362 |
GHS08 Wng |
H361 H362 |
|
|
|
|
602-110-00-X |
tetrafluorethyleen |
204-126-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
603-001-00-X |
methanol |
200-659-6 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 |
H225 H331 H311 H301 H370 ** |
GHS02 GHS06 GHS08 Dgr |
H225 H331 H311 H301 H370 ** |
|
* STOT SE 1; H370: C≥10 % STOT SE 2; H371: 3 % ≤ C<10 % |
|
|
|
603-002-00-5 |
ethanol; ethylalcohol |
200-578-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
603-003-00-0 |
propaan-1-ol; n-propanol |
200-746-9 |
Flam. Liq. 2 Eye Dam. 1 STOT SE 3 |
H225 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H225 H318 H336 |
|
|
|
|
|
603-004-00-6 |
butaan-1-ol; n-butanol |
200-751-6 |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H302 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H335 H315 H318 H336 |
|
|
|
|
|
603-005-00-1 |
2-methylpropaan-2-ol; tert-butylalcohol |
200-889-7 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H319 H335 |
|
|
|
|
|
603-006-00-7 |
pentanolisomeren, tenzij elders in deze bijlage vermeld |
250-378-8 |
|
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 |
H226 H332 H335 |
GHS02 GHS07 Wng |
H226 H332 H335 |
EUH066 |
|
C |
|
603-007-00-2 |
2-methylbutaan-2-ol; tert-pentanol |
200-908-9 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H225 H332 H335 H315 |
GHS02 GHS07 Dgr |
H225 H332 H335 H315 |
|
|
|
|
|
603-008-00-8 |
4-methylpentaan-2-ol; methylisobutylcarbinol |
203-551-7 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 25 % |
|
|
|
603-009-00-3 |
cyclohexanol |
203-630-6 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H332 H302 H335 H315 |
GHS07 Wng |
H332 H302 H335 H315 |
|
|
|
|
|
603-010-00-9 |
2-methylcyclohexanol, mengsel van isomeren; [1] cis-2-methylcyclohexanol; [2] trans-2-methylcyclohexanol [3] |
209-512-0 [1] 231-187-9 [2] 231-186-3 [3] |
583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
C |
|
603-011-00-4 |
2-methoxyethanol; ethyleenglycolmonomethylether |
203-713-7 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
|
|
603-012-00-X |
2-ethoxyethanol; ethyleenglycolmonoëthylether |
203-804-1 |
Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H226 H360FD H331 H302 |
GHS02 GHS08 GHS06 Dgr |
H226 H360FD H331 H302 |
|
|
|
|
|
603-013-00-5 |
2-isopropoxyethanol; ethyleenglycolmonoïsopropylether |
203-685-6 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H332 H312 H319 |
GHS07 Wng |
H332 H312 H319 |
|
|
|
|
|
603-014-00-0 |
2-butoxyethanol; ethyleenglycolmonobutylether |
203-905-0 |
Acute Tox. 3 Acute Tox. 4 Skin Irrit. 2 Eye Irrit. 2 |
H331 H302 H315 H319 |
GHS06 Dgr |
H331 H302 H315 H319 |
|
inademing: ATE = 3 mg/l (dampen) oraal: ATE = 1 200 mg/kg lg |
|
|
|
603-015-00-6 |
allylalcohol |
203-470-7 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H331 H311 H301 H319 H335 H315 H400 |
GHS02 GHS06 GHS09 Dgr |
H225 H331 H311 H301 H319 H335 H315 H400 |
|
|
|
|
|
603-016-00-1 |
4-hydroxy-4-methylpentaan-2-on; diacetonalcohol |
204-626-7 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
Eye Irrit. 2; H319: C≥ 10 % |
|
|
|
603-018-00-2 |
furfurylalcohol |
202-626-1 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 |
H351 H331 H312 H302 H373** H319 H335 |
GHS06 GHS08 Dgr |
H351 H331 H312 H302 H373** H319 H335 |
|
|
|
|
|
603-019-00-8 |
dimethylether |
204-065-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
603-020-00-3 |
ethylmethylether |
— |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
|
|
603-021-00-9 |
methylvinylether |
203-475-4 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
D U |
|
|
603-022-00-4 |
diëthylether; ether |
200-467-2 |
Flam. Liq. 1 Acute Tox. 4 * STOT SE 3 |
H224 H302 H336 |
GHS02 GHS07 Dgr |
H224 H302 H336 |
EUH019 EUH066 |
|
|
|
|
603-023-00-X |
ethyleenoxide; oxiraan |
200-849-9 |
Flam. Gas 1 Press. Gas Carc. 1B Muta. 1B Repr. 1B Acute Tox. 3 Acute Tox. 3 STOT SE 3 STOT SE 3 STOT RE 1 Skin Corr. 1 Eye Dam. 1 |
H220 H350 H340 H360Fd H331 H301 H335 H336 H372 (zenuwstelsel) H314 H318 |
GHS02 GHS08 GHS06 GHS05 Dgr |
H220 H350 H340 H360Fd H331 H301 H335 H336 H372 (zenuwstelsel) H314 |
|
inademing: ATE = 700ppm (gassen) oraal: ATE = 100 mg/kg lichaamsgewicht |
U |
|
|
603-024-00-5 |
1,4-dioxaan |
204-661-8 |
Flam. Liq. 2 Carc. 1B STOT SE 3 Eye Irrit. 2 |
H225 H350 H335 H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H335 H319 |
EUH019 EUH066 |
|
D |
|
|
603-025-00-0 |
tetrahydrofuran |
203-726-8 |
Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS07 GHS08 Dgr |
H225 H351 H319 H335 |
EUH019 |
STOT SE 3; H335: C≥25 % Eye Irrit.2; H319: C ≥ 25 % |
|
|
|
603-026-00-6 |
1-chloor-2,3-epoxypropaan; epichloorhydrine |
203-439-8 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
* |
|
|
|
603-027-00-1 |
ethaandiol; ethyleenglycol |
203-473-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-028-00-7 |
2-chloorethanol; ethyleenchloorhydrine |
203-459-7 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
|
603-029-00-2 |
bis(2-chloorethyl)ether |
203-870-1 |
Carc. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H351 H330 H310 H300 |
GHS06 GHS08 Dgr |
H351 H330 H310 H300 |
|
|
|
|
|
603-030-00-8 |
2-aminoëthanol; ethanolamine |
205-483-3 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H332 H312 H302 H314 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
603-031-00-3 |
1,2-dimethoxyethaan; ethyleenglycoldimethylether; EGDME |
203-794-9 |
Flam. Liq. 2 Repr. 1B Acute Tox. 4 * |
H225 H360FD H332 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H332 |
EUH019 |
|
|
|
|
603-032-00-9 |
ethyleendinitraat; ethyleenglycoldinitraat |
211-063-0 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 |
H200 H330 H310 H300 H373** |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373** |
|
|
|
|
|
603-033-00-4 |
oxydiëthyleendinitraat; diëthyleenglycoldinitraat; diglycoldinitraat |
211-745-8 |
Unst. Expl Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H200 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373 ** H412 |
|
|
|
|
|
603-033-01-1 |
oxydiëthyleendinitraat; diëthyleenglycoldinitraat; diglycoldinitraat [> 25 % flegmatisator] |
211-745-8 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H201 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Dgr |
H201 H330 H310 H300 H373 ** H412 |
|
|
|
|
|
603-034-00-X |
glyceroltrinitraat; nitroglycerine |
200-240-8 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H200 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H330 H310 H300 H373 ** H411 |
|
|
|
|
|
603-034-01-7 |
glyceroltrinitraat; nitroglycerine; [> 40 % flegmatisator] |
200-240-8 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H201 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373 ** H411 |
|
|
|
|
|
603-035-00-5 |
pentaërytritoltetranitraat; pentaërytriettetranitraat; PETN; pentriet |
201-084-3 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
|
603-035-01-2 |
pentaërytritoltetranitraat; pentaërytriettetranitraat; PETN; pentriet [> 20 % flegmatisator] |
201-084-3 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
|
|
603-036-00-0 |
mannitolhexanitraat; nitromanniet |
239-924-6 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
|
|
603-036-01-8 |
mannitolhexanitraat; nitromanniet; [≥ 40 % flegmatisator] |
239-924-6 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
|
|
|
603-037-00-6 |
cellulosenitraat; nitrocellulose |
— |
— |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
|
603-038-00-1 |
allylglycidylether; allyl-2,3-epoxypropylether prop-2-een-1-yl-2,3-epoxypropylether |
203-442-4 |
Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
|
|
|
|
|
603-039-00-7 |
n-butylglycidylether; 1-butoxy-2,3-epoxy-propaan; 2,3-epoxypropylbutylether |
219-376-4 |
Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H332 H302 H335 H317 H412 |
GHS02 GHS08 GHS07 Wng |
H226 H351 H341 H332 H302 H335 H317 H412 |
|
|
|
|
|
603-040-00-2 |
natriummethanolaat; natriummethoxide; [1] kaliummethanolaat; kaliummethoxide; [2] lithiummethanolaat; lithiummethoxide [3] |
204-699-5 [1] 212-736-1 [2] 212-737-7 [3] |
124-41-4 [1] 865-33-8 [2] 865-34-9 [3] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
|
603-041-00-8 |
kaliumethanolaat; kaliumethoxide; [1] natriumethanolaat; natriumethoxide [2] |
213-029-0 [1] 205-487-5 [2] |
917-58-8 [1] 141-52-6 [2] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
|
603-042-00-3 |
aluminiumisopropylaat; aluminiumtriisopropoxide |
209-090-8 |
Flam. Sol. 1 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
|
|
603-043-00-9 |
triarimol (ISO); 2,4-dichloor-α-(pyrimidine-5-yl)benzhydrylalcohol |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-044-00-4 |
dicofol (ISO); 2,2,2-trichloor-1,1-bis(4-chloorfenyl)ethanol |
204-082-0 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H315 H317 H410 |
|
|
|
|
|
603-045-00-X |
diisopropylether; [1] dipropylether [2] |
203-560-6 [1] 203-869-6 [2] |
108-20-3 [1] 111-43-3 [2] |
Flam. Liq. 2 STOT SE 3 |
H225 H336 |
GHS02 GHS07 Dgr |
H225 H336 |
EUH019 EUH066 |
|
C |
|
603-046-00-5 |
bis(chloormethyl)ether; oxybis(chloormethaan) |
208-832-8 |
Flam. Liq. 2 Carc. 1A Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * |
H225 H350 H330 H311 H302 |
GHS02 GHS06 GHS08 Dgr |
H225 H350 H330 H311 H302 |
|
Carc. 1A; H350: C ≥ 0,001 % |
|
|
|
603-047-00-0 |
2-dimethylaminoethanol; N,N-dimethylethanolamine |
203-542-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-048-00-6 |
2-diëthylaminoethanol; N,N-diëthylethanolamine |
202-845-2 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-049-00-1 |
chloorfenethol (ISO); 1,1-bis(4-chloorfenyl)ethanol |
201-246-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
603-050-00-7 |
1-(2-butoxypropoxy)propaan-2-ol |
246-011-6 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
603-051-00-2 |
2-ethylbutaan-1-ol |
202-621-4 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
603-052-00-8 |
3-butoxypropaan-2-ol; propyleenglycolmonobutylether |
225-878-4 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
603-053-00-3 |
2-methylpentaan-2,4-diol |
203-489-0 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
603-054-00-9 |
di-n-butylether; dibutylether |
205-575-3 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H226 H319 H335 H315 H412 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H412 |
|
STOT SE 3; H335: C≥10 % |
|
|
|
603-055-00-4 |
propyleenoxide; 1,2-epoxypropaan; methyloxiraan |
200-879-2 |
Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 |
H224 H350 H340 H331 H311 H302 H335 H319 |
GHS02 GHS08 GHS06 Dgr |
H224 H350 H340 H331 H311 H302 H335 H319 |
|
|
|
|
|
603-056-00-X |
[(p-tolyloxy)methyl]oxiraan; [1] [(m-tolyloxy)methyl]oxiraan; [2] 2,3-epoxypropyl-o-tolylether; [3] [(tolyloxy)methyl]oxiraan; cresylglycidylether [4] |
218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] |
2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] |
Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H315 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H315 H317 H411 |
|
|
C |
|
603-057-00-5 |
benzylalcohol |
202-859-9 |
Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1B |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
oraal: ATE = 1 200 mg/kg lg |
|
|
|
603-058-00-0 |
1,3-epoxypropaan; 1,3-propyleenoxide |
207-964-3 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
|
|
|
603-059-00-6 |
hexaan-1-ol |
203-852-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-060-00-1 |
2,2'-bioxiraan; 1,2:3,4-diëpoxybutaan |
215-979-1 |
Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H350 H340 H330 H311 H301 H314 |
GHS06 GHS08 GHS05 Dgr |
H350 H340 H330 H311 H301 H314 |
|
|
|
|
|
603-061-00-7 |
tetrahydro-2-furylmethanol; tetrahydrofurfurylalcohol |
202-625-6 |
Repr. 1B Eye Irrit. 2 |
H360Df H319 |
GHS08 GHS07 Dgr |
H360Df H319 |
|
|
|
|
|
603-062-00-2 |
tetrahydrofuran-2,5-diyldimethanol |
203-239-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥10 % |
|
|
|
603-063-00-8 |
2,3-epoxypropaan-1-ol; glycidol; oxiraanmethanol |
209-128-3 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
|
|
|
|
|
603-064-00-3 |
1-methoxypropaan-2-ol; propyleenglycolmonomethylether |
203-539-1 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
|
|
603-065-00-9 |
m-bis(2,3-epoxypropoxy)benzeen; resorcinoldiglycidylether |
202-987-5 |
Carc. 1B Muta. 2 Acute Tox. 3 Acute Tox. 4 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H311 H302 H315 H319 H317 H412 |
GHS08 GHS06 Dgr |
H350 H341 H311 H302 H315 H319 H317 H412 |
|
dermaal: ATE = 300 mg/kg lichaamsgewicht oraal: ATE = 500 mg/kg lichaamsgewicht |
|
|
|
603-066-00-4 |
7-oxa-3-oxiranylbicyclo[4.1.0]heptaan; 1,2-epoxy-4-epoxyethylcyclohexaan; 4-vinylcyclohexeendiëpoxide |
203-437-7 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H350 H341 H360F H331 H302 |
GHS08 GHS06 Dgr |
H350 H341 H360F H331 H302 |
|
inademing: ATE = 0,5 mg/l (stofdeeltjes of nevels) oraal: ATE = 1 847 mg/kg lichaamsgewicht |
|
|
|
603-067-00-X |
fenylglycidylether; 2,3-epoxypropylfenylether; 1,2-epoxy-3-fenoxypropaan |
204-557-2 |
Carc. 1B Muta. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H332 H335 H315 H317 H412 |
GHS08 GHS07 Dgr |
H350 H341 H332 H335 H315 H317 H412 |
|
|
|
|
|
603-068-00-5 |
2,3-epoxypropyl-2-ethylcyclohexylether; 2-ethylcyclohexyl-glycidylether |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
|
|
603-069-00-0 |
2,4,6-tris(dimethylaminomethyl)fenol |
202-013-9 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
603-070-00-6 |
2-amino-2-methylpropanol |
204-709-8 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
|
603-071-00-1 |
2,2'-iminodiëthanol; diëthanolamine |
203-868-0 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 |
|
|
|
|
|
603-072-00-7 |
1,4-bis(2,3-poxypropoxy)butaan; butaandioldiglycidylether |
219-371-7 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H312 H319 H315 H317 |
GHS07 Wng |
H332 H312 H319 H315 H317 |
|
|
|
|
|
603-073-00-2 |
bis-[4-(2,3-epoxypropoxy)fenyl]propaan |
216-823-5 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 % |
|
|
|
603-074-00-8 |
reactieproduct: bisfenol-A-epichloorhydrine; epoxyhars (gemiddeld molecuulgewicht ≤ 700) |
500-033-5 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H315 H317 H411 |
|
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 % |
|
|
|
603-075-00-3 |
chloormethyl-methylether; chloordimethylether |
203-480-1 |
Flam. Liq. 2 Carc. 1A Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H312 H302 |
|
|
|
|
|
603-076-00-9 |
but-2-yn-1,4-diol; 2-butyn-1,4-diol |
203-788-6 |
Skin Corr. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H331 H301 H312 H373 ** H317 |
GHS06 GHS05 GHS08 Dgr |
H314 H331 H301 H312 H373 ** H317 |
|
Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 % Eye Irrit. 2; H319: 25 %≤ C<50 % |
D |
|
|
603-077-00-4 |
1-dimethylaminopropaan-2-ol; dimepranol (INN) |
203-556-4 |
Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B |
H226 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H314 |
|
|
|
|
|
603-078-00-X |
prop-2-yn-1-ol; propargylalcohol |
203-471-2 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H311 H301 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H311 H301 H314 H411 |
|
|
|
|
|
603-079-00-5 |
2,2'-methyliminodiëthanol; N-methyldiëthanolamine |
203-312-7 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-080-00-0 |
2-methylaminoëthanol; N-methyl-2-aminoëthanol; N-methyl-2-ethanolamine; N-methyl-2-aminoëthanol; 2-(methylamino)ethanol |
203-710-0 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-081-00-6 |
2,2'-thiodiëthanol; thiodiglycol |
203-874-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-082-00-1 |
1-aminopropaan-2-ol; isopropanolamine |
201-162-7 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
603-083-00-7 |
1,1'-iminodipropaan-2-ol diisopropanolamine |
203-820-9 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-084-00-2 |
styreenoxide; (epoxyethyl)benzeen; fenyloxiraan |
202-476-7 |
Carc. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H312 H319 |
GHS08 GHS07 Dgr |
H350 H312 H319 |
|
|
|
|
|
603-085-00-8 |
bronopol (INN); 2-broom-2-nitropropaan-1,3-diol |
200-143-0 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H312 H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H335 H315 H318 H400 |
|
M=10 |
|
|
|
603-086-00-3 |
ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidine-4-ol |
245-949-3 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
|
|
603-087-00-9 |
2-ethylhexaan-1,3-diol; octyleenglycol; ethohexadiol |
202-377-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-088-00-4 |
2-(octylthio)ethanol; 2-hydroxyethyloctylsulfide |
222-598-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-089-00-X |
7,7-dimethyl-3-oxa-6-azaoctaan-1-ol |
400-390-6 |
— |
Skin Corr. 1A Acute Tox. 4 * |
H314 H302 |
GHS05 GHS07 Dgr |
H314 H302 |
|
|
|
|
603-090-00-5 |
2-(2-broomethoxy)anisool |
402-010-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-091-00-0 |
exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptaan-2-ol |
402-470-6 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
603-092-00-6 |
4-fenyl-2-methylpentanol |
402-770-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
603-093-00-1 |
cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptaan |
402-410-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Dgr |
H332 H411 |
|
|
|
|
|
603-094-00-7 |
1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropaan |
241-536-7 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
603-095-00-2 |
2-(propyloxy)ethanol; EGPE |
220-548-6 |
Acute Tox. 4 * Eye Irrit. 2 |
H312 H319 |
GHS07 Wng |
H312 H319 |
|
|
|
|
|
603-096-00-8 |
2-(2-butoxyethoxy)ethanol; diëthyleenglycolmonobutylether |
203-961-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-097-00-3 |
1,1’,1’-nitrilotripropaan-2-ol; triisopropanolamine |
204-528-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-098-00-9 |
2-fenoxyethanol |
204-589-7 |
Acute Tox. 4 STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
oraal: ATE = 1 394 mg/kg lichaamsgewicht |
|
|
|
603-099-00-4 |
3-(N-methyl-N-(4-methylamino-3-nitrofenyl)amino)propaan-1,2-diolhydrochloride |
403-440-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-100-00-8 |
1,2-dimethoxypropaan |
404-630-0 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
|
|
603-101-00-3 |
tetrahydro-2-isobutyl-4-methylpyran-4-ol, mengsel van isomeren (cis en trans) |
405-040-6 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
603-102-00-9 |
1,2-epoxybutaan |
203-438-2 |
Ontvlm. vlst. 2 Carc. 2 Acute tox. 4* Acute tox. 4* Acute tox. 4* STOT SE 3 Huidirrit. 2 Oogirrit. 2 |
H225 H351 H302 H312 H332 H335 H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H302 H312 H332 H335 H315 H319 |
|
|
|
|
|
603-103-00-4 |
oxiraan, mono[(C12-14-alkyloxy)methyl]-derivaten |
271-846-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
603-104-00-X |
fenarimol (ISO); 2,4'-dichloor-α-(pyrimidine-5-yl)benzhydrylalcohol |
262-095-7 |
Repr. 2 Lact. Aquatic Chronic 2 |
H361fd H362 H411 |
GHS08 GHS09 Wng |
H361fd H362 H411 |
|
|
|
|
|
603-105-00-5 |
furan |
203-727-3 |
Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 3 |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
GHS02 GHS08 GHS07 Dgr |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
EUH019 |
|
|
|
|
603-106-00-0 |
2-methoxypropanol |
216-455-5 |
Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H360D *** H335 H315 H318 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H360D *** H335 H315 H318 |
|
|
|
|
|
603-107-00-6 |
2-(2-methoxyethoxy)ethanol; diëthyleenglycolmonomethylether |
203-906-6 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
Repr. 1B; H360D: C ≥ 3 % |
|
|
|
603-108-00-1 |
2-methylpropaan-1-ol; isobutanol |
201-148-0 |
Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H315 H318 H336 |
|
|
|
|
|
603-109-00-7 |
reactiemassa van: 1-ethoxy-1,1,2,3,3,3-hexafluor-2-(trifluormethyl)propaan; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorbutaan |
425-340-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-110-00-2 |
reactiemassa van: cis-2-isobutyl-5-methyl-1,3-dioxaan; trans-2-isobutyl-5-methyl-1,3-dioxaan |
426-130-1 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
603-111-00-8 |
reactiemassa van: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexaan; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexaan |
426-530-6 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-112-00-3 |
cyclopentyl-2-fenylethylether |
428-340-9 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
603-113-00-9 |
6-glycidyloxynaft-1-yloxymethyloxiraan |
429-960-2 |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H341 H312 H315 H317 H412 |
GHS08 GHS07 Wng |
H341 H312 H315 H317 H412 |
|
|
|
|
|
603-114-00-4 |
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(of - 4)-een |
430-830-2 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
603-115-00-X |
reactiemassa van: O, O',O''-(methylsilaantriyl)tris(4-methyl-2-pentanonoxim) (3 stereoisomeren) |
423-580-0 |
— |
STOT RE 2 * Aquatic Chronic 4 |
H373** H413 |
GHS08 Wng |
H373** H413 |
|
|
|
|
603-116-00-5 |
(Z)-(2,4-difluorfenyl)piperidine-4-ylmethanonoxim-monohydrochloride |
424-740-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
603-117-00-0 |
propaan-2-ol; isopropylalcohol; isopropanol |
200-661-7 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
|
|
603-118-00-6 |
6-dimethylaminohexaan-1-ol |
404-680-3 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
|
|
603-119-00-1 |
1,1'-(1,3-fenyleendioxy)bis(3-(2-(prop-2-enyl)fenoxy)propaan-2-ol) |
405-840-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
603-120-00-7 |
2-methyl-5-fenylpentanol |
405-890-8 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
603-121-00-2 |
4-[4-(1,3-dihydroxyprop-2-yl)fenylamino]-1,8-dihydroxy-5-nitroantrachinon |
406-057-1 |
Carc. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H317 H413 |
GHS08 GHS07 Wng |
H351 H317 H413 |
|
|
|
|
|
603-122-00-8 |
natrium-2-ethylhexanolaat |
406-150-7 |
Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 |
H228 H314 H412 |
GHS02 GHS05 Dgr |
H228 H314 H412 |
|
|
T |
|
|
603-123-00-3 |
4-methyl-8-methyleentricyclo[3.3.1.1 3,7]decaan-2-ol |
406-330-5 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
|
603-124-00-9 |
1,4-bis[2-(vinyloxy)ethoxy]benzeen |
406-900-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-125-00-4 |
2-(2,4-dichloorfenyl)-1-(1H—1,2,4-triazool-1-yl)pent-4-een-2-ol |
407-850-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-126-00-X |
2-((4-methyl-2-nitrofenyl)amino)ethanol |
408-090-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
|
603-127-00-5 |
butaan-2-ol; [1] (S)-butaan-2-ol; [2] (R)-butaan-2-ol; [3] (±)-butaan-2-ol [4] |
201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] |
78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H226 H319 H335 H336 |
GHS02 GHS07 Wng |
H226 H319 H335 H336 |
|
|
C |
|
603-128-00-0 |
2-(fenylmethoxy)naftaleen |
405-490-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-129-00-6 |
1-tert-butoxypropaan-2-ol |
406-180-0 |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
|
|
603-130-00-1 |
reactiemassa van isomeren van: α-((dimethyl)bifenyl)-ω-hydroxypoly(oxyethyleen) |
406-325-8 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-131-00-7 |
reactiemassa (3:1) van: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol |
407-290-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-132-00-2 |
2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decaan |
408-200-3 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
|
603-133-00-8 |
reactiemassa van: 3-[(4-amino-2-chloor-5-nitrofenyl)amino]propaan-1,2-diol; 3,3'-(2-chloor-5-nitro-1,4-fenyleendiimino)bis(propaan-1,2-diol) |
408-240-1 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
603-134-00-3 |
reactiemassa van gesubstitueerde dodecyl- en/of tetradecyl-difenylethers. De stof wordt geproduceerd door de Friedel-Crafts-reactie. De katalysator wordt weggenomen uit het reactieproduct. Difenylether wordt vervangen door C1-C10-alkylgroepen. De alkylgroepen worden willekeurig tussen C1 en C6 gebonden. Er wordt lineair C12 en C14 gebruikt in 50/50-verhouding. |
410-450-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-135-00-9 |
bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titaan |
410-500-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
603-136-00-4 |
3-((4-(bis(2-hydroxyethyl)amino)-2-nitrofenyl)amino)-1-propanol |
410-910-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
603-137-00-X |
reactiemassa van:1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxoöctadecyl)amino]-D-glucitol |
411-130-6 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
603-138-00-5 |
3-(2,2-dimethyl-3-hydroxypropyl)tolueen; (alt.): 2,2-dimethyl-3-(3-methylfenyl)propanol |
403-140-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
603-139-00-0 |
bis(2-methoxyethyl)ether |
203-924-4 |
Flam. Liq. 3 Repr. 1B |
H226 H360FD |
GHS02 GHS08 Dgr |
H226 H360FD |
EUH019 |
|
|
|
|
603-140-00-6 |
2,2'-oxybisethanol; diëthyleenglycol |
203-872-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
603-141-00-1 |
reactiemassa van: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]pentadecaan; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]heptadecaan |
413-780-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-142-00-7 |
2-(2-(2-hydroxyethoxy)-ethyl)-2-aza-bicyclo[2.2.1]heptaan |
407-360-1 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H373 ** H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H312 H302 H373 ** H315 H318 |
|
|
|
|
|
603-143-00-2 |
R—2,3-epoxy-1-propanol |
404-660-4 |
Self-react. C **** Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
|
|
|
|
|
603-144-00-8 |
Reactiemassa van: 2,6,9-trimethyl-2,5,9-cyclododecatrieen-1-ol; 6,9-dimethyl-2-methyleen-5,9-cyclododecadieen-1-ol |
413-530-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
603-145-00-3 |
2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropaan |
406-970-5 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
603-146-00-9 |
2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol |
406-080-7 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
|
|
603-147-00-4 |
(–)-trans-4-(4'-fluorfenyl)-3-hydroxymethyl-N-methylpiperidine |
406-030-4 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-148-00-X |
1,4-bis[(vinyloxy)methyl]cyclohexaan |
413-370-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
603-149-00-5 |
reactiemassa van: diastereoisomeren van 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexaan |
407-640-3 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
|
603-150-00-0 |
(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-een-1-yl)-pent-4-een-2-ol |
411-580-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
603-151-00-6 |
(±)-2-(2,4-dichloorfenyl)-3-(1H-1,2,4-triazool-1-yl)propaan-1-ol |
413-570-4 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-152-00-1 |
2-(4-tert-butylfenyl)ethanol |
410-020-5 |
Repr. 2 STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H361f *** H373 ** H318 H411 |
|
|
|
|
|
603-153-00-7 |
3-((2-nitro-4-(trifluormethyl)fenyl)amino)propaan-1,2-diol |
410-010-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-154-00-2 |
1-[(2-tert-butyl)cyclohexyloxy]-2-butanol |
412-300-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
603-156-00-3 |
2-(2,4-dichloorfenyl)-2-(2-propenyl)oxiraan |
411-210-0 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
603-157-00-9 |
6,9-bis(hexadecyloxymethyl)-4,7-dioxanonaan-1,2,9-triol |
411-450-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-158-00-4 |
reactiemassa van: 4 diastereoisomeren van 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-dieen |
412-460-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-159-00-X |
2-cyclododecylpropaan-1-ol |
411-410-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-160-00-5 |
1,2-diëthoxypropaan |
412-180-1 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
|
|
603-161-00-0 |
1,3-diëthoxypropaan |
413-140-6 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
603-162-00-6 |
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylfenoxy)poly[oxo(methyl-1,2-ethaandiyl)] |
413-420-8 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
|
603-163-00-1 |
2-fenyl-1,3-propaandiol |
411-810-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-164-00-7 |
2-butyl-4-chloor-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-trifenylmethyl-1,2,3,4-2H-tetrazool-5-yl)-1,1'-bifenyl-4-methyl]-1H-imidazool |
412-420-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-165-00-2 |
reactiemassa van: 4-allyl-2,6-bis(2,3-epoxypropyl)fenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)fenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)fenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)fenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)fenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)fenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)fenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)fenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)fenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)fenol |
417-470-1 |
— |
Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Wng |
H341 H317 |
|
|
|
|
603-166-00-8 |
(R)-1-chloor-2,3-epoxypropaan |
424-280-2 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
|
|
|
|
603-167-00-3 |
3,3',5,5'-tetra-tert-butylbifenyl-2,2'-diol |
407-920-5 |
Aquatic Chronic 4 |
H413 |
GHS05 Dgr |
H413 |
|
|
|
|
|
603-168-00-9 |
3-(2-ethylhexyloxy)propaan-1,2-diol |
408-080-2 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
603-169-00-4 |
(±)-trans-4-(4-fluorfenyl)-3-hydroxymethyl-N-methylpiperidine |
415-550-0 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-170-00-X |
reactiemassa van: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-een-2-yl)pent-1-een-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-een-2-yl)-pent-1-een-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-een-2-yl)pent-1-een-3-ol |
415-990-3 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
|
603-171-00-5 |
5-thiazolylmethanol |
414-780-9 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
603-172-00-0 |
mono-2-[2-(4-dibenzo[b,f][1,4]thiazepine-11-yl)piperazinium-1-yl]ethoxy)ethanol-trans-buteendioaat |
415-180-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
603-173-00-6 |
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octaan |
421-750-9 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
603-174-00-1 |
4-cyclohexyl-2-methyl-2-butanol |
420-630-3 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
603-175-00-7 |
2-(2-hexyloxyethoxy)ethanol; DEGHE; diëthyleenglycolmonohexylether; 3,6-dioxa-1-dodecanol; hexylcarbitol; 3,6-dioxadodecaan-1-ol |
203-988-3 |
Acute Tox. 4 * Eye Dam. 1 |
H312 H318 |
GHS05 GHS07 Dgr |
H312 H318 |
|
|
|
|
|
603-176-00-2 |
1,2-bis(2-methoxyethoxy)ethaan; TEGDME; triëthyleenglycoldimethylether; triglyme |
203-977-3 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
EUH019 |
|
|
|
|
603-177-00-8 |
1-ethoxypropaan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propyleenglycolmonoëthylether; [1] 2-ethoxy-1-methylethylacetaat; 2PG1EEA [2] |
216-374-5 [1] 259-370-9 [2] |
1569-02-4 [1] 54839-24-6 [2] |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
|
603-178-00-3 |
2-hexyloxyethanol; ethyleenglycolmonohexylether; n-hexylglycol |
203-951-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
|
603-179-00-9 |
ergocalciferol (ISO); vitamine D2 |
200-014-9 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Dgr |
H330 H311 H301 H372 ** |
|
|
|
|
|
603-180-00-4 |
colecalciferol; cholecalciferol; vitamine D3 |
200-673-2 |
Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 |
H330 H310 H300 H372 |
GHS06 GHS08 Dgr |
H330 H310 H300 H372 |
|
inademing: ATE = 0,05 mg/L (stofdeeltjes of nevels) dermaal: ATE = 50 mg/kg lg oraal: ATE = 35 mg/kg lg STOT RE 1; H372: C ≥ 3 % STOT RE 2; H373: 0,3 % ≤ C < 3 % |
|
|
|
603-181-00-X |
tert-butylmethylether; MTBE; 2-methoxy-2-methylpropaan |
216-653-1 |
Flam. Liq. 2 Skin Irrit. 2 |
H225 H315 |
GHS02 GHS07 Dgr |
H225 H315 |
|
|
|
|
|
603-182-00-5 |
reactieproduct van: verzadigde, enkelvoudig onverzadigde en meervoudig onverzadigde gedeeltelijk veresterde alcoholen met een lange keten van plantaardige oorsprong (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) met O, O-diisobutyldithiofosfaat en 2-ethylhexylamine en waterstofperoxide |
428-630-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
603-183-00-0 |
2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triëthyleenglycolmonobutylether; butoxytriëthyleenglycol |
205-592-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 % |
|
|
|
603-184-00-6 |
2-(hydroxymethyl)-2-[[2-hydroxy-3-(isoöctadecyloxy)propoxy]methyl]-1,3-propaandiol |
416-380-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-185-00-1 |
2,4-dichloor-3-ethyl-6-nitrofenol |
420-740-1 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
|
|
603-186-00-7 |
trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepaan-5-ol |
419-050-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
603-187-00-2 |
2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)fenylamino)-1,3,5-triazine-2-yl)(2-hydroxyethyl)amino)ethanoldichloride |
419-360-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-188-00-8 |
reactiemassa van: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaftaleen; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaftaleen |
426-970-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
603-189-00-3 |
reactiemassa van complexen van: titaan, 2,2'-oxydiëthanol, ammoniumlactaat, nitrilotris(2-propanol) en ethyleenglycol |
405-250-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-190-00-9 |
8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decaan |
424-030-2 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
603-191-00-4 |
2-(4,6-bis(2,4-dimethylfenyl)-1,3,5-triazine-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)fenol |
419-740-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-192-00-X |
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraeen-3-ol |
423-240-1 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
603-193-00-5 |
dinatrium-9,10-antraceendioxide |
426-030-8 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
603-194-00-0 |
2-(2-aminoethylamino)ethanol; (AEEA) |
203-867-5 |
Repr. 1B Skin Corr. 1B Skin Sens. 1 |
H360Df H314 H317 |
GHS05 GHS08 GHS07 Dgr |
H360Df H314 H317 |
|
STOT SE 3; H335: C≥5 % |
|
|
|
603-195-00-6 |
2-[4-(4-methoxyfenyl)-6-fenyl-1,3,5-triazine-2-yl]fenol |
430-810-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
603-196-00-1 |
2-(7-ethyl-1H-indool-3-yl)ethanol |
431-020-1 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
|
|
603-197-00-7 |
tebuconazool (ISO); 1-(4-chloorfenyl)-4,4-dimethyl-3-(1,2,4-triazool-1-ylmethyl)pentaan-3-ol |
403-640-2 |
Repr. 2 Acute tox. 4 Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d*** H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d*** H302 H410 |
|
M = 1 M = 10 |
|
|
|
603-199-00-8 |
etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorfenyl)-4,5-dihydro-1,3-oxazool-4-yl]fenetool |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 |
|
|
|
603-200-00-1 |
1-pentanol; [1] 3-pentanol [2] |
200-752-1 [1] 209-526-7 [2] |
71-41-0 [1] 584-02-1 [2] |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H226 H332 H335 H315 |
GHS02 GHS07 Wng |
H226 H332 H335 H315 |
|
|
|
|
603-201-00-7 |
(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-een-1-ol |
416-120-5 |
— |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
|
603-202-00-2 |
4,4,5,5,5-pentafluorpentaan-1-ol |
421-360-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
603-203-00-8 |
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecaan |
427-580-1 |
— |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
|
603-204-00-3 |
reactiemassa van: 2,2'-(heptaan-1,7-diyl)bis-(1,3-dioxolaan); 2,2'-(heptaan-1,6-diyl)bis-(1,3-dioxolaan) |
428-110-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-205-00-9 |
(1S-cis)-4-(2-amino-6-chloor-9H-purine-9-yl)-2-cyclopenteen-1-methanolhydrochloride |
426-200-1 |
STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H372** H302 H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H372** H302 H318 H317 H412 |
|
|
|
|
|
603-206-00-4 |
2,2-dichloor-1,3-benzodioxool |
426-850-6 |
Flam. Liq. 3 Skin Corr. 1A Acute Tox. 4 * Skin Sens. 1 |
H226 H314 H302 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H314 H302 H317 |
EUH014 |
|
|
|
|
603-207-00-X |
2-isobutyl-2-isopropyl-1,3-dimethoxypropaan |
430-800-9 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
603-208-00-5 |
1,2-diëthoxyethaan |
211-076-1 |
Flam. Liq. 2 Repr. 1A Eye Irrit. 2 |
H225 H360Df H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H360Df H319 |
EUH019 |
|
|
|
|
603-209-00-0 |
spinosad (ISO) (reactiemassa van spinosyn A en spinosyn D in verhoudingen tussen 95:5 en 50:50); reactiemassa van 50-95 % van (2R,3aS,5aR,5bS,9S,13S,14R, 16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erytropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indaceen-7,15-dion en 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erytropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indaceen-7,15-dion; [1] spinosyn A; [2] spinosyn D [3] |
-[1] -[2] -[3] |
-[1] 131929-60-7 [2] 131929-63-0 [3] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=10 |
|
|
603-210-00-6 |
2,4-diëthyl-1,5-pentaandiol |
429-310-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
603-211-00-1 |
2,3-epoxypropyltrimethylammoniumchloride … %; glycidyltrimethylammoniumchloride … % |
221-221-0 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
|
|
B |
|
|
603-212-00-7 |
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) |
214-946-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
603-213-00-2 |
2-methoxy-2-methylbutaan; tert-amylmethylether |
213-611-4 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 |
H225 H302 H336 |
GHS02 GHS07 Dgr |
H225 H302 H336 |
|
|
|
|
|
603-214-00-8 |
1,1-diisopropoxycyclohexaan |
413-740-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
603-215-00-3 |
1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octaanbis(tetrafluoroboraat) |
418-330-2 |
Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H302 H373** H318 H317 H400 H410 |
GHS01 GHS05 GHS08 GHS07 GHS09 Dgr |
H201 H302 H373** H318 H317 H410 |
|
|
|
|
|
603-216-00-9 |
cis-1-amino-2,3-dihydro-1H-indeen-2-ol |
422-660-2 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
603-217-00-4 |
2,4,6-tri-tert-butylfenyl-2-butyl-2-ethyl-1,3-propaandiolfosfiet |
423-560-1 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
603-220-00-0 |
1-{]benzyl[}2-(2-methoxyfenoxy)ethyl]amino}-3-(9H-carbazool-4-yloxy)propaan-2-ol |
432-890-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-221-00-6 |
1-(2-amino-5-chloorfenyl)-2,2,2-trifluor-1,1-ethaandiol, hydrochloride; [met < 0,1 % 4-chlooraniline (EG-nr. 203-401-0)] |
433-580-2 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
|
|
603-221-01-3 |
1-(2-amino-5-chloorfenyl)-2,2,2-trifluor-1,1-ethaandiol, hydrochloride; [met ≥ 0,1 % 4-chlooraniline (EG-nr. 203-401-0)] |
433-580-2 |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H350 H302 H314 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H350 H302 H314 H411 |
|
|
|
|
|
603-222-00-1 |
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecaan |
433-820-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
603-223-00-7 |
2-cyclopentylideencyclopentanol; 1,1'-bi(cyclopentylideen)-2-ol |
434-270-1 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
|
603-224-00-2 |
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)hexaan |
435-790-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
603-225-00-8 |
erytromycine A9-oxim (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecaan-2-on-10-oxim (E) |
437-070-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
603-226-00-3 |
4,4'-(4-(4-methoxyfenyl)-1,3,5-triazine-2,4-diyl)bisbenzeen-1,3-diol |
444-500-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
603-227-00-9 |
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]poly[oxy(methyl-1,2-ethaandiyl)], ether met 2,2-bis(hydroxymethyl)propaan-1,3-diol (4:1); reactieproduct van: α-hydro-ω-((chloorcarbonyl)oxy)poly(oxy(methyl-1,2-ethaandiyl)), ether met 2,2-bis(hydroxymethyl)propaan-1,3-diol, met kalium-1,1-dimethylethylperoxalaat |
445-060-2 |
**** Aquatic Acute 1 Aquatic Chronic 1 |
**** H400 H410 |
**** GHS09 Wng |
**** H410 |
|
|
|
|
|
603-228-00-4 |
(±)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluor-2-(2-oxiranyl)chromaan |
419-620-1 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
603-229-00-X |
natrium-(Z)-3-chloor-3-(4-chloorfenyl)-1-hydroxy-2-propeen-1-sulfonaat |
420-800-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
603-230-00-5 |
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan |
440-030-5 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 |
H315 H318 H413 |
GHS05 Dgr |
H315 H318 H413 |
|
|
|
|
603-231-00-0 |
(S)-1,1-difenylpropaan-1,2-diol |
443-220-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
603-232-00-6 |
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxyfenyl)ethoxy]-1,5-dioxa-9-azaspiro[5.5]undecaan |
444-420-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
603-233-00-1 |
reactiemassa van: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)-3-methylbutaan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)-3-methylbutaan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)pentaan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)pentaan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoïndeen-5-yl)-3-methylbut-3-een-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoïndeen-5-yl)-3-methylbut-3-een-2-ol |
444-430-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
603-234-00-7 |
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo[6.2.1.01,6]undec-5-een |
444-480-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
603-235-00-2 |
linalool; 3,7-dimethyl-1,6-octadieen-3-ol; dl-linalool; [1] coriandrol; (S)-3,7-dimethyl-1,6-octadieen-3-ol; d-linalool; [2] licareol; (R)-3,7-dimethyl-1,6-octadieen-3-ol; l-linalool [3] |
201-134-4 [1] 204-810-7 [2] 204-811-2 [3] |
78-70-6 [1] 126-90-9 [2] 126-91-0 [3] |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
603-236-00-8 |
ethanol, 2,2'-iminobis-, N-(C13-15-vertakt en lineair alkyl)-derivaten |
308-208-6 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
|
|
603-237-00-3 |
ipconazool (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chloorbenzyl)-5-isopropyl-1-(1H-1,2,4-triazool-1-ylmethyl)cyclopentanol |
— |
Repr. 1B Acute Tox. 4 STOT RE 2 Aquatic Chronic 1 |
H360D H302 H373 (ogen, huid, lever) H410 |
GHS08 GHS07 GHS09 Dgr |
H360D H302 H373 (ogen, huid, lever) H410 |
|
oraal: ATE = 500 mg/kg lichaamsgewicht M = 100 |
|
|
|
603-238-00-9 |
bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme |
205-594-7 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
603-239-00-4 |
paclobutrazol (ISO); (2RS,3RS)-1-(4-chloorfenyl)-4,4-dimethyl-2-(1H-1,2,4-triazool-1-yl)pentaan-3-ol |
— |
Repr. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H332 H302 H319 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H332 H302 H319 H410 |
|
inademing: ATE = 3,13 mg/l (stofdeeltjes of nevels) oraal: ATE = 490 mg/kg lichaamsgewicht M = 10 M = 10 |
|
|
|
603-240-00-X |
2,2-bis(broommethyl)propaan-1,3-diol |
221-967-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
|
|
|
603-241-00-5 |
geraniol; (2E)-3,7-dimethylocta-2,6-dieen-1-ol |
203-377-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
603-243-00-6 |
2,2-dimethylpropaan-1-ol, tribroomderivaat; 3-broom-2,2-bis(broommethyl)propaan-1-ol |
253-057-0 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
|
|
603-244-00-1 |
reactiemassa van 1-(2,3-epoxypropoxy)-2,2-bis((2,3-epoxypropoxy)methyl)butaan en 1-(2,3-epoxypropoxy)-2-((2,3-epoxypropoxy)methyl)-2-hydroxymethylbutaan |
— |
— |
Muta. 2 Repr. 1B |
H341 H360F |
GHS08 Dgr |
H341 H360F |
|
|
|
|
603-245-00-7 |
2,2'-[[3-methyl-4-[(4-nitrofenyl)azo]fenyl]imino]bisethanol |
221-665-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
603-246-00-2 |
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoroctaan-1-ol |
211-477-1 |
STOT RE 2 Aquatic Chronic 1 |
H373 (tanden, beenderen) H410 |
GHS08 GHS09 Wng |
H373 (tanden, beenderen) H410 |
|
M = 1 |
|
|
|
603-247-00-8 |
reactiemassa van 1,3-dioxaan-5-ol en 1,3-dioxolaan-4-ylmethanol |
— |
— |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
604-001-00-2 |
fenol; carbolzuur; monohydroxybenzeen; fenylalcohol |
203-632-7 |
Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B |
H341 H331 H311 H301 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H341 H331 H311 H301 H373 ** H314 |
|
* Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315 1 % ≤ C<3 % Eye Irrit. 2; H319:1 % ≤C<3 % |
|
|
|
604-002-00-8 |
pentachloorfenol |
201-778-6 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
|
|
604-003-00-3 |
natriumpentachloorfenolaat; [1] kaliumpentachloorfenolaat [2] |
205-025-2 [1] 231-911-3 [2] |
131-52-2 [1] 7778-73-6 [2] |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
|
604-004-00-9 |
m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] |
203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] |
108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
* |
C |
|
604-005-00-4 |
1,4-dihydroxybenzeen; hydrochinon; chinol |
204-617-8 |
Carc. 2 Muta. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H302 H318 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H351 H341 H302 H318 H317 H400 |
|
M=10 |
|
|
|
604-006-00-X |
3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(of 2,5)-xylenol [7] |
202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] |
95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H301 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H301 H314 H411 |
|
|
C |
|
604-007-00-5 |
2-naftol |
205-182-7 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
|
|
|
|
|
604-008-00-0 |
2-chloorfenol; [1] 4-chloorfenol; [2] 3-chloorfenol; [3] chloorfenol [4] |
202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] |
95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H312 H302 H411 |
GHS07 GHS09 Wng |
H332 H312 H302 H411 |
|
|
C |
|
604-009-00-6 |
pyrogallol; 1,2,3-trihydroxybenzeen |
201-762-9 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H341 H332 H312 H302 H412 |
GHS08 GHS07 Wng |
H341 H332 H312 H302 H412 |
|
* |
|
|
|
604-010-00-1 |
resorcinol; 1,3-benzeendiol |
203-585-2 |
Acute Tox. 4 STOT SE 1 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1B Aquatic Acute 1 |
H302 H370 (zenuwstelsel) H315 H319 H317 H400 |
GHS07 GHS08 GHS09 Dgr |
H302 H370 (zenuwstelsel) H315 H319 H317 H400 |
|
oraal: ATE = 500 mg/kg lg M = 1 |
|
|
|
604-011-00-7 |
2,4-dichloorfenol |
204-429-6 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H411 |
|
|
|
|
|
604-012-00-2 |
4-chloor-o-cresol; 4-chloor-2-methylfenol |
216-381-3 |
Acute Tox. 3 * Skin Corr. 1A Aquatic Acute 1 |
H331 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H314 H400 |
|
STOT SE 3; H335: C≥1 % |
|
|
|
604-013-00-8 |
2,3,4,6-tetrachloorfenol |
200-402-8 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H301 H319 H315 H410 |
|
* Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; H315: C≥5 % |
|
|
|
604-014-00-3 |
chloorcresol; 4-chloor-m-cresol; 4-chloor-3-methylfenol |
200-431-6 |
Acute Tox. 4 Skin Corr. 1C Eye Dam. 1 STOT SE 3 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 3 |
H302 H314 H318 H335 H317 H400 H412 |
GHS07 GHS05 GHS09 Dgr |
H302 H314 H335 H317 H410 |
|
M = 1 |
|
|
|
604-015-00-9 |
2,2'-methyleen-bis-(3,4,6-trichloorfenol); hexachlorofeen |
200-733-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
* |
|
|
|
604-016-00-4 |
1,2-dihydroxybenzeen; pyrocatechol |
204-427-5 |
Carc. 1Β Muta. 2 Acute Tox. 3 Acute Tox. 3 Skin Irrit. 2 Eye Irrit. 2 |
H350 H341 H311 H301 H315 H319 |
GHS08 GHS06 Dgr |
H350 H341 H311 H301 H315 H319 |
|
oraal: ATE = 300 mg/kg lg dermaal: ATE = 600 mg/kg lg |
|
|
|
604-017-00-X |
2,4,5-trichloorfenol |
202-467-8 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
* Eye Irrit. 2; H319: C≥5 % Skin Irrit.2; H315: C ≥5 % |
|
|
|
604-018-00-5 |
2,4,6-trichloorfenol |
201-795-9 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H319 H315 H410 |
|
|
|
|
|
604-019-00-0 |
dichlorofeen (ISO) |
202-567-1 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
|
|
604-020-00-6 |
bifenyl-2-ol; 2-fenylfenol; 2-hydroxybifenyl; |
201-993-5 |
Carc. 2 Skin Corr. 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H351 H314 H318 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H314 H317 H410 |
|
M = 1 M = 1 |
|
|
|
604-021-00-1 |
natrium-2-bifenylaat; 2-fenylfenol, natriumzout |
205-055-6 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Wng |
H302 H335 H315 H318 H400 |
|
|
|
|
|
604-022-00-7 |
2,2-dimethyl-1,3-benzodioxool-4-ol |
400-900-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
604-023-00-2 |
2,4-dichloor-3-ethylfenol |
401-060-4 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
|
604-024-00-8 |
4,4-isobutylethylideendifenol |
401-720-1 |
Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360F *** H319 H400 H410 |
GHS08 GHS09 Dgr |
H360F *** H319 H410 |
|
|
|
|
|
604-025-00-3 |
2,5-bis(1,1-dimethylbutyl)hydrochinon |
400-220-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-026-00-9 |
2,2-spirobi(6-hydroxy-4,4,7-trimethylchromaan) |
400-270-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
604-027-00-4 |
2-methyl-5-(1,1,3,3-tetramethylbutyl)hydrochinon |
400-530-6 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
604-028-00-X |
4-amino-3-fluorfenol |
402-230-0 |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H302 H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H411 |
|
|
|
|
|
604-029-00-5 |
1-naftol |
201-969-4 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H335 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H335 H315 H318 |
|
|
|
|
|
604-030-00-0 |
4,4'-isopropylideendifenol; bisfenol A |
201-245-8 |
Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360F H335 H318 H317 H400 H410 |
GHS08 GHS07 GHS05 GHS09 Dgr |
H360F H335 H318 H317 H410 |
|
M = 1 M = 10 |
|
|
|
604-031-00-6 |
guajacol |
201-964-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
604-032-00-1 |
thymol |
201-944-8 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
|
|
604-033-00-7 |
isobutylbut-3-enoaat |
401-170-2 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
604-034-00-2 |
4,4'-thiodi-o-cresol |
403-330-7 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
604-035-00-8 |
4-nonylfenol, reactieproducten met formaldehyde en dodecaan-1-thiol |
404-160-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
604-036-00-3 |
4,4'-oxybis(ethyleenthio)difenol |
404-590-4 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
604-037-00-9 |
3,5-xylenol; 3,5-dimethylfenol |
203-606-5 |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
|
|
|
|
604-038-00-4 |
4-chloor-3,5-dimethylfenol; [1] chloorxylenol [2] |
201-793-8 [1] 215-316-6 [2] |
88-04-0 [1] 1321-23-9 [2] |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H315 H317 |
GHS07 Wng |
H302 H319 H315 H317 |
|
|
|
|
604-039-00-X |
ethyl-2-[4-[(6-chloorbenzoxazool-2-yl)oxy]fenoxy]propionaat; fenoxaprop-ethyl |
266-362-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
604-040-00-5 |
fomesafen (ISO); 5-[2-chloor-4-(trifluormethyl)fenoxy]-N-(methylsulfonyl)-2-nitrobenzamide |
276-439-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
604-041-00-0 |
acifluorfen (ISO); 5-[2-chloor-4-(trifluormethyl)fenoxy]-2-nitrobenzoëzuur [1] natrium-5-[2-chloor-4-(trifluormethyl)fenoxy]-2-nitrobenzoaat; acifluorfen-natrium [2] |
256-634-5 [1] 263-560-7 [2] |
50594-66-6 [1] 62476-59-9 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
|
604-042-00-6 |
4-nitrosofenol |
203-251-6 |
Muta. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H341 H302 H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H341 H302 H318 H411 |
|
|
|
|
|
604-043-00-1 |
monobenzon; 4-hydroxyfenylbenzylether; hydrochinonmonobenzylether |
203-083-3 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
604-044-00-7 |
mequinol; 4-methoxyfenol; hydrochinonmonomethylether |
205-769-8 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
604-045-00-2 |
2,3,5-trimethylhydrochinon |
211-838-3 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H335 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H332 H335 H315 H318 H317 H410 |
|
|
|
|
|
604-046-00-8 |
4-(4-isopropoxyfenylsulfonyl)fenol |
405-520-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-047-00-3 |
4-(4-tolyloxy)bifenyl |
405-730-7 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
|
|
604-048-00-9 |
4,4',4''-(ethaan-1,1,1-triyl)trifenol |
405-800-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-049-00-4 |
4-4'-methyleenbis(oxyethyleenthio)difenol |
407-480-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-051-00-5 |
3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylfenol |
401-110-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
604-052-00-0 |
2,2'-methyleenbis(6-(2H-benzotriazool-2-yl)-4-(1,1,3,3-tetramethylbutyl)fenol) |
403-800-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-053-00-6 |
2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-fenol |
410-760-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
604-054-00-1 |
reactiemassa van: 2-methoxy-4-(tetrahydro-4-methyleen-2H-pyran-2-yl)-fenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyfenol |
412-020-0 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
604-055-00-7 |
2,2'-((3,3', 5,5'-tetramethyl-(1,1'-bifenyl)-4,4'-diyl)-bis(oxymethyleen))-bis-oxiraan |
413-900-7 |
Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Wng |
H351 H317 |
|
|
|
|
|
604-056-00-2 |
2-(2-hydroxy-3,5-dinitroanilino)ethanol |
412-520-9 |
Flam. Sol. 2 Repr. 2 Acute Tox. 4 * |
H228 H361f *** H302 |
GHS02 GHS07 GHS08 Dgr |
H228 H361f *** H302 |
|
|
|
|
|
604-057-00-8 |
reactiemassa van: isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-dodecylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-tetracosylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-5,6-didodecyl-fenol. n = 5 of 6 |
401-680-5 |
— |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
604-058-00-3 |
1,2-bis(3-methylfenoxy)ethaan |
402-730-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
604-059-00-9 |
2-n-hexadecylhydrochinon |
406-400-5 |
— |
STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H373 ** H315 H317 H413 |
GHS08 GHS07 Wng |
H373 ** H315 H317 H413 |
|
|
|
|
604-060-00-4 |
9,9-bis(4-hydroxyfenyl)fluoreen |
406-950-6 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
|
|
604-061-00-X |
reactiemassa van: 2-chloor-5-sec-tetradecylhydrochinonen waarbij sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl |
407-740-7 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
|
604-062-00-5 |
2,4-dimethyl-6-(1-methyl-pentadecyl)-fenol |
411-220-5 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
604-063-00-0 |
5,6-dihydroxy-indool |
412-130-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
604-064-00-6 |
2-(4,6-difenyl-1,3,5-triazine-2-yl)-5-((hexyl)oxy)-fenol |
411-380-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-065-00-1 |
4,4',4''-(1-methylpropaan-1-yl-3-ylideen)tris(2-cyclohexyl-5-methylfenol) |
407-460-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
604-066-00-7 |
reactiemassa van: fenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylfenyl)methyl (C41-verbinding) en methaan, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-fenyl)]-(C45-verbinding); 2,6-bis(1,1-dimethylethyl)-4-tetrapropylfenol en 2-(1,1-dimethylethyl)-4-tetrapropylfenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylfenyl)methyl]-4-(tetrapropyl)fenol en 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylfenylmethyl]-6-[1-hydroxy-4-tetrapropylfenyl)methyl]-4-(tetrapropyl)fenol |
414-550-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
604-067-00-2 |
reactiemassa van: 2,2'-[[(2-hydroxyethyl)imino]bis(methyleen)bis[4-dodecylfenol]; formaldehyde, oligomeer met 4-dodecylfenol en 2-aminoethanol(n = 2); formaldehyde, oligomeer met 4-dodecylfenol en 2-aminoethanol(n = 3, 4 en hoger) |
414-520-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
604-068-00-8 |
(±)-4-[2-[[3-(4-hydroxyfenyl)-1-methylpropyl]amino]-1-hydroxyethyl]fenolhydrochloride |
415-170-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 |
H332 H302 H317 |
GHS07 Wng |
H332 H302 H317 |
|
|
|
|
|
604-069-00-3 |
2-(1-methylpropyl)-4-tert-butylfenol |
421-740-4 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
|
|
604-070-00-9 |
triclosan; 2,4,4'-trichloor-2'-hydroxy-difenylether; 5-chloor-2-(2,4-dichloorfenoxy)fenol |
222-182-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
M = 100 |
|
|
|
604-071-00-4 |
4,4'-(1-{4-[1-(4-hydroxyfenyl)-1-methylethyl]fenyl}ethylideen)difenol |
425-600-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-072-00-X |
1,2-bis(fenoxymethyl)benzeen |
428-620-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
604-073-00-5 |
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]fenyl]-2-fenylbut-1-enyl]fenol |
428-010-4 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360F*** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H317 H410 |
|
|
|
|
|
604-074-00-0 |
2,2,6,6'-tetrabroom-4,4'-isopropylidenedifenol; tetrabroombisfenol-A |
201-236-9 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410” |
|
|
|
|
|
604-075-00-6 |
4-(1,1,3,3-tetramethylbutyl)fenol; 4-tert-octylfenol |
205-426-2 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
M=10 |
|
|
|
604-076-00-1 |
fenolftaleïne |
201-004-7 |
Carc. 1B Muta. 2 Repr. 2 |
H350 H341 H361f*** |
GHS08 Dgr |
H350 H341 H361f*** |
|
Carc. 1B; H350: C ≥1 % |
|
|
|
604-077-00-7 |
2-benzotriazool-2-yl-4-methyl-6-(2-methylallyl)fenol |
419-750-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
604-079-00-8 |
4,4'-(1,3-fenyleenbis(1-methylethylideen))bisfenol |
428-970-4 |
Repr. 2 Skin Sens. 1 Aquatic Chronic 2 |
H361f*** H317 H411 |
GHS08 GHS07 GHS09 Wng |
H361f*** H317 H411 |
|
|
|
|
|
604-080-00-3 |
4-fluor-3-trifluormethylfenol |
432-560-0 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 |
H332 H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H314 H317 H411 |
|
|
|
|
|
604-081-00-9 |
1,1-bis(4-hydroxyfenyl)-1-fenylethaan |
433-130-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
604-082-00-4 |
2-chloor-6-fluorfenol |
433-890-8 |
Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H340 H361f*** H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H340 H361f*** H302 H314 H317 H411 |
|
|
|
|
|
▼M22 ————— |
||||||||||
|
604-084-00-5 |
1-ethoxy-2,3-difluorbenzeen |
441-000-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
604-087-00-1 |
reactiemassa van: 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), monoester met 4,4'-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol; 1,2-naftochinondiazide-5-sulfonylchloride(of -sulfonzuur), diëster met 4,4'-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol; 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), triëster met 4,4'-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol |
433-640-8 |
— |
Pyr. Sol. 1 Aquatic Chronic 4 |
H250 H413 |
GHS02 Dgr |
H250 H413 |
EUH044 |
|
|
|
604-089-00-2 |
2-methyl-5-tert-butylthiofenol |
444-970-7 |
— |
Flam. Liq. 3 Repr. 2 STOT RE 2 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H361d*** H373** H304 H319 H315 H317 H336 H410 |
|
|
|
|
604-090-00-8 |
4-tert-butylfenol |
202-679-0 |
Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 1 |
H361f H315 H318 H410 |
GHS08 GHS05 GHS09 Dgr |
H361f H315 H318 H410 |
|
M = 1 |
|
|
|
604-091-00-3 |
etofenprox (ISO); 2-(4-ethoxyfenyl)-2-methylpropyl-3-fenoxybenzylether |
407-980-2 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
|
M = 100 M = 1 000 |
|
|
|
604-092-00-9 |
fenol, dodecyl-, vertakt; [1] fenol, 2-dodecyl-, vertakt; [2] fenol, 3-dodecyl-, vertakt; [3] fenol, 4-dodecyl-, vertakt; [4] fenol, (tetrapropenyl)-derivaten [5] |
310-154-3 [1] [2] [3] [4] [5] |
121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] |
Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360F H314 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H360F H314 H410 |
|
M = 10 M = 10 |
|
|
604-093-00-4 |
chlorofeen; 2-benzyl-4-chloorfenol |
204-385-8 |
Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361f H332 H315 H317 H318 H373 (nier) H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H361f H332 H315 H317 H318 H373 (nier) H410 |
|
M = 1 M = 100 |
|
|
|
604-094-00-X |
iso-eugenol; [1] (E)-2-methoxy-4-(prop-1-enyl)fenol; [2] (Z)-2-methoxy-4-(prop-1-enyl)fenol [3] |
202-590-7 [1] 227-678-2 [2] 227-633-7 [3] |
97-54-1 [1] 5932-68-3 [2] 5912-86-7 [3] |
Skin Sens. 1A |
H317 |
GHS07 Wng |
H317 |
|
Skin Sens. 1A; H317: C ≥ 0,01 % |
|
|
604-095-00-5 |
6,6’-di-tert-butyl-2,2’-methyleendi-p-cresol; [DBMC] |
204-327-1 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
604-096-00-0 |
piperonylbutoxide (ISO); 2-(2-butoxyethoxy)ethyl-6-propylpiperonylether |
200-076-7 |
STOT SE 3 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H319 H400 H410 |
GHS07 GHS09 Wng |
H335 H319 H410 |
EUH066 |
M = 1 M = 1 |
|
|
|
604-097-00-6 |
2,4,6-tri-tert-butylfenol |
211-989-5 |
Repr. 1B Acute Tox. 4 STOT RE 2 Skin Sens. 1B |
H360D H302 H373 (lever) H317 |
GHS08 GHS07 Dgr |
H360D H302 H373 (lever) H317 |
|
oraal: ATE = 500 mg/kg lg |
|
|
|
604-098-00-1 |
4,4'-sulfonyldifenol; bisfenol S |
201-250-5 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
604-099-00-7 |
4,4'-[2,2,2-trifluor-1-(trifluormethyl)ethylideen]difenol; bisfenol AF |
216-036-7 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
|
|
604-100-00-0 |
nonylfenol, vertakt en lineair, geëthoxyleerd (met een gemiddeld moleculair gewicht van ≤ 1 540 g/mol) [omvat ortho-, meta- of para-isomeren of een combinatie daarvan] |
500-315-8 500-024-6 500-045-0 500-209-1 248-762-5 243-816-4 248-291-5 — 230-770-5 248-743-1 247-555-7 248-293-6 — en andere |
1119449-38-5 7311-27-5 27942-27-4 26264-02-8 27177-05-5 14409-72-4 en andere |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1 M = 10 |
|
|
605-001-00-5 |
formaldehyde … % |
200-001-8 |
Carc. 1B Muta. 2 Acute Tox. 2 Acute Tox. 4 Skin Corr. 1B Skin Sens. 1A |
H350 H341 H330 H302 H314 H317 |
GHS08 GHS06 GHS05 Dgr |
H350 H341 H330 H302 H314 H317 |
EUH071 |
inademing: ATE = 100 ppmV (gassen) oraal: ATE = 500 mg/kg lg STOT SE 3; H335: C ≥ 5 % Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 5 % ≤ C < 25 % |
B, D, F |
|
|
605-002-00-0 |
1,3,5-trioxaan; trioxymethyleen |
203-812-5 |
Flam. Sol. 1 Repr. 2 STOT SE 3 |
H228 H361d *** H335 |
GHS02 GHS08 GHS07 Dgr |
H228 H361d *** H335 |
|
|
T |
|
|
605-003-00-6 |
aceetaldehyde; ethanal |
200-836-8 |
Flam. Liq. 1 Carc. 1B Muta. 2 STOT SE 3 Eye Irrit. 2 |
H224 H350 H341 H335 H319 |
GHS02 GHS08 GHS07 Dgr |
H224 H350 H341 H335 H319 |
|
|
|
|
|
605-004-00-1 |
2,4,6-trimethyl-1,3,5-trioxaan; paraldehyde |
204-639-8 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
605-005-00-7 |
metaldehyde (ISO); 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacycloöctaan |
203-600-2 |
Flam. Sol. 2 Repr. 2 Acute Tox. 3 Aquatic Chronic 3 |
H228 H361f H301 H412 |
GHS02 GHS08 GHS06 Dgr |
H228 H361f H301 H412 |
|
oraal: ATE = 283 mg/kg lichaamsgewicht |
|
|
|
605-006-00-2 |
butyraldehyde |
204-646-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
605-007-00-8 |
1,1-dimethoxyethaan; dimethylacetaal |
208-589-8 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
605-008-00-3 |
acroleïne; prop-2-enal; acrylaldehyde |
203-453-4 |
Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H225 H330 H300 H311 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H225 H330 H300 H311 H314 H410 |
EUH071 |
Skin Corr. 1B; H314:C≥ 0,1 % M = 100 M = 1 |
D |
|
|
605-009-00-9 |
crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] |
224-030-0 [1] 204-647-1 [2] |
4170-30-3 [1] 123-73-9 [2] |
Flam. Liq. 2 Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
|
|
|
|
605-010-00-4 |
2-furaldehyde |
202-627-7 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H331 H301 H312 H319 H335 H315 |
GHS06 GHS08 Dgr |
H351 H331 H301 H312 H319 H335 H315 |
|
|
|
|
|
605-011-00-X |
2-chloorbenzaldehyde; o-chloorbenzaldehyde |
201-956-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
605-012-00-5 |
benzaldehyde |
202-860-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
605-013-00-0 |
chloralose (INN); (R)-1,2-O-(2,2,2-trichloroethylideen)-α-D-glucofuranose; glucochloralose; anhydroglucochloral |
240-016-7 |
Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H301 H336 H400 H410 |
GHS06 GHS09 Dgr |
H332 H301 H336 H410 |
|
M = 10 M = 10 |
C |
|
|
605-014-00-6 |
chloralhydraat; 2,2,2-trichloorethaan-1,1-diol |
206-117-5 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
|
|
|
|
|
605-015-00-1 |
1,1-diëthoxy-ethaan; acetaal |
203-310-6 |
Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 |
H225 H319 H315 |
GHS02 GHS07 Dgr |
H225 H319 H315 |
|
|
|
|
|
605-016-00-7 |
glyoxal … %; ethandial … % |
203-474-9 |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H341 H332 H319 H315 H317 |
GHS07 GHS08 Wng |
H341 H332 H319 H315 H317 |
|
* |
B |
|
|
605-017-00-2 |
1,3-dioxolaan |
211-463-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
605-018-00-8 |
propanal; propionaldehyde |
204-623-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
|
|
605-019-00-3 |
citral |
226-394-6 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
|
|
605-020-00-9 |
safrool; 5-allyl-1,3-benzodioxool |
202-345-4 |
Carc. 1B Muta. 2 Acute Tox. 4 * |
H350 H341 H302 |
GHS08 GHS07 Dgr |
H350 H341 H302 |
|
|
|
|
|
605-021-00-4 |
formaldehyde, reactieproducten met butylfenol |
294-145-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
605-022-00-X |
glutaral; glutaaraldehyde; 1,5-pentanedial |
203-856-5 |
Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 2 |
H330 H301 H335 H314 H334 H317 H400 H411 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H330 H301 H335 H314 H334 H317 H410 |
EUH071 |
STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1 |
|
|
|
605-023-00-5 |
5-chloor-2-(4-chloorfenoxy)fenol; [DCPP] |
429-290-0 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
M = 10 M = 10 |
|
|
|
605-024-00-0 |
2-broom-5-hydroxy-4-methoxybenzaldehyde |
426-540-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
605-025-00-6 |
chlooraceetaldehyde |
203-472-8 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H351 H330 H311 H301 H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H330 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5 % |
|
|
|
605-026-00-1 |
2,5,7,7-tetramethyloctanal |
405-690-0 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
|
605-027-00-7 |
reactiemassa van: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indeen-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indeen-5-carboxaldehyde |
410-480-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-028-00-2 |
β-methyl-3-(1-methylethyl)-benzeenpropanal |
412-050-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
605-029-00-8 |
2-cyclohexyl propanal |
412-270-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
605-030-00-3 |
1-(p-methoxyfenyl)-aceetaldehydeoxim |
411-510-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
605-031-00-9 |
reactiemassa van: 2,2-dimethoxyethanal [hoewel deze component qua identiteit, structuur en samenstelling als watervrij wordt beschouwd, bestaat 2,2-dimethoxyethanal ook als hydraat. 60 % watervrij stemt overeen met 70.4 % hydraat; water (met inbegrip van vrij water en water in gehydrateerd 2,2-dimethoxyethanal) |
421-890-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-032-00-4 |
3-[3-(4-fluorfenyl)-1-(1-methylethyl)-1H-indool-2-yl]-(E)-2-propenal |
425-370-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
605-033-00-X |
reactiemassa van: 3,7,11-trimethyl-cis-6,10-dodecadiënal; 3,7,11-trimethyl-trans-6,10-dodecadiënal |
425-910-9 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
605-034-00-5 |
reactiemassa van: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.02,6]decaan-3-carbaldehyde; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decaan-3-carbaldehyde; (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decaan-4-carbaldehyde |
429-860-9 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
605-035-00-0 |
(E)-3-(4-(4-fluorfenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridine-3-yl)prop-2-enal |
426-330-9 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H319 H317 H413 |
GHS07 Wng |
H319 H317 H413 |
|
|
|
|
|
605-036-00-6 |
2-broommalonaldehyde |
430-470-6 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
605-037-00-1 |
trans-3-[2-(7-chloor-2-chinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloor-2-chinolinyl)vinyl]benzaldehyde |
421-800-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
605-038-00-7 |
5-fenyl-3-methylpentaan-1-al |
433-900-0 |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H302 H315 H317 H411 |
GHS07 GHS09 Wng |
H302 H315 H317 H411 |
|
|
|
|
|
605-039-00-2 |
3,4-dihydroxy-5-nitrobenzaldehyde |
441-810-8 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
605-040-00-8 |
hydroxyisohexyl 3-cyclohexeen carboxaldehyde (INCI); reactiemassa van 4-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde en 3-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde; [1] 4-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde; [2] 3-(4-hydroxy-4-methylpentyl)cyclohex-3-een-1-carbaldehyde [3] |
- [1] 250-863-4 [2] 257-187-9 [3] |
130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3] |
Skin Sens. 1A |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-041-00-3 |
2-(4-tert-butylbenzyl)propionaldehyde |
201-289-8 |
Repr. 1B |
H360Fd |
GHS08 Dgr |
H360Fd |
|
|
|
|
|
605-042-00-9 |
α-methyl-1,3-benzodioxool-5-propionaldehyde [1] (S)-α-methyl-1,3-benzodioxool-5-propionaldehyde; (2S)-3-(1,3-benzodioxool-5-yl)-2-methylpropanal [2] (R)-α-methyl-1,3-benzodioxool-5-propionaldehyde; (2R)-3-(1,3-benzodioxool-5-yl)-2-methylpropanal [3] |
214-881-6 [1] — [2] — [3] |
1205-17-0 [1] 737776-68-0 [2] 737776-59-9 [3] |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
605-043-00-4 |
2,4-dimethylcyclohex-3-een-1-carbaldehyde [1] (1α,2α,5α)-2,5-dimethylcyclohex-3-een-1-carbaldehyde [2] 2,6-dimethylcyclohex-3-een-1-carbaldehyde [3] 3,5-dimethylcyclohex-3-een-1-carbaldehyde [4] 3,6-dimethylcyclohex-3-een-1-carbaldehyde [5] 4,6-dimethylcyclohex-3-een-1-carbaldehyde [6] reactiemassa van 3,5-dimethylcyclohex-3-een-1-carbaldehyde en 2,4-dimethylcyclohex-3-een-1-carbaldehyde [7] dimethylcyclohex-3-een-1-carbaldehyde [8] dimethylcyclohex-3-een-1-carbaldehyde [9] 1,2,4(of 1,3,5)-trimethylcyclohex-3-een-1-carbaldehyde [10] 1,3,4-trimethylcyclohex-3-een-1-carbaldehyde [11] 2,2,4-trimethylcyclohex-3-een-1-carbaldehyde [12] 2,4,6-trimethylcyclohex-3-eencarbaldehyde [13] isocyclocitral [14] 3,5,6-trimethylcyclohex-3-een-1-carbaldehyde [15] 4,6,6-trimethylcyclohex-3-een-1-carbaldehyde [16] |
268-264-1 [1] 252-395-6 [2] — [3] 268-263-6 [4] 267-186-5 [5] 253-139-6 [6] — [7] 248-742-6 [8] 272-113-5 [9] 276-055-1 [10] — [11] — [12] 215-833-7 [13] 215-638-7 [14] 266-810-3 [15] — [16] |
68039-49-6 [1] 35145-02-9 [2] 6975-94-6 [3] 68039-48-5 [4] 67801-65-4 [5] 36635-35-5 [6] — [7] 27939-60-2 [8] 68737-61-1 [9] 71832-78-5 [10] 40702-26-9 [11] 1726-47-2 [12] 1423-46-7 [13] 1335-66-6 [14] 67634-07-5 [15] 6754-27-4 [16] |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-001-00-8 |
aceton; propaan-2-on; propanon |
200-662-2 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
606-002-00-3 |
butanon; ethylmethylketon |
201-159-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
606-003-00-9 |
heptaan-3-on; butylethylketon |
203-388-1 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 |
H226 H332 H319 |
GHS02 GHS07 Wng |
H226 H332 H319 |
|
|
|
|
|
606-004-00-4 |
4-methylpentaan-2-on; isobutylmethylketone |
203-550-1 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 |
H225 H351 H332 H336 H319 |
GHS02 GHS07 GHS08 Dgr |
H225 H351 H332 H336 H319 |
EUH066 |
inademing: ATE = 11 mg/l (dampen) |
|
|
|
606-005-00-X |
2,6-dimethylheptaan-4-on; diisobutylketon |
203-620-1 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
606-006-00-5 |
pentaan-3-on; diëthylketon |
202-490-3 |
Flam. Liq. 2 STOT SE 3 STOT SE 3 |
H225 H335 H336 |
GHS02 GHS07 Dgr |
H225 H335 H336 |
EUH066 |
|
|
|
|
606-007-00-0 |
3-methylbutaan-2-on; methylisopropylketon |
209-264-3 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
606-009-00-1 |
4-methyl-3-penteen-2-on; mesityloxide |
205-502-5 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H226 H332 H312 H302 |
|
* |
|
|
|
606-010-00-7 |
cyclohexanon |
203-631-1 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-011-00-2 |
2-methylcyclohexanon |
209-513-6 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-012-00-8 |
3,5,5-trimethylcyclohex-2-enon; isoforon |
201-126-0 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H351 H312 H302 H319 H335 |
GHS08 GHS07 Wng |
H351 H312 H302 H319 H335 |
|
STOT SE 3; H335: C ≥10 % |
|
|
|
606-013-00-3 |
p-benzochinon; chinon |
203-405-2 |
Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H331 H301 H319 H335 H315 H400 |
GHS06 GHS09 Dgr |
H331 H301 H319 H335 H315 H400 |
|
M=10 |
|
|
|
606-014-00-9 |
chloorfacinon (ISO); 2-[(4-chloorfenyl)(fenyl)acetyl]-1H-indan-1,3(2H)-dion |
223-003-0 |
Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (bloed) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (bloed) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (bloed): C ≥ 0,1 % STOT RE 2; H373 (bloed): 0,01 % ≤ C < 0,1 % M = 1 M = 1 |
|
|
|
606-016-00-X |
pindone (ISO); 2-pivaloylindaan-1,3-dion |
201-462-8 |
Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H372 ** H410 |
|
|
|
|
|
606-017-00-5 |
diketeen; diketen |
211-617-1 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
D |
|
|
606-018-00-0 |
dichlone (ISO); 2,3-dichloor-1,4-naftochinon |
204-210-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
|
606-019-00-6 |
chloordecone (ISO); perchloorpentacyclo[5,3,0,02,6,03,9,0 4,8]decaan-5-on; decachloorpentacyclo[5,2,1,02,6,03,9,05,8]decaan-4-on |
205-601-3 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H410 |
|
|
|
|
|
606-020-00-1 |
5-methylheptaan-3-on |
208-793-7 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
STOT SE 3; H335: C≥10 % |
|
|
|
606-021-00-7 |
N-methyl-2-pyrrolidon; 1-methyl-2-pyrrolidon |
212-828-1 |
Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 |
H360D*** H335 H315 H319 |
GHS08 GHS07 Dgr |
H360D*** H335 H315 H319 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
606-022-00-2 |
1-fenyl-3-pyrazolidon |
202-155-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
606-023-00-8 |
4-methoxy-4-methylpentaan-2-on |
203-512-4 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-024-00-3 |
heptaan-2-on; amyl(methyl)keton |
203-767-1 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H302 |
GHS02 GHS07 Wng |
H226 H332 H302 |
|
|
|
|
|
606-025-00-9 |
cyclopentanon |
204-435-9 |
Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 |
H226 H319 H315 |
GHS02 GHS07 Wng |
H226 H319 H315 |
|
|
|
|
|
606-026-00-4 |
5-methylhexaan-2-on; isoamyl(methyl)ketone |
203-737-8 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-027-00-X |
heptaan-4-on; di-n-propylketon |
204-608-9 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
606-028-00-5 |
2,4-dimethylpentaan-3-on; diisopropylketon |
209-294-7 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
|
|
606-029-00-0 |
pentaan-2,4-dion; acetylaceton |
204-634-0 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H302 |
GHS02 GHS07 Wng |
H226 H302 |
|
|
|
|
|
606-030-00-6 |
hexaan-2-on; methylbutylketon; butylmethylketon; methyl-n-butylketon |
209-731-1 |
Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 |
H226 H361f *** H372 ** H336 |
GHS02 GHS08 GHS07 Dgr |
H226 H361f *** H372 ** H336 |
|
|
|
|
|
606-031-00-1 |
3-propanolide; 1,3-propiolacton |
200-340-1 |
Carc. 1B Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 |
H350 H330 H319 H315 |
GHS06 GHS08 Dgr |
H350 H330 H319 H315 |
|
|
|
|
|
606-032-00-7 |
hexachlooraceton |
204-129-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
606-033-00-2 |
2-(3,4-dichloorfenyl)-4-methyl-1,2,4-oxadiazolidinedion; methazool |
243-761-6 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H312 H302 H319 H315 H411 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H411 |
|
|
|
|
|
606-034-00-8 |
metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazine-5(4H)-on; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazine-5-on |
244-209-7 |
Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 (bloed) H400 H410 |
GHS07 GHS08 GHS09 Wng |
H302 H373 (bloed) H410 |
|
oraal: ATE = 320 mg/kg lg M = 10 M = 10 |
|
|
|
606-035-00-3 |
chlooridazon (ISO); 5-amino-4-chloor-2-fenylpyridazine-3-(2H)-on; pyrazon |
216-920-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
606-036-00-9 |
quinomethionaat; chinomethionaat (ISO); 6-methyl-1,3-dithiolo(4,5-b)chinoxaline-2-on |
219-455-3 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H332 H312 H302 H373 ** H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H332 H312 H302 H373 ** H319 H317 H410 |
|
|
|
|
|
606-037-00-4 |
triadimefon (ISO); 1-(4-chloorfenoxy)-3,3-dimethyl-1-(1,2,4-triazool-1-yl)butanon |
256-103-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
606-038-00-X |
difacinon (ISO); 2-difenylacetylindaan-1,3-dion |
201-434-5 |
Acute Tox. 2 * STOT RE 1 |
H300 H372 ** |
GHS06 GHS08 Dgr |
H300 H372 ** |
|
|
|
|
|
606-039-00-5 |
5(of 6)-tert-butyl-2'-chloor-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xantheen)-3-on |
400-680-2 |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H400 H410 |
GHS07 GHS09 Wng |
H332 H410 |
|
|
|
|
606-040-00-0 |
(N-benzyl-N-ethyl)amino-3-hydroxyacetofenonhydrochloride |
401-840-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
606-041-00-6 |
2-methyl-1-(4-methylthiofenyl)-2-morfolinopropaan-1-on |
400-600-6 |
Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H360FD H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H360FD H302 H411 |
|
|
|
|
|
606-042-00-1 |
acetofenon |
202-708-7 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
606-043-00-7 |
2,4-di-tert-butylcyclohexanon |
405-340-7 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
606-044-00-2 |
2,4,6-trimethylbenzofenon |
403-150-9 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
|
|
606-045-00-8 |
oxadiazon (ISO); 3-[2,4-dichloor-5-(1-methylethoxy)fenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazool-2(3H)-on |
243-215-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-046-00-3 |
reactiemassa van cis- en trans-cyclohexadec-8-een-1-on |
401-700-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-047-00-9 |
2-benzyl-2-dimethylamino-4'-morfolinobutyrofenon |
404-360-3 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D H400 H410 |
GHS08 GHS09 Dgr |
H360D H410 |
|
|
|
|
|
606-048-00-4 |
2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xantheen)-3-on |
406-480-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-049-00-X |
4-(trans-4-propylcyclohexyl)acetofenon |
406-700-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-050-00-5 |
6-anilino-1-benzoyl-4-(4-tert-pentylfenoxy)nafto[1,2,3-de]chinoline-2,7-(3H)-dion |
412-480-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-051-00-0 |
4-pentylcyclohexanon |
406-670-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-052-00-6 |
4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzofenon |
410-410-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
606-053-00-1 |
flurtamone (ISO); (RS)-5-methylamino-2-fenyl-4-(α, α,α-trifluor-m-tolyl)furan-3(2H)-on |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-054-00-7 |
isoxaflutool (ISO); 5-cyclopropyl-1,2-oxazol- 4-yl α,α,α-trifluor-2-mesyl-p-tolylketon |
— |
Repr. 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d*** H400 H410 |
GHS08 GHS09 Wng |
H361d*** H410 |
|
M = 10 M = 100 |
|
|
|
606-055-00-2 |
1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-indeen-5-yl)-ethanon |
411-180-9 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
|
|
606-056-00-8 |
4-chloor-3',4'-dimethoxybenzofenon |
404-610-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-057-00-3 |
4-propylcyclohexanon |
406-810-4 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
606-058-00-9 |
4'-fluor-2,2-dimethoxyacetofenon |
407-500-1 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-059-00-4 |
2,4-difluor-α-(1H-1,2,4-triazool-1-yl)acetofenonhydrochloride |
412-390-3 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
606-060-00-X |
reactiemassa van: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naftaleen-2-yl)-1,3-dioxolaan; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naftaleen-2-yl)-1,3-dioxolaan |
412-950-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-061-00-5 |
(3-chloorfenyl)-(4-methoxy-3-nitrofenyl)methanon |
423-290-4 |
Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H400 H410 |
GHS08 GHS09 Wng |
H341 H410 |
|
|
|
|
|
606-062-00-0 |
tetrahydrothiopyran-3-carboxaldehyde |
407-330-8 |
Repr. 1B Eye Dam. 1 Aquatic Chronic 3 |
H360D *** H318 H412 |
GHS08 GHS05 Dgr |
H360D *** H318 H412 |
|
|
|
|
|
606-063-00-6 |
(E)-3-(2-chloorfenyl)-2-(4-fluorfenyl)propenal |
410-980-5 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
606-064-00-1 |
pregn-5-een-3,20-dionbis(ethyleenketal) |
407-450-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-065-00-7 |
1-(4-morfolinofenyl)butaan-1-on |
413-790-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
606-066-00-2 |
(E)-5[(4-chloorfenyl)methyleen]-2,2-dimethylcyclopentanon |
410-440-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-067-00-8 |
reactiemassa van: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz[g]indeen-4-yl)ethanon; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz[f]indeen-4-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz[g]indeen-5-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz[g]indeen-5-yl)ethanon |
414-870-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-068-00-3 |
2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-een-1-yl)tridecahexaeen-2,4,6,8,10,12-al |
415-770-7 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H317 H412 |
GHS08 GHS07 Wng |
H373 ** H317 H412 |
|
|
|
|
|
606-069-00-9 |
spiro[1,3-dioxolaan-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaftaleen)] |
415-460-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-070-00-4 |
butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylfenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-een-1-on; |
414-790-3 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361fd H302 H315 H410 |
|
|
|
|
|
606-071-00-X |
17-spiro(5,5-dimethyl-1,3-dioxaan-2-yl)androsta-1,4-dieen-3-on |
421-050-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-072-00-5 |
3-acetyl-1-fenylpyrrolidine-2,4-dion |
421-600-2 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
|
|
606-073-00-0 |
4,4'-bis(dimethylamino)benzofenon; Michlers keton |
202-027-5 |
Carc. 1B Muta. 2 Eye Dam. 1 |
H350 H341 H318 |
GHS08 GHS05 Dgr |
H350 H341 H318 |
|
|
|
|
|
606-074-00-6 |
reactiemassa van: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaftaleen; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaftaleen |
425-570-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-075-00-1 |
1-benzyl-5-ethoxyimidazolidine-2,4-dion |
417-340-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
606-076-00-7 |
1-((2-chinolinylcarbonyl)oxy)-2,5-pyrrolidinedion |
418-630-3 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
606-077-00-2 |
(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanon |
418-650-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-078-00-8 |
1-octylazepine-2-on |
420-040-6 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
|
606-079-00-3 |
2-n-butylbenzo[d]isothiazool-3-on |
420-590-7 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
606-081-00-4 |
(3β, 5α, 6β)-3-(acetyloxy)-5-broom-6-hydroxy-androstaan-17-on |
419-790-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-082-00-X |
reactiemassa van: butaan-2-on-oxim; syn-O,O'-di(butaan-2-on-oxim)diëthoxysilaan |
406-930-7 |
|
STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H372 ** H317 H412 |
GHS08 GHS07 Dgr |
H372 ** H317 H412 |
|
|
|
|
606-083-00-5 |
2-chloor-5-sec-hexadecylhydrochinon |
407-750-1 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H315 H317 H412 |
GHS07 Wng |
H319 H315 H317 H412 |
|
|
|
|
|
606-084-00-0 |
1-(4-methoxy-5-benzofuranyl)-3-fenyl-1,3-propaandion |
414-540-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-085-00-6 |
(1R,4S)-2-azabicyclo[2.2.1]hept-5-een-3-on |
418-530-1 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
606-086-00-1 |
1-(3,3-dimethylcyclohexyl)pent-4-een-1-on |
422-330-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-087-00-7 |
6-ethyl-5-fluor-4(3H)-pyrimidon |
422-460-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
606-088-00-2 |
2,4,4,7-tetramethyl-6-octeen-3-on |
422-520-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
606-089-00-8 |
reactiemassa van: 1,4-diamino-2-chloor-3-fenoxyantrachinon; 1,4-diamino-2,3-bis-fenoxyantrachinon |
423-220-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-090-00-3 |
1-[3-[(dimethylamino)methyl]-4-hydroxyfenyl]ethanon |
430-920-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
606-091-00-9 |
6-chloor-5-(2-chloorethyl)-1,3-dihydroïndool-2-on |
421-320-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-092-00-4 |
reactiemassa van: (E)-oxacyclohexadec-12-een-2-on; (E)-oxacyclohexadec-13-een-2-on; a) (Z)-oxacyclohexadec-(12)-een-2-on en b) (Z)-oxacyclohexadec-(13)-een-2-on |
422-320-3 |
|
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
606-093-00-X |
5-ethyl-2,4-dihydro-4-(2-fenoxyethyl)-3H-1,2,4-triazool-3-on |
414-470-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
606-094-00-5 |
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-fenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazool-4(1H),1'(3'H)-isobenzofuran]-3'-on |
417-460-7 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
606-095-00-0 |
(R,S)-2-azabicyclo[2.2.1]hept-5-een-3-on |
421-830-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
|
606-096-00-6 |
3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-D-glucopyranosyl)-(β-D-glucopyranosyl)oxy)-2-(3,4-dihydroxydenyl)-5,7-dihydroxy-4H-1-benzopyran-4-on |
424-170-4 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
606-097-00-1 |
2,2''-dihydroxy-4,4''-(2-hydroxypropaan-1,3-diyldioxy)dibenzofenon |
424-210-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-098-00-7 |
1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedion |
431-220-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-099-00-2 |
5-methoxy-4'-(trifluormethyl)valerofenon |
425-000-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-100-00-6 |
2-butyryl-3-hydroxy-5-thiocyclohexaan-3-ylcyclohex-2-een-1-on |
425-150-8 |
Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H360F*** H302 H317 H412 |
GHS08 GHS07 Dgr |
H360F*** H302 H317 H412 |
|
|
|
|
|
606-101-00-1 |
reactiemassa van: 1,5-bis[(2-ethylhexyl)amino]-9,10-antraceendion; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-antraceendion; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-antraceendion; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthraceendion; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-antraceendion; 1,5-bis[(3-methyloxypropyl)amino]-9,10-antraceendion |
426-050-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
606-102-00-7 |
4-(3-triëthoxysilylpropoxy)-2-hydroxybenzofenon |
431-490-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-103-00-2 |
1-(4-(trans-4-ethylcyclohexyl)fenyl)ethanon |
426-460-6 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-104-00-8 |
1-(4-(trans-4-pentylcyclohexyl)fenyl)ethanon |
426-830-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-105-00-3 |
3,4,3', 4'-tetrafenyl-1,1'-ethaandiylbispyrol-2,5-dion |
431-500-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-106-00-9 |
1-(4-(trans-4-butylcyclohexyl)fenyl)ethanon |
427-320-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-107-00-4 |
8-azaspiro[4.5]decaan-7,9-dion |
427-770-4 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
|
|
606-108-00-X |
1,1,1,2,2,4,5,5,5-nonafluor-4-(trifluormethyl)-3-pentanon |
436-710-6 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
606-109-00-5 |
2-(4-methyl-3-pentenyl)antrachinon |
428-320-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 |
H302 H317 H413 |
GHS07 Wng |
H302 H317 H413 |
|
|
|
|
|
606-110-00-0 |
5-ethoxy-5H-furan-2-on |
428-330-4 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H312 H302 H373** H317 |
GHS05 GHS08 GHS07 Dgr |
H314 H312 H302 H373** H317 |
|
|
|
|
|
606-111-00-6 |
5-amino-6-methyl-1,3-dihydrobenzoïmidazool-2-on |
428-410-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
606-112-00-1 |
(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepine-6-on |
428-690-2 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 |
H302 H319 H412 |
GHS07 Wng |
H302 H319 H412 |
|
|
|
|
|
606-113-00-7 |
1-[4-(4-benzoylfenylsulfanyl)fenyl]-2-methyl-2-(4-methylfenylsulfonyl)propaan-1-on |
429-040-0 |
Eye Dam. 1 Aquatic Chronic 4 |
H318 H413 |
GHS05 Dgr |
H318 H413 |
|
|
|
|
|
606-114-00-2 |
4,4', 5,5',6,6',7,7'-octachloor-(2,2')biisoïndolyl-1,1',3,3'-tetraon |
429-150-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-115-00-8 |
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chloorfenoxy)propoxyimino]butyl}-3-hydroxy-5-(thiaan-3-yl)cyclohex-2-een-1-on |
— |
Carc. 2 Repr. 2 Skin Sens. 1 |
H351 H361d H317 |
GHS08 GHS07 Wng |
H351 H361d H317 |
|
|
|
|
|
606-116-00-3 |
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-een-1-on |
— |
Carc. 2 Repr. 2 |
H351 H361fd |
GHS08 Wng |
H351 H361fd |
|
|
|
|
|
606-117-00-9 |
2,6-bis(1,1-dimethylethyl)-4-(fenyleenmethyleen)cyclohexa-2,5-dieen-1-on |
429-460-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
606-118-00-4 |
N-(1,3-dimethylbutyl)-N'-fenyl-1,4-benzochinondiimine |
429-640-2 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
|
|
606-119-00-X |
(E)-3-methyl-5-cyclopentadeceen-1-on |
429-900-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
606-120-00-5 |
2,5-dihydroxy-5-methyl-3-(morfoline-4-yl)-2-cyclopenteen-1-on |
430-170-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
606-121-00-0 |
(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptaan-3-spiro-1'-(cyclohex-2'-een-4'-on) |
430-460-1 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
|
|
606-122-00-6 |
3-(2-broompropionyl)-4,4-dimethyl-1,3-oxazolaan-2-on |
430-820-8 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H315 H318 H317 H410 |
|
|
|
|
|
606-123-00-1 |
4-hexadecyl-1-fenylpyrazolidine-3-on |
430-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
606-124-00-7 |
1-cyclopropyl-3-(2-methylthio-4-trifluormethylfenyl)-1,3-propaandion |
421-080-7 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
|
|
|
|
606-125-00-2 |
1-benzylimidazolidine-2,4-dion |
421-340-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
606-126-00-8 |
1,4-bis(2,3-dihydroxypropylamino)antrachinon |
421-470-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
606-128-00-9 |
2,2'-(1,3-fenyleen)bis[5-chloor-1H-isoïndool]-1,3(2H)-dion |
422-650-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-129-00-4 |
5-amino-[2S-di(methylfenyl)amino]-1,6-difenyl-4Z-hexeen-3-on; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-difenylhex-4-een-3-on |
423-090-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-130-00-X |
4-(1,4-dioxaspiro[4.5]dec-8-yl)cyclohexanon |
423-860-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-131-00-5 |
cyclisch 3-(1,2-ethaandiylacetaal)oestra-5(10),9(11)-dieen-3,17-dion |
427-230-8 |
Repr. 1B STOT RE 2 * Aquatic Chronic 2 |
H360F*** H373** H411 |
GHS08 GHS09 Dgr |
H360F*** H373** H411 |
|
|
|
|
|
606-132-00-0 |
(6β)-6,19-epoxyandrost-4-een-3,17-dion |
433-490-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
606-134-00-1 |
androsta-1,4,9(11)-trieen-3,17-dion |
433-560-3 |
Repr. 2 |
H361f*** |
GHS08 Wng |
H361f*** |
|
|
|
|
|
606-135-00-7 |
cyclohexadecanon |
438-930-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-136-00-2 |
(3S,6R, S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraïsobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraäzacyclo-tetracosaan-2,5,8,11,14,17,20,23-octaon |
444-350-6 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
|
|
606-137-00-8 |
trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylideen]-3,3'-dion |
444-750-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-138-00-3 |
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)fenyl]methanon |
444-800-1 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373** H315 H318 H317 H400 H410 |
GHS02 GHS05 GHS08 GHS07 GHS09 Dgr |
H226 H302 H373** H315 H318 H317 H410 |
|
M=10 |
|
|
|
606-139-00-9 |
(S)-4-(3,4-dichloorfenyl)-3,4-dihydro-2H-naftaleen-1-on |
444-830-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
606-140-00-4 |
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)fenyl)-2-methylpropaan-1-on |
444-860-9 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wn |
H373** H410 |
|
|
|
|
|
606-141-00-X |
natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolaat |
418-410-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
606-142-00-5 |
reactiemassa van: (1RS,2SR,7SR,8SR, E) 9 en 10-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on (1RS,2SR,7SR,8SR, Z)-10-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on; (1RS,2SR,7SR,8SR, Z)-9-ethylideen-3-oxatricyclo[6.2.1.02,7]undecaan-4-on |
434-290-9 |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
606-143-00-0 |
abamectine (combinatie van avermectine B1a en avermectine B1b) (ISO) [1] avermectine B1a (zuiverheid ≥ 80 %); [2] |
_ [1] 265-610-3 [2] |
71751-41-2 [1] 65195-55-3 [2] |
Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H300 H330 H372 (zenuwstelsel) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d H300 H330 H372 (zenuwstelsel) H410 |
|
STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C< 5 % M = 10 000 |
|
|
606-144-00-6 |
acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaftaleen-2-ylacetaat |
— |
Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H370 (long) (inademing) H373 (bloed) H400 H410 |
GHS07 GHS08 GHS09 Dgr |
H317 H370 (long) (inademing) H373 (bloed) H410 |
|
M = 1 000 |
|
|
|
606-145-00-1 |
sulcotrione (ISO); 2-[2-chloor-4-(methylsulfonyl)benzoyl]cyclohexaan-1,3-dion |
|
Repr. 2 STOT RE 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H361d H373 (nieren) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (nieren) H317 H410 |
|
M = 1 M = 10 |
|
|
|
606-146-00-7 |
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-een-1-on |
— |
Carc. 2 Acute Tox. 4 Aquatic Chronic 2 |
H351 H302 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H411 |
|
|
|
|
|
606-147-00-2 |
cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-een-1-on |
405-230-9 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
|
|
606-148-00-8 |
carvon (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1] d-carvon; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2] l-carvon; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3] |
202-759-5 [1] 218-827-2 [2] 229-352-5 [3] |
99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] |
Huidgev. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-149-00-3 |
tembotrion (ISO); 2-{2-chloor-4-(methylsulfonyl)-3-[(2,2,2-trifluoorethoxy)methyl]benzoyl}cyclohexaan-1,3-dion |
— |
Repr. 2 STOT RE 2 Huidgev. 1 Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d H373 (ogen, nieren, lever) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (ogen, nieren, lever) H317 H410 |
|
M = 100 M = 10 |
|
|
|
606-150-00-9 |
clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloorallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on |
— |
Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
EUH066 |
|
|
|
|
606-151-00-4 |
antrachinon |
201-549-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
606-152-00-X |
(5-chloor-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenon |
— |
Carc. 2 Aquatic Chronic 1 |
H351 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 |
|
|
|
606-153-00-5 |
benzofenon |
204-337-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
606-154-00-0 |
quinoclamin (ISO); 2-amino-3-chloor-1,4-naftochinon |
220-529-2 |
Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d H302 H373 (bloedstelsel, nieren) H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361d H302 H373 (bloedstelsel, nieren) H319 H317 H410 |
|
oraal: ATE = 500 mg/kg lg M = 10 M = 10 |
|
|
|
606-155-00-6 |
kaneelaldehyde; 3-fenylprop-2-enal; kaneelaldehyde; cinnamal; [1] (2E)-3-fenylprop-2-enal [2] |
203-213-9 [1] — [2] |
104-55-2 [1] 14371-10-9 [2] |
Skin Sens. 1A |
H317 |
GHS07 Wng |
H317 |
|
►C17 Skin Sens. 1A; H317: C ≥ 0,01 % ◄ |
|
|
606-156-00-1 |
acetonoxim |
204-820-1 |
Carc. 1B Acute Tox. 4 STOT SE 3 STOT RE 2 Eye Dam. 1 Skin Sens. 1 |
H350 H312 H336 H373 (bloed) H318 H317 |
GHS08 GHS07 GHS05 Dgr |
H350 H312 H336 H373 (bloed) H318 H317 |
|
dermaal: ATE = 1 100 mg/kg lg |
|
|
|
606-157-00-7 |
(3E)-dec-3-een-2-on |
— |
Acute Tox. 4 Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 2 |
H332 H304 H315 H411 |
GHS07 GHS08 GHS09 Dgr |
H332 H304 H315 H411 |
EUH071 |
inademing: ATE = 1,5 mg/l (stofdeeltjes of nevels) |
|
|
|
606-158-00-2 |
2-(dimethylamino)-2-[(4-methylfenyl)methyl]-1-[4-(morfoline-4-yl)fenyl]butaan-1-on |
438-340-0 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Dgr |
H360Df H410 |
|
M = 1 M = 1 |
|
|
|
607-001-00-0 |
mierenzuur … % |
200-579-1 |
Flam. Liq. 3 Met. Corr. 1 Acute Tox. 3 Acute Tox. 4 Skin Corr. 1A Eye Dam. 1 |
H226 H290 H331 H302 H314 H318 |
GHS02 GHS05 GHS06 Dgr |
H226 H290 H331 H302 H314 |
EUH071 |
inademing: ATE = 7,4 mg/l (dampen) oraal: ATE = 500 mg/kg lg Flam. Liq. 3; H226: C > 85 % Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; 314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤ C < 10 % Eye Dam. 1; H318: C ≥ 10 % Eye Irrit. 2; H319: 2 % ≤ C < 10 % |
B |
|
|
607-002-00-6 |
azijnzuur … % |
200-580-7 |
Flam. Liq. 3 Skin Corr. 1A |
H226 H314 |
GHS02 GHS05 Dgr |
H226 H314 |
|
Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 % Skin Irrit. 2; H315: 10 % ≤C <25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
|
|
607-003-00-1 |
chloorazijnzuur |
201-178-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H331 H311 H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5 % |
|
|
|
607-004-00-7 |
TCA (ISO); trichloorazijnzuur |
200-927-2 |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-005-00-2 |
TCA-natrium (ISO); natriumtrichlooracetaat |
211-479-2 |
STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H400 H410 |
GHS07 GHS09 Wng |
H335 H410 |
|
|
|
|
|
607-006-00-8 |
oxaalzuur |
205-634-3 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
|
|
|
607-007-00-3 |
zouten van oxaalzuur (tenzij elders in deze bijlage vermeld) |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
A |
|
607-008-00-9 |
azijnzuuranhydride |
203-564-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H302 H314 |
|
Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C < 25 % Eye Dam. 1; H318: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 1 % ≤C < 5 % STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-009-00-4 |
ftaalzuuranhydride |
201-607-5 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H335 H315 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H335 H315 H318 H334 H317 |
|
|
|
|
|
607-010-00-X |
propionzuuranhydride |
204-638-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
|
|
|
607-011-00-5 |
acetylchloride |
200-865-6 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
|
|
|
607-012-00-0 |
benzoylchloride |
202-710-8 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H332 H312 H302 H314 H317 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 H317 |
|
|
|
|
|
607-013-00-6 |
dimethylcarbonaat |
210-478-4 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
607-014-00-1 |
methylformiaat |
203-481-7 |
Flam. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H224 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H224 H332 H302 H319 H335 |
|
|
|
|
|
607-015-00-7 |
ethylformiaat |
203-721-0 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H302 H319 H335 |
|
|
|
|
|
607-016-00-2 |
propylformiaat; [1] isopropylformiaat [2] |
203-798-0 [1] 210-901-2 [2] |
110-74-7 [1] 625-55-8 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H225 H319 H335 H336 |
GHS02 GHS07 Dgr |
H225 H319 H335 H336 |
|
|
C |
|
607-017-00-8 |
butylformiaat; [1] tert-butylformiaat; [2] isobutylformiaat [3] |
209-772-5 [1] 212-105-0 [2] 208-818-1 [3] |
592-84-7 [1] 762-75-4 [2] 542-55-2 [3] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
|
607-018-00-3 |
isopentylformiaat; [1] 2-methylbutylformiaat [2] |
203-769-2 [1] 252-343-2 [2] |
110-45-2 [1] 35073-27-9 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
|
607-019-00-9 |
methylchloorformiaat |
201-187-3 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H312 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H312 H302 H314 |
|
|
|
|
|
607-020-00-4 |
ethylchloorformiaat |
208-778-5 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H302 H314 |
|
|
|
|
|
607-021-00-X |
methylacetaat |
201-185-2 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
607-022-00-5 |
ethylacetaat |
205-500-4 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
|
|
607-023-00-0 |
vinylacetaat |
203-545-4 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 |
H225 H351 H332 H335 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H335 |
|
|
D |
|
|
607-024-00-6 |
propylacetaat; [1] isopropylacetaat [2] |
203-686-1 [1] 203-561-1 [2] |
109-60-4 [1] 108-21-4 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
C |
|
607-025-00-1 |
n-butylacetaat |
204-658-1 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
EUH066 |
|
|
|
|
607-026-00-7 |
sec-butylacetaat; [1] isobutylacetaat; [2] tert-butylacetaat [3] |
203-300-1 [1] 203-745-1 [2] 208-760-7 [3] |
105-46-4 [1] 110-19-0 [2] 540-88-5 [3] |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH066 |
|
C |
|
607-027-00-2 |
methylpropionaat |
209-060-4 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
|
|
607-028-00-8 |
ethylpropionaat |
203-291-4 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
607-029-00-3 |
n-butylpropionaat; [1] sec-butylpropionaat; [2] isobutylpropionaat [3] |
209-669-5 [1] -[2] 208-746-0 [3] |
590-01-2 [1] 591-34-4 [2] 540-42-1 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-030-00-9 |
propylpropionaat |
203-389-7 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
|
|
607-031-00-4 |
butylbutyraat |
203-656-8 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
|
607-032-00-X |
ethylacrylaat |
205-438-8 |
Flam. Liq. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 |
H225 H331 H312 H302 H335 H315 H319 H317 |
GHS02 GHS06 Dgr |
H225 H331 H312 H302 H335 H315 H319 H317 |
|
inademing: ATE = 9 mg/l (dampen) dermaal: ATE = 1 800 mg/kg lg oraal: ATE = 1 120 mg/kg lg STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |
D |
|
|
607-033-00-5 |
n-butylmethacrylaat |
202-615-1 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
|
|
607-034-00-0 |
methylacrylaat; methylpropenoaat |
202-500-6 |
Flam. Liq. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 |
H225 H331 H312 H302 H335 H315 H319 H317 |
GHS02 GHS06 Dgr |
H225 H331 H312 H302 H335 H315 H319 H317 |
|
inademing: ATE = 3 mg/l (dampen) dermaal: ATE = 1 100 mg/kg lg oraal: ATE = 500 mg/kg lg |
D |
|
|
607-035-00-6 |
methylmethacrylaat; methyl-2-methylprop-2-enoaat; methyl-2-methylpropenoaat |
201-297-1 |
Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H335 H315 H317 |
|
|
D |
|
|
607-036-00-1 |
2-methoxyethylacetaat; methylglycolacetaat |
203-772-9 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H360FD H332 H312 H302 |
GHS08 GHS07 Dgr |
H360FD H332 H312 H302 |
|
|
|
|
|
607-037-00-7 |
2-ethoxyethylacetaat; ethylglycolacetaat |
203-839-2 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
|
|
607-038-00-2 |
2-butoxyethylacetaat; butylglycolacetaat |
203-933-3 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 |
GHS07 Wng |
H332 H312 |
|
|
|
|
|
607-039-00-8 |
2,4-D (ISO); 2,4-dichloorfenoxyazijnzuur |
202-361-1 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H335 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H335 H318 H317 H412 |
|
|
|
|
|
607-040-00-3 |
zouten van 2,4-D |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
A |
|
607-041-00-9 |
2,4,5-T (ISO); 2,4,5-trichloorfenoxyazijnzuur |
202-273-3 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
|
|
607-042-00-4 |
zouten en esters van 2,4,5-T; zouten en esters van 2,4,5-trichloorfenoxyazijnzuur |
— |
— |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
A |
|
607-043-00-X |
dicamba (ISO); 2,5-dichloor-6-methoxybenzoëzuur; 3,6-dichloor-2-methoxybenzoëzuur |
217-635-6 |
Acute Tox. 4 Acute Tox. 4 STOT SE 3 STOT SE 3 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 2 |
H332 H302 H335 H336 H318 H400 H411 |
GHS07 GHS05 GHS09 Dgr |
H332 H302 H335 H336 H318 H410 |
|
inademing: ATE = 4,0 mg/l (stofdeeltjes of nevels) oraal: ATE = 1 500 mg/kg lg M = 1 |
|
|
|
607-044-00-5 |
3,6-dichloor-o-anijszuur, verbinding met dimethylamine (1:1); [1] kalium-3,6-dichloor-o-anisaat[2] |
218-951-7 [1] 233-002-7 [2] |
2300-66-5 [1] 10007-85-9 [2] |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
607-045-00-0 |
dichloorprop (ISO); 2-(2,4-dichloorfenoxy)propionzuur |
204-390-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H315 H318 |
|
|
|
|
|
607-046-00-6 |
zouten van dichloorprop |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
A |
|
607-047-00-1 |
fenoprop (ISO); 2-(2,4,5-trichloorfenoxy)propionzuur |
202-271-2 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
607-048-00-7 |
zouten van fenoprop; zouten van 2-(2,4,5-trichloorfenoxy)propionzuur |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
|
607-049-00-2 |
mecoprop (ISO); 2-(4-chloor-o-tolyloxy)propionzuur; (RS)-2-(4-chloor-o-tolyloxy)propionzuur; [1] 2-(4-chloor-2-methylfenoxy)propionzuur [2] |
230-386-8 [1] 202-264-4 [2] |
7085-19-0 [1] 708519-0 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
M=100 |
|
|
607-050-00-8 |
zouten van mecoprop |
— |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
A |
|
607-051-00-3 |
MCPA (ISO); 4-chloor-o-tolyloxyazijnzuur |
202-360-6 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
|
|
607-052-00-9 |
zouten en esters van MCPA |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
|
607-053-00-4 |
MCPB (ISO); 4-(4-chloor-o-tolyloxy)boterzuur |
202-365-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-054-00-X |
zouten en esters van MCPB |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
A |
|
607-055-00-5 |
endothal-natrium (ISO); dinatrium-7-oxabicyclo(2,2,1)heptaan-2,3-dicarboxylaat |
204-959-8 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
|
|
607-056-00-0 |
warfarine (ISO); 4-hydroxy-3-(3-oxo-1-fenylbutyl)-2H-chromeen-2-on; [1] (S)-4-hydroxy-3-(3-oxo-1- fenylbutyl)-2-benzopyron; [2] (R)-4-hydroxy-3-(3-oxo-1-fenylbutyl)-2-benzopyron [3] |
201-377-6 [1] 226-907-3 [2] 226-908-9 [3] |
81-81-2 [1] [2] [3] |
Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 |
H360D H330 H310 H300 H372 (bloed) H411 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (bloed) H411 |
|
Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (bloed): C ≥ 0,5 % STOT RE 2; H373 (bloed): 0,05 % ≤ C < 0,5 % |
|
|
607-057-00-6 |
cumachloor (ISO); 3-[1-(4-chloorfenyl)-3-oxobutyl]-4-hydroxycumarine |
201-378-1 |
STOT RE 2 * Aquatic Chronic 3 |
H373 ** H412 |
GHS08 Wng |
H373 ** H412 |
|
|
|
|
|
607-058-00-1 |
cumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycumarine; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]cumarine |
204-195-5 |
Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H301 H372 ** H412 |
GHS06 GHS08 Dgr |
H301 H372 ** H412 |
|
|
|
|
|
607-059-00-7 |
cumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naftyl)cumarine |
227-424-0 |
Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 |
H360D H330 H311 H300 H372 (bloed) H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H311 H300 H372 (bloed) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (bloed): C ≥ 1,0 % STOT RE 2; H373 (bloed) 0,1 % ≤ C < 1,0 % M = 10 |
|
|
|
607-060-00-2 |
dicumarol; 4,4'-dihydroxy-3,3'-methyleenbis(2H-chromeen-2-on) |
200-632-9 |
STOT RE 1 Acute Tox. 4 * Aquatic Chronic 2 |
H372 ** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H302 H411 |
|
|
|
|
|
607-061-00-8 |
acrylzuur; prop-2-eenzuur |
201-177-9 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H226 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 H400 |
|
STOT SE 3; H335: C ≥ 1 % |
D |
|
|
607-062-00-3 |
n-butylacrylaat |
205-480-7 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
|
|
607-063-00-9 |
isoboterzuur |
201-195-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
607-064-00-4 |
benzylchloorformiaat |
207-925-0 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-065-00-X |
broomazijnzuur |
201-175-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H331 H311 H301 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H317 H400 |
|
|
|
|
|
607-066-00-5 |
dichloorazijnzuur |
201-207-0 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
|
|
607-067-00-0 |
dichlooracetylchloride |
201-199-9 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
|
|
607-068-00-6 |
joodazijnzuur |
200-590-1 |
Acute Tox. 3 * Skin Corr. 1A |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
|
|
|
|
607-069-00-1 |
ethylbroomacetaat |
203-290-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
|
|
607-070-00-7 |
ethylchlooracetaat |
203-294-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H331 H311 H301 H400 |
GHS06 GHS09 Dgr |
H331 H311 H301 H400 |
|
|
|
|
|
607-071-00-2 |
ethylmethacrylaat |
202-597-5 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 H317 |
|
|
D |
|
|
607-072-00-8 |
2-hydroxyethylacrylaat |
212-454-9 |
Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 |
H311 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H314 H317 H400 |
|
* Skin Sens. 1; H317: C ≥ 0,2 % |
D |
|
|
607-073-00-3 |
4-CPA (ISO); 4-chloorfenoxyazijnzuur |
204-581-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-074-00-9 |
chloorfenac (ISO); 2,3,6-trichloorfenylazijnzuur |
201-599-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-075-00-4 |
chloorfenprop-methyl; methyl-2-chloor-3-(4-chloorfenyl)propionaat |
238-413-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
607-076-00-X |
dodine (ISO); dodecylguanidiniumacetate |
219-459-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
|
|
607-077-00-5 |
erbon (ISO); 2-(2,4,5-trichloorfenoxy)ethyl2,2-dichloorpropionaat |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-078-00-0 |
fluenetil (ISO); 2-fluorethylbifenyl-4-ylacetaat |
— |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
607-079-00-6 |
kelevan (ISO); ethyl-5-(perchloor-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decaan-5-yl)-4-oxopentanoaat; ethyl-5-(1,2,3,5,6,7,8,9,10,10-decachloor-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovaleraat |
— |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H311 H302 H411 |
GHS06 GHS09 Dgr |
H311 H302 H411 |
|
|
|
|
|
607-080-00-1 |
chlooracetylchloride |
201-171-6 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Aquatic Acute 1 |
H331 H311 H301 H372 ** H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H311 H301 H372 ** H314 H400 |
EUH014 EUH029 |
|
|
|
|
607-081-00-7 |
fluorazijnzuur |
205-631-7 |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
|
|
|
607-082-00-2 |
fluoracetaten, oplosbare |
— |
— |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
A |
|
607-083-00-8 |
2,4-DB (ISO); 4-(2,4-dichloorfenoxy)boterzuur |
202-366-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-084-00-3 |
zouten van 2,4-DB |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
A |
|
607-085-00-9 |
benzylbenzoaat |
204-402-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-086-00-4 |
diallylftalaat |
205-016-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-088-00-5 |
methacrylzuur; 2-methylpropenzuur |
201-204-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
D |
|
|
607-089-00-0 |
propionzuur … % |
201-176-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B |
|
|
607-090-00-6 |
thioglycolzuur |
200-677-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H331 H311 H301 H314 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 |
|
* |
|
|
|
607-091-00-1 |
trifluorazijnzuur . . . % |
200-929-3 |
Acute Tox. 4 * Skin Corr. 1A Aquatic Chronic 3 |
H332 H314 H412 |
GHS05 GHS07 Dgr |
H332 H314 H412 |
|
* |
B |
|
|
607-092-00-7 |
methyllactaat; [1] methyl-(±)-lactaat; [2] methyl-(R)-lactaat; [3] methyl (S)-(–)-lactaat [4] |
208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] |
547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
|
C |
|
607-093-00-2 |
propionylchloride |
201-170-0 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
B D |
|
|
607-094-00-8 |
perazijnzuur… % |
201-186-8 |
Org. Perox. D Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H242 H330 H310 H301 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H242 H330 H310 H301 H314 H410 |
EUH071 |
inademing: ATE = 0,2 mg/l (stofdeeltjes of nevels) dermaal: ATE = 60 mg/kg lg oraal: ATE = 80 mg/kg lg STOT SE 3; H335: C ≥ 1 % M = 10 M = 100 |
B, D, T |
|
|
607-095-00-3 |
maleïnezuur |
203-742-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H335 H315 H317 |
GHS07 Wng |
H302 H319 H335 H315 H317 |
|
Skin Sens. 1; H317: C ≥0,1 % |
|
|
|
607-096-00-9 |
maleïnezuuranhydride |
203-571-6 |
Acute Tox. 4 STOT RE 1 Skin Corr. 1B Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1A |
H302 H372 (luchtwegen) (inademing) H314 H318 H334 H317 |
GHS07 GHS08 GHS05 Dgr |
H302 H372 (luchtwegen) (inademing) H314 H334 H317 |
EUH071 |
Skin Sens. 1A; H317: C ≥ 0,001 % |
|
|
|
607-097-00-4 |
benzeen-1,2,4-tricarbonzuur-1,2-anhydride; trimellietzuuranhydride |
209-008-0 |
STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H335 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H335 H318 H334 H317 |
|
|
|
|
|
607-098-00-X |
benzeen-1,2:4,5-tetracarbonzuurdianhydride; 1,2,4,5-benzeentetracarbonzuurdianhydride; pyromellietzuurdianhydride; |
201-898-9 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
|
|
|
607-099-00-5 |
1,2,3,6-tetrahydroftaalzuuranhydride; [1] cis-1,2,3,6-tetrahydroftaalzuuranhydride; [2] 3,4,5,6-tetrahydroftaalzuuranhydride; [3] tetrahydroftaalzuuranhydride [4] |
201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] |
85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H334 H317 H412 |
GHS08 GHS05 Dgr |
H318 H334 H317 H412 |
|
|
C |
|
607-100-00-9 |
benzofenon-3,3',4,4'-tetracarbonzuurdianhydride; 4,4'-carbonyldi(ftaalzuuranhydride) |
219-348-1 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-101-00-4 |
1,4,5,6,7,7-hexachloorbicyclo[2,2,1]hept-5-een-2,3-dicarbonzuuranhydride; chlorendinezuuranhydride |
204-077-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-102-00-X |
cyclohexaan-1,2-dicarbonzuuranhydride; [1] cis-cyclohexaan-1,2-dicarbonzuuranhydride; [2] trans-cyclohexaan-1,2-dicarbonzuuranhydride [3] |
201-604-9 [1] 236-086-3 [2] 238-009-9 [3] |
85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-103-00-5 |
barnsteenzuuranhydride |
203-570-0 |
Acute Tox. 4 Skin Corr. 1 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H314 H318 H334 H317 |
GHS07 GHS05 GHS08 Dgr |
H302 H314 H334 H317 |
EUH071 |
|
|
|
|
607-104-00-0 |
cyclopentaan-1,2,3,4-tetracarbonzuurdianhydride |
227-964-7 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
|
|
607-105-00-6 |
8,9,10-trinorborn-5-een-2,3-dicarbonzuuranhydride; [1] 1,2,3,6-tetrahydro-3,6-methanoftaalzuuranhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanoftaalzuuranhydride [3] |
204-957-7 [1] 212-557-9 [2] 220-384-5 [3] |
129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-106-00-1 |
8,9-dinorborn-5-een-2,3-dicarbonzuuranhydride |
— |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H302 H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H302 H319 H335 H315 H334 |
|
STOT SE 3; H335: C ≥ 10 % |
C |
|
|
607-107-00-7 |
2-ethylhexylacrylaat |
203-080-7 |
STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H335 H315 H317 |
GHS07 Wng |
H335 H315 H317 |
|
|
D |
|
|
607-108-00-2 |
2-hydroxy-1-methylethylacrylaat; [1] 2-hydroxypropylacrylaat; [2] acrylzuur, monoester met propaan-1,2-diol [3] |
220-852-9 [1] 213-663-8 [2] 247-118-0 [3] |
2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
C D |
|
607-109-00-8 |
hexamethyleendiacrylaat; hexaan-1,6-dioldiacrylaat |
235-921-9 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-110-00-3 |
pentaërytritoltriacrylaat |
222-540-8 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-111-00-9 |
2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propaandiyldiacrylaat; 2,2-bis(acryloyloxymethyl)butylacrylaat; trimethylolpropaantriacrylaat |
239-701-3 |
Carc. 2 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H315 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H315 H319 H317 H410 |
|
M = 1 M = 1 |
D |
|
|
607-112-00-4 |
2,2-dimethyltrimethyleendiacrylaat; neopentylglycoldiacrylaat |
218-741-5 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* |
D |
|
|
607-113-00-X |
isobutylmethacrylaat |
202-613-0 |
Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Skin Sens. 1B |
H226 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H335 H315 H317 |
|
|
D |
|
|
607-114-00-5 |
ethyleendimethacrylaat |
202-617-2 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
STOT SE 3; H335: C ≥ 10 % |
D |
|
|
607-115-00-0 |
isobutylacrylaat |
203-417-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H226 H332 H312 H315 H317 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 H317 |
|
|
D |
|
|
607-116-00-6 |
cyclohexylacrylaat |
221-319-3 |
STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H335 H315 H411 |
GHS07 GHS09 Wng |
H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
D |
|
|
607-117-00-1 |
2,3-epoxypropylacrylaat; glycidylacrylaat |
203-440-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
D |
|
|
607-118-00-7 |
1-methyltrimethyleendiacrylaat; 1,3-butyleenglycoldiacrylaat |
243-105-9 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
|
|
607-119-00-2 |
tetramethyleendiacrylaat; 1,4-butyleenglycoldiacrylaat |
213-979-6 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
|
|
607-120-00-8 |
2,2'-oxydiëthyldiacrylaat; diëthyleenglycoldiacrylaat |
223-791-6 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* Skin Sens. 1; H317:C≥0,2 % |
D |
|
|
607-121-00-3 |
8,9,10-trinorborn-2-ylacrylaat |
— |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H312 H315 H317 |
GHS07 Wng |
H312 H315 H317 |
|
|
D |
|
|
607-122-00-9 |
pentaërytritoltetraäcrylaat |
225-644-1 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-123-00-4 |
2,3-epoxypropylmethacrylaat; glycidylmethacrylaat |
203-441-9 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1 |
H350 H341 H360F H311 H302 H335 H372 (luchtwegen) (inademing) H318 H314 H317 |
GHS08 GHS06 GHS05 Dgr |
H350 H341 H360F H311 H302 H335 H372 (luchtwegen) (inademing) H314 H317 |
|
|
D |
|
|
607-124-00-X |
2-hydroxyethylmethacrylaat |
212-782-2 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-125-00-5 |
2-hydroxypropylmethacrylaat; [1] 3-hydroxypropylmethacrylaat [2] |
213-090-3 [1] 220-426-2 [2] |
923-26-2 [1] 2761-09-3 [2] |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
C D |
|
607-126-00-0 |
2,2'-(ethyleendioxy)diëthyldiacrylaat; triëthyleenglycoldiacrylaat |
216-853-9 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-127-00-6 |
2-diëthylaminoëthylmethacrylaat |
203-275-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H319 H315 H317 |
GHS07 Wng |
H332 H319 H315 H317 |
|
|
D |
|
|
607-128-00-1 |
2-tert-butylaminoëthylmethacrylaat |
223-228-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
|
|
607-129-00-7 |
ethyllactaat; ethyl-DL-lactaat; [1] ethyl-(S)-2-hydroxypropionaat; ethyl-L-lactaat; ethyl-(S)-lactaat [2] |
202-598-0 [1] 211-694-1 [2] |
97-64-3 [1] 687-47-8 [2] |
Flam. Liq. 3 STOT SE 3 Eye Dam. 1 |
H226 H335 H318 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H318 |
|
|
C |
|
607-130-00-2 |
pentylacetaat; [1] isopentylacetaat; [2] 1-methylbutylacetaat; [3] 2-methylbutylacetaat; [4] 2(of 3)-methylbutylacetaat [5] |
211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] |
628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
EUH066 |
|
C |
|
607-131-00-8 |
isopentylpropionaat; [1] pentylpropionaat; [2] 2-methylbutylpropionaat [3] |
203-322-1 [1] 210-852-7 [2] 219-449-0 [3] |
105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
|
607-132-00-3 |
2-dimethylaminoëthylmethacrylaat |
220-688-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H312 H302 H319 H315 H317 |
GHS07 Wng |
H312 H302 H319 H315 H317 |
|
|
D |
|
|
607-133-00-9 |
monoalkyl- of monoaryl- of monoalkylarylesters van acrylzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H335 H315 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
A |
|
607-134-00-4 |
monoalkyl- of monoaryl- of monoalkylarylesters van methacrylzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOTSE 3; H335: C ≥ 10 % |
A |
|
607-135-00-X |
boterzuur |
203-532-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-136-00-5 |
butyrylchloride |
205-498-5 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
|
607-137-00-0 |
methylacetoacetaat |
203-299-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-138-00-6 |
butylchloorformiaat; chloormierenzuur, butylester |
209-750-5 |
Flam. Liq. 3 Acute Tox. 3 * Skin Corr. 1B |
H226 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H314 |
|
|
|
|
|
607-139-00-1 |
2-chloorpropionzuur |
209-952-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
|
607-140-00-7 |
isobutyrylchloride |
201-194-1 |
Flam. Liq. 2 Skin Corr. 1A |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
|
|
607-141-00-2 |
oxydiëthyleenbis(chloorformiaat) |
203-430-9 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H411 |
|
|
|
|
|
607-142-00-8 |
propylchloorformiaat; chloormierenzuur, propylester; n-propylchloorformiaat |
203-687-7 |
Flam. Liq. 2 Acute Tox. 3 * Skin Corr. 1B |
H225 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H331 H314 |
|
|
|
|
|
607-143-00-3 |
valeriaanzuur |
203-677-2 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
|
607-144-00-9 |
adipinezuur |
204-673-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-145-00-4 |
methaansulfonzuur |
200-898-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-146-00-X |
fumaarzuur |
203-743-0 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-147-00-5 |
oxaalzuur, diëthylester diëthyloxalaat |
202-464-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
607-148-00-0 |
guanidiniumchloride; guanadinehydrochloride |
200-002-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
|
|
607-149-00-6 |
urethaan (INN); ethylcarbamaat |
200-123-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
|
|
607-150-00-1 |
endothal (ISO); 7-oxabicyclo(2,2,1)heptaan-2,3-dicarbonzuur |
205-660-5 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
|
|
607-151-00-7 |
propargiet (ISO); 2-(4-tert-butylfenoxy)cyclohexyl-prop-2-ynyl-sulfiet |
219-006-1 |
Carc. 2 Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H315 H318 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H331 H315 H318 H410 |
|
M = 10 |
|
|
|
607-152-00-2 |
2,3,6-TBA (ISO); 2,3,6-trichloorbenzoëzuur |
200-026-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-153-00-8 |
benazoline (ISO); 4-chloor-2,3-dihydro-2-oxo-1,3-benzothiazool-3-ylazijnzuur |
223-297-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
|
|
607-154-00-3 |
ethyl-N-benzoyl-N-(3,4-dichloorfenyl)-DL-alaninaat; benzoylprop-ethyl (ISO) |
244-845-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-155-00-9 |
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidine-1-yl)-2,3-dihydro-(6H)-pyran-2-carbonzuur; blasticidin-s |
— |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
|
|
607-156-00-4 |
chloorfenson (ISO); 4-chloorfenyl-4-chloorbenzeensulfonaat |
201-270-4 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
607-157-00-X |
difenacum (ISO); 3-(3-bifenyl-4-yl-1,2,3,4-tetrahydro-1-naftyl)-4-hydroxycumarine |
259-978-4 |
Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (bloed) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (bloed) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (bloed): C ≥ 0,02 % STOT RE 2; H373 (bloed): 0,002 % ≤ C < 0,02 % M = 10 M = 10 |
|
|
|
607-158-00-5 |
natriumzout van chloorazijnzuur; natriumchlooracetaat |
223-498-3 |
Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 |
H301 H315 H400 |
GHS06 GHS09 Dgr |
H301 H315 H400 |
|
|
|
|
|
607-159-00-0 |
chloorbenzilaat (ISO); ethyl-2,2-di(4-chloorfenyl)-2-hydroxyacetaat; ethyl-4,4'-dichloorbenzilaat; |
208-110-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-160-00-6 |
isobutyl-2-(4-(4-chloorfenoxy)fenoxy)propionaat; clofop-isobutyl (ISO) |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-161-00-1 |
diëthanolaminezout van 4-CPA |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
607-162-00-7 |
dalapon; 2,2-dichloorpropionzuur; [1] dalapon-natrium; natrium-2,2-dichloorpropionaat [2] |
200-923-0 [1] 204-828-5 [2] |
75-99-0 [1] 127-20-8 [2] |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
607-163-00-2 |
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dion; dehydroazijnzuur |
208-293-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-164-00-8 |
natrium-1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylideen)ethanolaat; natrium-dehydracetaat |
224-580-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-165-00-3 |
diclofop-methyl (ISO); methyl-2-(4-(2,4-dichloorfenoxy)fenoxy)propionaat; methyl-(RS)-2-[4-(2,4-dichloorfenoxy)fenoxy]propionaat; |
257-141-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
607-166-00-9 |
medinoterb-acetaat (ISO); 6-tert-butyl-3-methyl-2,4-dinitrofenylacetaat |
219-634-6 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
|
|
607-167-00-4 |
natrium-3-chlooracrylaat |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
|
|
607-168-00-X |
dipropyl-6,7-methyleendioxy-1,2,3,4-tetrahydro-3-methylnaftaleen-1,2-dicarboxylaat; propylisome |
— |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H400 H410 |
GHS06 GHS09 Dgr |
H311 H302 H410 |
|
|
|
|
|
607-169-00-5 |
natriumfluoracetaat |
200-548-2 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H330 H310 H300 H400 |
GHS06 GHS09 Dgr |
H330 H310 H300 H400 |
|
|
|
|
|
607-170-00-0 |
bis(1,2,3-trithiacyclohexyldimethylammonium)oxalaat; thiocyclam-oxalaat |
250-859-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
|
|
607-172-00-1 |
brodifacoum (ISO); 4-hydroxy-3-(3-(4′ -broom-4-bifenylyl)-1,2,3,4-tetrahydro-1-naftyl)cumarine |
259-980-5 |
Repr. 1A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (bloed) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (bloed) H410 |
|
Repr. 1A; H360D: C ≥ 0,003 % STOT RE 1; H372 (bloed): C ≥ 0,02 % STOT RE 2; H373 (bloed): 0,002 % ≤ C < 0,02 % M = 10 M = 10 |
|
|
|
607-173-00-7 |
dimethyl-(3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thiënyl)azo)fenylnitrilodipropionaat |
400-460-6 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-174-00-2 |
reactiemassa van dodecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosaan-20-yl)propionaat en tetradecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosaan-20-yl)propionaat |
400-580-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-175-00-8 |
methyl-2-(2-nitrobenzylideen)acetoacetaat |
400-650-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-176-00-3 |
reactiemassa van α-3-(3-(2H-benzotriazool-2-yl)-5-tert-butyl-4-hydroxyfenyl)propionyl-ω-hydroxypoly(oxyethyleen) en α-3-(3-(2H-benzotriazool-2-yl)-5-tert-butyl-4-hydroxyfenyl)propionyl-ω-3-(3-(2H-benzotriazool-2-yl)-5-tert-butyl-4-hydroxyfenyl)propionyloxypoly(oxyethyleen) |
400-830-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-177-00-9 |
tribenuron-methyl (ISO); methyl-2-[N-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)-N-methylcarbamoylsulfamoyl]benzoaat |
401-190-1 |
STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 H317 H410 |
|
M = 100 M = 100 |
|
|
|
607-178-00-4 |
methyl-α-((4,6-dimethoxypyrimidine-2-yl)ureïdosulfonyl)-o-toluaat |
401-340-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-179-00-X |
(benzothiazool-2-ylthio)barnsteenzuur |
401-450-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-180-00-5 |
kalium-2-hydroxycarbazool-1-carboxylaat |
401-630-2 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H302 H319 H335 H412 |
GHS07 Wng |
H302 H319 H335 H412 |
|
|
|
|
|
607-181-00-0 |
3,5-dichloor-2,4-difluorbenzoylfluoride |
401-800-6 |
Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H331 H314 H302 H317 H412 |
GHS06 GHS05 Dgr |
H331 H314 H302 H317 H412 |
EUH029 |
|
|
|
|
607-182-00-6 |
methyl-3-sulfamoyl-2-thenoaat |
402-050-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-183-00-1 |
zink-2-hydroxy-5-C13-18 alkylbenzoaat |
402-280-3 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
|
607-184-00-7 |
S-(3-trimethoxysilyl)propyl-19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraäzanonadecaanthioaat |
402-290-8 |
Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 |
H226 H334 H317 |
GHS02 GHS08 Dgr |
H226 H334 H317 |
|
|
|
|
|
607-185-00-2 |
ethyl-trans-3-dimethylaminoacrylaat |
402-650-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-186-00-8 |
quinclorac (ISO); 3,7-dichloorchinoline-8-carbonzuur; |
402-780-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-187-00-3 |
bis(2,2,6,6-tetramethyl-4-piperidyl)succinaat |
402-940-0 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
|
|
607-188-00-9 |
hydrogeen-natrium-N-carboxylatoëthyl-N-octadec-9-enylmaleamaat |
402-970-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-189-00-4 |
trimethyleendiaminetetraäzijnzuur |
400-400-9 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
607-190-00-X |
methylacrylamidomethoxyacetaat (met ≥ 0,1 % acrylamide) |
401-890-7 |
Carc. 1B Muta. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H340 H302 H319 |
GHS08 GHS07 Dgr |
H350 H340 H302 H319 |
|
|
|
|
|
607-191-00-5 |
isobutyl-3,4-epoxybutyraat |
401-920-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
|
607-192-00-0 |
dinatrium-N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinaat |
402-360-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-194-00-1 |
propyleencarbonaat |
203-572-1 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-195-00-7 |
2-methoxy-1-methylethylacetaat |
203-603-9 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
|
|
607-196-00-2 |
heptaanzuur |
203-838-7 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-197-00-8 |
nonaanzuur |
203-931-2 |
Huidirrit. 2 Oogirrit. 2 Aquatisch chronisch 3 |
H315 H319 H412 |
GHS07 Wng |
H315 H319 H412 |
|
|
|
|
|
607-198-00-3 |
propyl-3,4,5-trihydroxybenzoaat |
204-498-2 |
Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
oraal: ATE = 1 700 mg/kg lg M = 1 M = 1 |
|
|
|
607-199-00-9 |
octyl-3,4,5-trihydroxybenzoaat |
213-853-0 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
|
|
607-200-00-2 |
dodecyl-3,4,5-trihydroxybenzoaat |
214-620-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-201-00-8 |
thiocarbonylchloride |
207-341-6 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H331 H302 H319 H335 H315 |
GHS06 Dgr |
H331 H302 H319 H335 H315 |
|
|
|
|
|
607-203-00-9 |
2-ethylhexyl-[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyfenyl]methyl]thio]acetaat |
279-452-8 |
Repr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H360D *** H317 H412 |
GHS08 GHS07 Dgr |
H360D *** H317 H412 |
|
|
|
|
|
607-204-00-4 |
(chloorfenyl)(chloortolyl)methaan, mengsel van isomeren |
400-140-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-205-00-X |
methylchlooracetaat |
202-501-1 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H331 H301 H335 H315 H318 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H301 H335 H315 H318 |
|
|
|
|
|
607-206-00-5 |
isopropylchlooracetaat |
203-301-7 |
Flam. Liq. 3 Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H226 H301 H319 H335 H315 |
GHS02 GHS06 Dgr |
H226 H301 H319 H335 H315 |
|
|
|
|
|
607-207-00-0 |
haloxyfop-etotyl (ISO); 2-ethoxyethyl-2-(4-(3-chloor-5-trifluormethyl-2-pyridyloxy)fenoxy)propionaat; haloxyfop-(2-ethoxyethyl) |
402-560-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-208-00-6 |
4,8,12-trimethyltrideca-3,7,11-trieenzuur, mengsel van isomeren |
403-000-2 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
|
607-209-00-1 |
reactiemassa van O,O'-diisopropyl-(pentathio)dithioformiaat en O,O'-diisopropyl-(trithio)dithioformiaat en O,O'-diisopropyl-(tetrathio)dithioformiaat |
403-030-6 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
607-210-00-7 |
methylacrylamidoglycolaat (met ≥ 0,1 % acrylamide) |
403-230-3 |
Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 |
H350 H340 H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H350 H340 H314 H317 |
|
|
|
|
|
607-211-00-2 |
methyl-3-(3-tert-butyl-4-hydroxy-5-methylfenyl)propionaat |
403-270-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-212-00-8 |
poly(oxypropyleencarbonyl-co-oxy(ethylethyleen)carbonyl), met 27 % hydroxyvaleraat |
403-300-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-213-00-3 |
ethyl-3,3-bis(tert-pentylperoxy)butyraat |
403-320-2 |
Org. Perox. D**** Flam. Liq. 3 Aquatic Chronic 2 |
H242 H226 H411 |
GHS02 GHS09 Dgr |
H242 H226 H411 |
|
|
|
|
|
607-214-00-9 |
N,N-hydrazinodiazijnzuur |
403-510-5 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H373 ** H317 H412 |
GHS06 GHS08 Dgr |
H301 H373 ** H317 H412 |
|
|
|
|
|
607-215-00-4 |
3-(3-tert-butyl-4-hydroxyfenyl)propionzuur |
403-920-4 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
607-216-00-X |
glutaminezuur, reactieproducten met N-(C12-14-alkyl)propyleendiamine |
403-950-8 |
— |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H330 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H302 H314 H400 |
|
|
|
|
607-217-00-5 |
2-ethoxyethyl-2-(4-(7-fenyl-2,6-dihydro-2,6-dioxo-1,5-dioxaïndaceen-3-yl)fenoxy)acetaat |
403-960-2 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-218-00-0 |
dichloorprop-P (ISO); (+)-R-2-(2,4-dichloorfenoxy)propionzuur |
403-980-1 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-219-00-6 |
bis(2-ethylhexyl)dithioacetaat |
404-510-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
|
|
607-221-00-7 |
2-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylfenantreen-1-yl)-3-oxo-2-oxafenaleen-1-yl)naftaleen-2-carbonzuur |
404-550-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
607-222-00-2 |
6-(2,3-dimethylmaleïmido)hexylmethacrylaat |
404-870-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-223-00-8 |
transfluthrin (ISO); 2,3,5,6-tetrafluorbenzyl-(1R,3S)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
405-060-5 |
Carc. 2 Acute Tox. 4 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H370 (zenuwstelsel) H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H370 (zenuwstelsel) H410 |
EUH066 |
oraal: ATE = 580 mg/kg lg M = 1 000 M = 1 000 |
|
|
|
607-224-00-3 |
methyl-2-(3-nitrobenzylideen)acetoacetaat |
405-270-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
607-225-00-9 |
3-azidosulfonylbenzoëzuur |
405-310-3 |
Self-React. C **** STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H241 H373 ** H318 H317 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H241 H373 ** H318 H317 |
|
|
|
|
|
607-226-00-4 |
reactiemassa van 2-acryloyloxyethyl-hydrogeen-cyclohexaan-1,2-dicarboxylaat en 2-methacryloyloxyethyl-hydrogeen-cyclohexaan-1,2-dicarboxylaat |
405-360-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H315 H318 H317 H412 |
GHS05 GHS07 Dgr |
H315 H318 H317 H412 |
|
|
|
|
607-227-00-X |
kalium-2-amino-2-methylpropionaat-octahydraat |
405-560-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
|
|
607-228-00-5 |
bis(2-methoxyethyl)ftalaat |
204-212-6 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
|
607-229-00-0 |
diëthylcarbamoylchloride |
201-798-5 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H332 H302 H319 H335 H315 |
GHS08 GHS07 Wng |
H351 H332 H302 H319 H335 H315 |
|
|
|
|
|
607-230-00-6 |
2-ethylhexaanzuur en zouten daarvan, tenzij elders in deze bijlage vermeld |
— |
— |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
A, X, 12 |
|
607-231-00-1 |
clopyralid (ISO); 3,6-dichloorpyridine-2-carbonzuur |
216-935-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-232-00-7 |
pyridaat (ISO); O-(6-chloor-3-fenylpyridazine-4-yl) S-octylthiocarbonaat |
259-686-7 |
Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H317 H410 |
|
oraal: ATE = 500 mg/kg lichaamsgewicht M = 1 M = 10 |
|
|
|
607-233-00-2 |
hexylacrylaat |
219-698-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
|
|
|
|
607-234-00-8 |
flurenol (ISO); 9-hydroxy-9H-fluoreen-9-carbonzuur |
207-397-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-235-00-3 |
mecrilaat; methyl-2-cyaanacrylaat |
205-275-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-236-00-9 |
ethyl-2-cyaanacrylaat |
230-391-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-237-00-4 |
benzyl-2-chloor-4-(trifluormethyl)thiazool-5-carboxylaat; flurazool |
276-942-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-238-00-X |
tau-fluvalinaat (ISO); cyaan-(3-fenoxyfenyl)methyl N-[2-chloor-4-(trifluormethyl)fenyl]-D-valinaat |
— |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
|
|
607-239-00-5 |
fenpropathrin (ISO); α-cyaan-3-fenoxybenzyl-2,2,3,3-tetramethylcyclopropaancarboxylaat; |
254-485-0 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
|
|
|
|
607-240-00-0 |
cis-1,2,3,6-tetrahydro-4-methylftaalzuuranhydride; [1] 1,2,3,6-tetrahydro-4-methylftaalzuuranhydride; [2] 1,2,3,6-tetrahydro-3-methylftaalzuuranhydride; [3] tetrahydromethylftaalzuuranhydride; [4] 1,2,3,6-tetrahydromethylftaalzuuranhydride; [5] tetrahydro-4-methylftaalzuuranhydride; [6] 2,3,5,6-tetrahydro-2-methylftaalzuuranhydride [7] |
216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] |
1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-241-00-6 |
hexahydro-4-methylftaalzuuranhydride; [1] hexahydromethylftaalzuuranhydride; [2] hexahydro-1-methylftaalzuuranhydride; [3] hexahydro-3-methylftaalzuuranhydride [4] |
243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] |
19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
|
607-242-00-1 |
tetrachloorftaalzuuranhydride |
204-171-4 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H317 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H318 H334 H317 H410 |
|
|
|
|
|
607-243-00-7 |
natrium-3,6-dichloor-o-anisaat; [1] 3,6-dichloor-o-anijszuur, verbinding met 2,2'-iminodiëthanol (1:1); [2] 3,6-dichloor-o-anijszuur, verbinding met 2-aminoëthanol (1:1) [3] |
217-846-3 [1] 246-590-5 [2] 258-527-9 [3] |
1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-244-00-2 |
isoöctylacrylaat |
249-707-8 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-245-00-8 |
tert-butylacrylaat |
216-768-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H312 H302 H335 H315 H317 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H312 H302 H335 H315 H317 H411 |
|
|
D |
|
|
607-246-00-3 |
allylmethacrylaat; 2-methyl-2-propeenzuur, 2-propenylester |
202-473-0 |
Flam. Liq. 3 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 |
H226 H330 H311 H302 H400 |
GHS02 GHS06 GHS09 Dgr |
H226 H330 H311 H302 H400 |
|
inademing: ATE = 1,5 mg/l (dampen) dermaal: ATE = 300 mg/kg lg oraal: ATE = 400 mg/kg lg |
|
|
|
607-247-00-9 |
dodecylmethacrylaat |
205-570-6 |
STOT SE 3 |
H335 |
GHS07 Wng |
H335 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-248-00-4 |
naptalam-natrium (ISO); natrium-N-naft-1-ylftalamaat |
205-073-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-249-00-X |
(1-methyl-1,2-ethaandiyl)bis[oxy(methyl-2,1-ethaandiyl)diacrylaat |
256-032-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
|
|
|
607-250-00-5 |
4H-3,1-benzoxazine-2,4(1H)-dion |
204-255-0 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
|
|
607-251-00-0 |
2-methoxypropylacetaat |
274-724-2 |
Flam. Liq. 3 Repr. 1B STOT SE 3 |
H226 H360D *** H335 |
GHS02 GHS08 GHS07 Dgr |
H226 H360D *** H335 |
|
|
|
|
|
607-252-00-6 |
lambda-cyhalothrin (ISO); reactiemassa van: (S)-α-cyaan-3-fenoxybenzyl(Z)-(1R)-cis-3-(2-chloor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropaancarboxylaat en (R)-α-cyaan-3-fenoxybenzyl(Z)-(1S)-cis-3-(2-chloor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropaancarboxylaat (1:1) |
415-130-7 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
M=10000 |
|
|
|
607-253-00-1 |
cyfluthrin (ISO); α-cyaan-4-fluor-3-fenoxybenzyl-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
269-855-7 |
Lact. Acute Tox. 2 Acute Tox. 2 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H362 H330 H300 H370 (zenuwstelsel) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H362 H330 H300 H370 (zenuwstelsel) H410 |
|
inademing: ATE = 0,14 mg/L (stofdeeltjes of nevels) oraal: ATE = 14 mg/kg lg M = 1 000 000 M = 1 000 000 |
|
|
|
607-254-00-7 |
bèta-cyfluthrin (ISO); reactiemassa van: rel-(R)-cyaan(4-fluor-3-fenoxyfenyl)methyl (1S,3S)-3-(2,2-dichloorethenyl)-2,2-dimethylcyclopropaan-1-carboxylaat en rel-(R)-cyaan(4-fluor-3-fenoxyfenyl)methyl (1S,3R)-3-(2,2-dichloorethenyl)-2,2-dimethylcyclopropaan-1-carboxylaat |
— |
Lact. Acute Tox. 2 Acute Tox. 2 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H362 H330 H300 H370 (zenuwstelsel) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H362 H330 H300 H370 (zenuwstelsel) H410 |
|
inademing: ATE = 0,081 mg/L (stofdeeltjes of nevels) oraal: ATE = 11 mg/kg lg M = 1 000 000 M = 1 000 000 |
|
|
|
607-255-00-2 |
fluroxypyr (ISO); 4-amino-3,5-dichloor-6-fluor-2-pyridyloxyazijnzuur |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-256-00-8 |
azoxystrobin (ISO); methyl-(E)-2-{2-[6-(2-cyaanfenoxy)pyrimidine-4-yloxy]fenyl-3-methoxyacrylaat |
— |
Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H400 H410 |
GHS06 GHS09 Dgr |
H331 H410 |
|
inademing: ATE = 0,7 mg/l (stofdeeltjes of nevels) M = 10 M = 10 |
|
|
|
607-257-00-3 |
isopropylpropionaat |
211-300-8 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
|
|
607-258-00-9 |
dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoïmidazolidine-1-yl)-3-(4-methoxybenzoyl)aceetamido)-4-chloorbenzoaat |
403-990-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-259-00-4 |
methyl-2R,3S-(–)-3-(4-methoxyfenyl)oxiraancarboxylaat |
404-130-2 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
607-260-00-X |
ethyl-2-(3-nitrobenzylideen)acetoacetaat |
404-490-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
607-261-00-5 |
iso(C10-C14)alkyl-(3,5-di-tert-butyl-4-hydroxyfenyl)methylthioacetaat |
404-800-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-262-00-0 |
7-chloor-1-cyclopropyl-6-fluor-1,4-dihydro-4-oxochinoline-3-carbonzuur |
405-050-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
|
|
607-263-00-6 |
kalium/ijzer(III)-1,3-propaandiamine-N,N,N',N'-tetraäcetaat-hemihydraat |
405-680-6 |
— |
Self-heat. 2 **** Aquatic Chronic 2 |
H252 H411 |
GHS02 GHS09 Wng |
H252 H411 |
|
|
|
|
607-264-00-1 |
2-chloor-4-(methylsulfonyl)benzoëzuur |
406-520-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-265-00-7 |
ethyl-2-chloor-2,2-difenylacetaat |
406-580-5 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
607-266-00-2 |
reactiemassa van: hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoaat]; 3,5-di-tert-butyl-salicylzuur |
406-890-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-267-00-8 |
tert-butyl-(5S,6R,7R)-3-broommethyl-5,8-dioxo-7-(2-fenylaceetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carboxylaat |
407-620-4 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H334 H317 H412 |
GHS08 Dgr |
H334 H317 H412 |
|
|
|
|
|
607-268-00-3 |
2-methylpropyl-(R)-2-hydroxypropanoaat |
407-770-0 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-269-00-9 |
(R)-2-(4-hydroxyfenoxy)propaanzuur |
407-960-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-270-00-4 |
3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylfenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro[5.5]undecaan |
410-730-5 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
|
|
607-271-00-X |
2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropaan |
417-420-9 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
|
607-272-00-5 |
fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloor-6-fluor-2-pyridyloxy)acetaat; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloor-6-fluor-2-pyridyloxy)acetaat [2] |
279-752-9 [1] -[2] |
81406-37-3 [1] 154486-27-8 [2] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-273-00-0 |
ammonium-7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naftyl)-3,5-dihydroxyheptanoaat |
404-520-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-274-00-6 |
2-(N-benzyl-N-methylamino)ethyl-3-amino-2-butenoaat |
405-350-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-275-00-1 |
natrium-benzoyloxybenzeen-4-sulfonaat |
405-450-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-276-00-7 |
bis[(1-methylimidazool)-(2-ethyl-hexanoaat)], zinkcomplex |
405-635-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-277-00-2 |
reactiemassa van: 2-(hexylthio)ethylaminehydrochloride; natrium-propionaat |
405-720-2 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
|
607-278-00-8 |
reactiemassa van isomeren van: natriumfenethylnaftaleensulfonaat; natriumnaftylethylbenzeensulfonaat |
405-760-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-279-00-3 |
reactiemassa van: n-octadecylaminodiëthylbis(hydrogeen-maleaat); n-octadecylaminodiëthyl-waterstofmaleaat-waterstofftalaat |
405-960-8 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-280-00-9 |
natrium-4-chloor-1-hydroxybutaan-1-sulfonaat |
406-190-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
|
|
607-281-00-4 |
reactiemassa van vertakte en lineaire C7-C9 alkyl-3-[3-(2H-benzotriazool-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyfenyl]propionaten |
407-000-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-282-00-X |
2-acetoxymethyl-4-benzyloxybutylacetaat |
407-140-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-283-00-5 |
E-ethyl-4-oxo-4-fenylcrotonaat |
408-040-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H317 H410 |
|
|
|
|
|
607-284-00-0 |
reactiemassa (9:1) van: natrium-3,3'-(1,4-fenyleenbis(carbonylimino-3,1-propaandiylimino))bis(10-amino-6,13-dichloor)-4,11-trifenodioxazinedisulfonaat); lithium-3,3'-(1,4-fenyleenbis(carbonylimino-3,1-propaandiylimino))bis(10-amino-6,13-dichloor)-4,11-trifenodioxazinedisulfonaat) |
410-040-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-285-00-6 |
reactiemassa van: 7-(((3-aminofenyl)sulfonyl)amino)-naftaleen-1,3-disulfonzuur; natrium-7-(((3-aminofenyl)sulfonyl)amino)-naftaleen-1,3-disulfonaat; kalium-7-(((3-aminofenyl)sulfonyl)amino)-naftaleen-1,3-disulfonaat |
410-065-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
|
|
|
|
|
607-286-00-1 |
reactiemassa van: natrium/kalium-7-[[[3-[[4-((2-hydroxy-naftyl)azo)-fenyl]azo]fenyl]sulfonyl]amino]naftaleen-1,3-disulfonaat |
410-070-8 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-287-00-7 |
O'-methyl-O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydroftalaat |
410-140-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-288-00-2 |
tetranatrium-(c-(3-(1-(3-(e-6-dichloor-5-cyaanpyrimidine-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatofenylsulfamoyl)ftalocyanine-a, b,d-trisulfonato(6–))nikkelaat(II), waarbij a is 1 of 2 of 3 of 4,b is 8 of 9 of 10 of 11,c is 15 of 16 of 17 of 18, d is 22 of 23 of 24 of 25 en waarbij e en f samen respectievelijk 2 en 4 of 4 en 2 zijn |
410-160-7 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
|
|
607-289-00-8 |
3-(3-(4-(2,4-bis(1,1-dimethylpropyl)fenoxy)butylaminocarbonyl-4-hydroxy-1-naftalenyl)thio)propaanzuur |
410-370-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-290-00-3 |
reactiemassa (verhouding onbekend) van: ammonium-1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethaan-1-sulfonaat; ammonium-2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethaan-1-sulfonaat |
410-540-2 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
|
607-291-00-9 |
dodecyl-ω-(C5/C6-cycloalkyl)alkylcarboxylaat |
410-630-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-292-00-4 |
reactiemassa van: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]azijnzuur; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]azijnzuur |
410-640-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-293-00-X |
reactiemassa van: N-aminoëthylpiperazonium-mono-2,4,6-trimethylnonyldifenyletherdisulfonaat; N-aminoëthylpiperazonium-di-2,4,6-trimethylnonyldifenyletherdisulfonaat |
410-650-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
607-294-00-5 |
natrium-2-benzoyloxy-1-hydroxyethaan-sulfonaat |
410-680-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-295-00-0 |
reactiemassa van: tetranatrium-fosfonethaan-1,2-dicarboxylaat; hexanatrium-fosfonobutaan-1,2,3,4-tetracarboxylaat |
410-800-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-296-00-6 |
reactiemassa van: tetraësters van pentaërytriol met heptaanzuur en 2-ethylhexaanzuur |
410-830-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-297-00-1 |
(E-E)-3,3'-(1,4-fenyleendimethylideen)bis(2-oxobornaan-10-sulfonzuur) |
410-960-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-298-00-7 |
2-(trimethylammonium)ethoxycarboxybenzeen-4-sulfonaat |
411-010-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-299-00-2 |
methyl-3-(acetylthio)-2-methyl-propanoaat |
411-040-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
607-300-00-6 |
trinatrium-[2-(5-chloor-2,6-difluorpyrimidine-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatoftalocyanine-a-yl-K 4,N 29,N 30,N 31,N 32-sulfonylamino)benzoato(5–)]cupraat(II) waarbij a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 |
411-430-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-301-00-1 |
reactiemassa van: dodecaanzuur; poly(1-7)lactaatesters van dodecaanzuur |
411-860-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
607-302-00-7 |
reactiemassa van: tetradecaanzuur; poly(1-7)lactaatesters van tetradecaanzuur |
411-910-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
|
607-303-00-2 |
1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxochinoline-3-carbonzuur |
413-760-7 |
Repr. 2 Aquatic Chronic 3 |
H361f *** H412 |
GHS08 Wng |
H361f *** H412 |
|
|
|
|
|
607-304-00-8 |
fluazifop-butyl (ISO); butyl-(RS)-2-[4-(5-trifluormethyl-2-pyridyloxy)fenoxy]propionaat |
274-125-6 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H400 H410 |
GHS08 GHS09 Dgr |
H360D *** H410 |
|
|
|
|
|
607-305-00-3 |
fluazifop-P-butyl (ISO); butyl-(R)-2-[4-(5-trifluormethyl-2-pyridyloxy)fenoxy]propionaat |
— |
Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H400 H410 |
GHS08 GHS09 Wng |
H361d *** H410 |
|
|
|
|
|
607-306-00-9 |
chlozolinaat (ISO); ethyl-(RS)-3-(3,5-dichloorfenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylaat |
282-714-4 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
|
|
607-307-00-4 |
vinclozolin (ISO); N-3,5-dichloorfenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dion |
256-599-6 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H351 H360FD H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360FD H317 H411 |
|
|
|
|
|
607-308-00-X |
esters van 2,4-D |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
|
607-309-00-5 |
carfentrazone-ethyl (ISO); ethyl-(RS)-2-chloor-3-[2-chloor-4-fluor-5-[4-difluormethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazool-1-yl]fenyl]propionaat |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-310-00-0 |
kresoxim-methyl (ISO); methyl-(E)-2-methoxyimino-[2-(o-tolyloxymethyl)fenyl]acetaat |
— |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
|
|
607-311-00-6 |
benazolin-ethyl; ethyl-4-chloor-2-oxo-2H-benzothiazool-3-acetaat; |
246-591-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-312-00-1 |
methoxyazijnzuur |
210-894-6 |
Repr. 1B Acute Tox. 4 * Skin Corr. 1B |
H360FD H302 H314 |
GHS08 GHS05 GHS07 Dgr |
H360FD H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-313-00-7 |
neodecanoylchloride |
254-875-0 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS06 Dgr |
H330 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
|
|
607-314-00-2 |
ethofumesaat (ISO); (RS)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-ylmethaansulfonaat; |
247-525-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1 M = 1 |
|
|
|
607-315-00-8 |
glyfosaat (ISO); N-(fosfonomethyl)glycine |
213-997-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
607-316-00-3 |
glyfosaat-trimesium; glyfosaat-trimethylsulfonium |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-317-00-9 |
bis(2-ethylhexyl)ftalaat; di-(2-ethylhexyl)ftalaat; DEHP |
204-211-0 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
607-318-00-4 |
dibutylftalaat; DBP |
201-557-4 |
Repr. 1B Aquatic Acute 1 |
H360Df H400 |
GHS08 GHS09 Dgr |
H360Df H400 |
|
|
|
|
|
607-319-00-X |
deltamethrin (ISO); (S)-α-cyaan-3-fenoxybenzyl(1R,3R)-3-(2,2-dibroomvinyl)-2,2-dimethylcyclopropaancarboxylaat |
258-256-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
M=1000000 |
|
|
|
607-320-00-5 |
bis[4-(ethenyloxy)butyl]-1,3-benzeendicarboxylaat |
413-930-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
607-321-00-0 |
(S)-methyl-2-chloorpropionaat |
412-470-8 |
Flam. Liq. 3 STOT RE 2 * Eye Irrit. 2 |
H226 H373 ** H319 |
GHS02 GHS08 Wng |
H226 H373 ** H319 |
|
|
|
|
|
607-322-00-6 |
4-(4,4-dimethyl-3-oxo-pyrazolidine-1-yl)-benzoëzuur |
413-120-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-323-00-1 |
2-(1-(2-hydroxy-3,5-di-tert-pentyl-fenyl)ethyl)-4,6-di-tert-pentylfenyl-acrylaat |
413-850-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-324-00-7 |
reactiemassa van: N, N-di(gehydrogeneerde alkyl C14-C18)ftaalaminezuur; digehydrogeneerde alkyl (C14-C18)amine |
413-800-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-325-00-2 |
(S)-2-chloorpropionzuur |
411-150-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
|
|
607-326-00-8 |
reactiemassa van: isobutylwaterstof-2-(α-2,4,6-trimethylnon-2-enyl)succinaat; isobutylwaterstof-2-(ß-2,4,6-trimeyhylnon-2-enyl)succinaat |
410-720-0 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
607-327-00-3 |
2-(2-joodethyl)-1,3-propaandiol-diacetaat |
411-780-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-328-00-9 |
methyl-4-broommethyl-3-methoxybenzoaat |
410-310-1 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-329-00-4 |
reactiemassa van: natrium-2-(C12-18-n-alkyl)amino-1,4-butandioaat; natrium-2-octadeceenyl-amino-1,4-butaandioaat |
411-250-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-330-00-X |
(S)-2,3-dihydro-1H-indool-2-carbonzuur |
410-860-2 |
Repr. 2 STOT RE 2 * Skin Sens. 1 |
H361f *** H373 ** H317 |
GHS08 GHS07 Wng |
H361f *** H373 ** H317 |
|
|
|
|
|
607-331-00-5 |
reactiemassa van: bis(2,2,6,6-tetramethyl-1-octyloxypiperidine-4-yl)-1,10-decaandioaat; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidine-4-yl)-decaan-1,10-dioyl)piperidine-1-yl)oxy]octaan |
406-750-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-332-00-0 |
cyclopentylchloorformiaat |
411-460-0 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H226 H331 H302 H373 ** H318 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H331 H302 H373 ** H318 H317 |
|
|
|
|
|
607-333-00-6 |
reactiemassa van: dodecyl-N-(2,2,6,6-tetramethylpiperidine-4-yl)-β-alaninaat; tetradecyl-N-(2,2,6,6-tetramethylpiperidine-4-yl)-β-alaninaat |
405-670-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H410 |
|
|
|
|
607-334-00-1 |
ethyl-1-ethyl-6,7,8-trifluor-1,4-dihydro-4-oxochinoline-3-carboxylaat |
405-880-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-335-00-7 |
methyl-(R)-2-(4-(3-chloor-5-trifluormethyl-2-pyridyloxy)fenoxy)propionaat |
406-250-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
|
|
607-336-00-2 |
4-methyl-8-methyleentricyclo[3.3.1.13,7]dec-2-ylacetaat |
406-560-6 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
|
|
607-337-00-8 |
di-tert-(C12-14)-alkylammonium-2-benzothiazoolylthiosuccinaat |
406-052-4 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H302 H315 H318 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H302 H315 H318 H411 |
|
|
|
|
|
607-338-00-3 |
2-methylpropyl-2-hydroxy-2-methylbut-3-enoaat |
406-235-9 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
|
|
607-339-00-9 |
2,3,4,5-tetrachloorbenzoylchloride |
406-760-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
|
607-340-00-4 |
1,3-bis(4-benzoyl-3-hydroxyfenoxy)prop-2-ylacetaat |
406-990-4 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-341-00-X |
(9S)-9-amino-9-deoxyerytromycine |
406-790-7 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
607-342-00-5 |
4-chloorbutylveratraat |
410-950-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-343-00-0 |
4,7-methanoöctahydro-1H-indeen-diyldimethylbis(2-carboxybenzoaat) |
407-410-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-344-00-6 |
reactiemassa van: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoralkylsulfonamido)propionzuur; N-[dimethyl-3-(C4-8-perfluoralkylsulfonamido)propylammonium-propionaat; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoralkylsulfonamido)propionzuur-propionaat |
407-810-7 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
|
607-345-00-1 |
kalium-2-(2,4-dichloorfenoxy)-(R)-propionaat |
413-580-9 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-346-00-7 |
3-icosyl-4-henicosylideen-2-oxetanon |
401-210-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-347-00-2 |
natrium-(R)-2-(2,4-dichloorfenoxy)propionaat |
413-340-3 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-348-00-8 |
magnesium-bis((R)-2-(2,4-dichloorfenoxy)propionaat) |
413-360-2 |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
607-349-00-3 |
mono-(tetrapropylammonium)waterstof-2,2'-dithiobisbenzoaat |
411-270-8 |
— |
Aquatic Chronic 3 |
H412 |
|
H412 |
|
|
|
|
607-350-00-9 |
bis(4-(1,2-bis(ethoxycarbonyl)-ethylamino)-3-methyl-cyclohexyl)methaan |
412-060-9 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-351-00-4 |
methyl-O-(4-amino-3,5-dichloor-6-fluorpyridine-2-yloxy)acetaat |
407-550-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-352-00-X |
4,4'-oxydiftaalzuuranhydride |
412-830-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-353-00-5 |
reactiemassa van: ethyl-exo-tricyclo[5.2.1.02,6]decaan-endo-2-carboxylaat; ethyl-endo-tricyclo[5.2.1.02,6]decaan-exo-2-carboxylaat |
407-520-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
607-354-00-0 |
ethyl-2-cyclohexylpropionaat |
412-280-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-355-00-6 |
p-tolyl-4-chloorbenzoaat |
411-530-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
607-356-00-1 |
ethyl-trans-2,2,6-trimethylcyclohexaancarboxylaat |
412-540-8 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
607-357-00-7 |
reactiemassa van: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran |
412-450-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-358-00-2 |
(1S,3S,5R,6R)-(4-nitrofenylmethyl)-1-dioxo-6-fenylaceetamido-penam-3-carboxylaat |
412-670-5 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
|
|
607-359-00-8 |
(1S,4R,6R,7R)-(4-nitrofenylmethyl)-3-methyleen-1-oxo-7-fenylaceetamido-cefam-4-carboxylaat |
412-800-0 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
|
|
607-360-00-3 |
natrium-3-acetoacetylamino-4-methoxytolyl-6-sulfonaat |
411-680-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-361-00-9 |
methyl-(R)-2-(4-hydroxyfenoxy)-propionaat |
411-950-4 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-362-00-4 |
reactiemassa van: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoaat; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoaat; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoaat; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium-2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoaat |
413-500-2 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H315 H318 H411 |
GHS05 GHS09 Dgr |
H315 H318 H411 |
|
|
|
|
607-363-00-X |
methyl-3-methoxyacrylaat |
412-900-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-364-00-5 |
3-fenyl-7-[4-(tetrahydrofurfuryloxy)fenyl]-1,5-dioxa-s-indaceen-2,6-dion |
413-330-9 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
|
607-365-00-0 |
2-(2-amino-1,3-thiazool-4-yl)-(Z)-2-methoxyiminoacetylchloride-hydrochloride |
410-620-7 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
|
|
607-366-00-6 |
3,5-dimethylbenzoylchloride |
413-010-9 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
|
|
607-367-00-1 |
kalium-bis(N-carboxymethyl)-N-methyl-glycinato-(2–)N,O,O,N)-ferraat-(1–)monohydraat |
411-640-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-368-00-7 |
1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazool |
411-650-3 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
|
|
607-369-00-2 |
reactiemassa van: trans-(2R)-5-acetoxy-1,3-oxathiolaan-2-carbonzuur; cis-(2R)-5-acetoxy-1,3-oxathiolaan-2-carbonzuur |
411-660-8 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-370-00-8 |
2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylfenyl]methyl]-6-(1,1-dimethylethyl)-4-methylfenol |
412-210-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-371-00-3 |
3-ethyl-5-methyl-4-(2-chloorfenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoïndool-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylaat |
413-410-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-372-00-9 |
geëthoxyleerde bisfenol A-di-(norborneencarboxylaat) |
412-410-0 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-373-00-4 |
quizalofop-P-tefuryl (ISO); (±)-tetrahydrofurfuryl-(R)-2-[4-(6-chloorchinoxaline-2-yloxy)-fenyloxy]propionaat |
414-200-4 |
Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H302 H373 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361fd H302 H373 H410 |
|
M = 1 M = 1 |
|
|
|
607-374-00-X |
5-amino-2,4,6-trijood-1,3-benzeendicarbonyldichloride |
417-220-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-375-00-5 |
flocumafen (ISO); reactiemassa van: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)fenyl)-1-naftyl)cumarine en trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)fenyl)-1-naftyl)cumarine |
421-960-0 |
Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (bloed) H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360D H330 H310 H300 H372 (bloed) H410 |
|
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (bloed): C ≥ 0,05 % STOT RE 2; H373 (bloed): 0,005 % ≤ C < 0,05 % M = 10 M = 10 |
|
|
|
607-376-00-0 |
benzyl-2,4-dibroombutanoaat |
420-710-8 |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H315 H317 H410 |
|
|
|
|
|
607-377-00-6 |
trans-4-cyclohexyl-L-proline-monohydrochloride |
419-160-1 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H361f *** H302 H315 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H361f *** H302 H315 H318 H317 |
|
|
|
|
|
607-378-00-1 |
ammonium-(Z)-α-methoxyimino-2-furylacetaat |
405-990-1 |
Flam. Sol. 2 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
|
|
607-379-00-7 |
reactiemassa van: 2-[N-(2-hydroxyethyl)stearamido]ethylstearaat; natrium-[bis[2-(stearoyloxy)ethyl]amino]methylsulfonaat; natrium-[bis(2-hydroxyethyl)amino]methylsulfonaat; N,N-bis(2-hydroxyethyl)stearamide |
401-230-8 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-380-00-2 |
reactiemassa van: ammonium-1,2-bis(hexyloxycarbonyl)ethaansulfonaat; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethaansulfonaat; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethaansulfonaat |
407-320-3 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
|
607-381-00-8 |
reactiemassa van triësters van 2,2-bis(hydroxymethyl)butanol met C7-alkaanzuren en 2-ethylhexaanzuur |
413-710-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-382-00-3 |
2-((4-amino-2-nitrofenyl)amino)benzoëzuur |
411-260-3 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
|
607-383-00-9 |
reactiemassa van: 2,2,6,6-tetramethylpiperidine-4-yl-hexadecanoaat; 2,2,6,6-tetramethylpiperidine-4-yl-octadecanoaat |
415-430-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
|
|
607-384-00-4 |
reactiemassa van: esters van C14-C15-vertakte alcoholen met 3,5-di-t-butyl-4-hydroxyfenylpropionzuur; C15-vertakt en lineair alkyl, 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzeenpropanoaat; C13-vertakt en lineair alkyl, 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzeenpropanoaat |
413-750-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-385-00-X |
copolymeer van vinylalcohol en vinylacetaat, gedeeltelijk geacetyleerd met 4-(2-(4-formylfenyl)ethenyl)-1-methylpyridinium-methylsulfaat |
414-590-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-386-00-5 |
reactiemassa van: tetradecaanzuur (42,5-47,5 %); poly(1-7)lactaatesters van tetradecaanzuur (52.5-57.5 %) |
412-580-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-387-00-0 |
reactiemassa van: dodecaanzuur (35-40 %); poly(1-7)lactaatesters van dodecaanzuur (60-65 %) |
412-590-0 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-388-00-6 |
4-ethylamino-3-nitrobenzoëzuur |
412-090-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
|
607-389-00-1 |
trinatrium-N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionaat |
414-130-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
607-390-00-7 |
1,2,3,4-tetrahydro-6-nitro-chinoxaline |
414-270-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
|
|
607-391-00-2 |
dimethylcyclopropaan-1,1-dicarboxylaat |
414-240-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-392-00-8 |
2-fenoxyethyl-4-((5-cyaan-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoaat |
414-260-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-393-00-3 |
3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carbonzuur |
415-750-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-394-00-9 |
5-methylpyrazine-2-carbonzuur |
413-260-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-395-00-4 |
reactiemassa van: natrium-1-tridecyl-4-allyl-(2 of 3)-sulfobutaandioaat; natrium-1-dodecyl-4allyl-(2 of 3)-sulfobutaandioaat |
410-230-7 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
|
607-396-00-X |
bis(1,2,2,6,6-pentamethyl-4-piperidinyl)-2-(4-methoxybenzylideen)malonaat |
414-840-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-397-00-5 |
reactiemassa van: Ca-salicylaten (vertakt C10-14 en C18-30 gealkyleerd); Ca-fenolaten (vertakt C10-14 en C18-30 gealkyleerd); Ca-gesulfureerde fenolaten (vertakt C10-14 en C18-30 gealkyleerd) |
415-930-6 |
— |
Repr. 2 Skin Sens. 1 |
H361f*** H317 |
GHS08 GHS07 Wng |
H361f*** H317 |
|
|
|
|
607-398-00-0 |
ethyl-N-(5-chloor-3-(4-(diëthylamino)-2-methylfenylimino)-4-methyl-6-oxo-1,4-cyclohexadiënyl)carbamaat |
414-820-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-399-00-6 |
2,2-dimethyl-3-methyl-3-butenylpropanoaat |
415-610-6 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
|
|
607-400-00-X |
methyl-3-[[(dibutylamino)thioxomethyl]thio]propanoaat |
414-400-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-401-00-5 |
ethyl-3-hydroxy-5-oxo-3-cyclohexeen-1-carboxylaat |
414-450-4 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
|
607-402-00-0 |
methyl-N-(fenoxycarbonyl)-L-valinaat |
414-500-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-403-00-6 |
reactiemassa van: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-fenyl)pentylammoniumsuccinaat; isopropylalcohol |
414-810-0 |
— |
STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H410 |
|
|
|
|
607-404-00-1 |
reactiemassa van: ((Z)-3,7-dimethyl-2,6-octadiënyl)oxycarbonylpropaanzuur; di-((E)-3,7-dimethyl-2,6-octadiënyl)butaandioaat; di-((Z)-3,7-dimethyl-2,6-octadiënyl)butaandioaat; (Z)-3,7-dimethyl-2,6-octadiënyl-butaandioaat; ((E)-3,7-dimethyl-2,6-octadiënyl)oxycarbonylpropaanzuur |
415-190-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-405-00-7 |
2-hexyldecyl-p-hydroxybenzoaat |
415-380-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-406-00-2 |
kalium-2,5-dichloorbenzoaat |
415-700-5 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
607-407-00-8 |
ethyl-2-carboxy-3-(2-thiënyl)propionaat |
415-680-8 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
|
|
607-408-00-3 |
kalium-N-(4-fluorfenyl)glycinaat |
415-710-1 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H318 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H373 ** H318 H317 H412 |
|
|
|
|
|
607-409-00-9 |
reactiemassa van: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naftaleen]-3,5-dihydroxyheptaanzuur; inerte biomassa van Aspergillus terreus |
415-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
607-410-00-4 |
mono[2-(dimethylamino)ethyl]monowaterstof-2-(hexadec-2-enyl)butaandioaat en/of mono[2-(dimethylamino)ethyl]monowaterstof-3-(hexadec-2-enyl)butaandioaat |
415-880-5 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
|
|
607-411-00-X |
oxiraanmethanol, 4-methylbenzeensulfonaat, (S)- |
417-210-7 |
Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H350 H341 H318 H317 H411 |
|
|
|
|
|
607-412-00-5 |
ethyl-2-(1-cyaancyclohexyl)acetaat |
415-970-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373 ** H412 |
GHS08 GHS07 Wng |
H302 H373 ** H412 |
|
|
|
|
|
607-413-00-0 |
trans-4-fenyl-L-proline |
416-020-1 |
Repr. 2 Skin Sens. 1 |
H361f *** H317 |
GHS08 GHS07 Wng |
H361f *** H317 |
|
|
|
|
|
▼M18 ————— |
||||||||||
|
607-415-00-1 |
poly-(methylmethacrylaat)-co-(butylmethacrylaat)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzylcarbamaat)-co-(maleïnezuuranhydride) |
419-590-1 |
— |
Flam. Sol. 1 Skin Sens. 1 |
H228 H317 |
GHS02 GHS07 Dgr |
H228 H317 |
|
|
T |
|
607-416-00-7 |
4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naftamide |
420-730-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-417-00-2 |
3-chloorpropylchloorformiaat |
425-770-9 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H331 H302 H373** H315 H318 H317 |
GHS06 GHS05 GHS08 Dgr |
H331 H302 H373** H315 H318 H317 |
|
|
|
|
|
607-418-00-8 |
2-ethylhexyl-4-aminobenzoaat |
420-170-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-419-00-3 |
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazool-2-ylideen)-1-methylethylideen)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinylideen-3-yl)-azijnzuur |
422-240-9 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-420-00-9 |
2,2-bis(hydroxymethyl)butaanzuur |
424-090-1 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-421-00-4 |
cypermethrin (ISO); α-cyaan-3-fenoxybenzyl 3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaan-carboxylaat; cypermethrin cis/trans +/- 40/60 |
257-842-9 |
Acute Tox. 4 Acute Tox. 4 STOT SE 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H335 H373 (zenuwstelsel) H400 H410 |
GHS07 GHS08 GHS09 Wng |
H332 H302 H335 H373 (zenuwstelsel) H410 |
|
oraal; ATE = 500 mg/kg lichaamsgewicht inademing; ATE = 3,3 mg/l (stofdeeltjes of nevels) M = 100000 M = 100000 |
|
|
|
607-422-00-X |
α-cypermethrin (ISO); een racemaat bestaande uit (R)-α-cyaan-3-fenoxybenzyl-(1S,3S)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat; (S)-α-cyaan-3-fenoxybenzyl(1R,3R)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
257-842-9 |
Acute Tox. 3 * STOT RE 2 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H335 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373** H335 H410 |
|
M=1000 |
|
|
|
607-423-00-5 |
esters van mecoprop en van mecoprop-P |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
|
607-424-00-0 |
trifloxystrobin (ISO); methyl(E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluor-m-tolyl)ethylidwenaminooxy]-o-tolyl}acetaat |
— |
Lact. Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H362 H317 H400 H410 |
GHS07 GHS09 Wng |
H362 H317 H410 |
|
M = 100 M = 10 |
|
|
|
607-425-00-6 |
metalaxyl (ISO); methyl-N-(2,6-dimethylfenyl)-N-(methoxyacetyl)-DL-alaninaat |
260-979-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
|
|
607-426-00-1 |
1,2-benzeendicarbonzuur, dipentylester, vertakt en lineair; [1] n-pentyl-isopentylftalaat; [2] di-n-pentylftalaat; [3] diisopentylftalaat [4] |
284-032-2 [1] -[2] 205-017-9 [3] 210-088-4 [4] |
84777-06-0 [1] -[2] 131-18-0 [3] 605-50-5 [4] |
Repr. 1B Aquatic Acute 1 |
H360FD H400 |
GHS08 GHS09 Dgr |
H360FD H400 |
|
|
|
|
607-427-00-7 |
bromoxynilheptanoaat (ISO); 2,6-dibroom-4-cyaanfenylheptanoaat |
260-300-4 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H332 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d *** H332 H302 H317 H410 |
|
|
|
|
|
607-428-00-2 |
tetranatriumethyleendiaminetetraäcetaat |
200-573-9 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
|
|
607-429-00-8 |
edetinezuur; (EDTA) |
200-449-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
|
|
607-430-00-3 |
BBP; benzylbutylftalaat e |
201-622-7 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Dgr |
H360Df H410 |
|
|
|
|
|
607-431-00-9 |
prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-een-1-yl-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat |
245-387-9 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
|
|
|
|
607-432-00-4 |
S-metolachloor (ISO); 2-chloor-N-(2-ethyl-6-methylfenyl)-N-[(2S)-1-methoxypropaan-2-yl]aceetamide; (R a S a)-2-chloor-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]aceetamide [bevat 80-100 % 2-chloor-N-(2-ethyl-6-methylfenyl)-N-[(2S)-1-methoxypropaan-2-yl]aceetamide en 0-20 % 2-chloor-N-(2-ethyl-6-methylfenyl)-N-[(2R)-1-methoxypropaan-2-yl]aceetamide] |
— |
Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H317 H410 |
EUH066 |
M = 10 M = 10 |
|
|
|
607-433-00-X |
cypermethrin cis/trans +/-80/20; (RS)-α-cyaan-3-fenoxybenzyl-(1RS;3RS; 1RS,3SR)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
257-842-9 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H335 H315 H317 H410 |
|
|
|
|
|
607-434-00-5 |
mecoprop-P (ISO) [1] en zouten daarvan; (R)-2-(4-chloor-2-methylfenoxy)propionzuur [1] en zouten daarvan |
240-539-0 [1] |
16484-77-8 [1] |
Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Dgr |
H302 H318 H410 |
|
oraal: ATE = 431 mg/kg lichaamsgewicht M = 10 M = 10 |
|
|
607-435-00-0 |
2S-isopropyl-5R-methyl-1R-cyclohexyl-2,2-dihydroxyacetaat |
416-810-6 |
STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H411 |
|
|
|
|
|
607-436-00-6 |
2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propylneodecanoaat |
417-350-9 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
|
607-437-00-1 |
3-(4-aminofenyl)-2-cyaan-2-propeenzuur |
417-480-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-438-00-7 |
methyl-2-[(aminosulfonyl)methyl]benzoaat |
419-010-5 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
|
|
607-439-00-2 |
methyltetrahydro-2-furancarboxylaat |
420-670-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-440-00-8 |
methyl-2-aminosulfonyl-6-(trifluormethyl)pyridine-3-carboxylaat |
421-220-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
|
|
607-441-00-3 |
3-[3-(2-dodecyloxy-5-methylfenylcarbamoyl)-4-hydroxy-1-naftylthio]propionzuur |
421-490-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-442-00-9 |
benzyl-[hydroxy-(4-fenylbutyl)fosfinyl]acetaat |
416-050-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
607-444-00-X |
reactiemassa van: cis-1,4-dimethylcyclohexyldibenzoaat; trans-1,4-dimethylcyclohexyldibenzoaat |
416-230-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-445-00-5 |
ijzer(III) tris(4-methylbenzeensulfonaat) |
420-960-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-446-00-0 |
methyl-2-[4-(2-chloor-4-nitrofenylazo)-3-(1-oxopropyl)amino]fenylaminopropionaat |
416-240-8 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
607-447-00-6 |
natrium-4-[4-(4-hydroxyfenylazo)fenylamino]-3-nitrobenzeensulfonaat |
416-370-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-448-00-1 |
2,3,5,6-tetrafluorbenzoëzuur |
416-800-1 |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
|
|
607-449-00-7 |
reactiemassa van: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methyleen(3,5,5-trimethyl-3,1-cyclohexaandiyl)iminocarbonyloxy-2,1-ethaandiyl(ethyl)amino]]trisbenzeendiazoniumtri[bis(2-methylpropyl)naftaleensulfonaat];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexaandiyl)methyleen]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methyleen(3,5,5-trimethyl-3,1-cyclohexaandiyl)iminocarbonyloxy-2,1-ethaandiyl(ethyl)amino]]tetrakisbenzeendiazoniumtetra[bis(2-methylpropyl)naftaleensulfonaat] |
417-080-1 |
— |
Self-react. D **** Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H317 H410 |
|
|
|
|
607-450-00-2 |
2-mercaptobenzothiazolyl-(Z)-(2-aminothiazool-4-yl)-2-(tert-butoxycarbonyl)-isopropoxyiminoacetaat |
419-040-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-451-00-8 |
4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)-fenylazo)-2,7-disulfonaft-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)-fenylazo)-2,7-disulfonaft-6-ylazo]-fenyl-carbonyl-amino]-benzeensulfonzuur, natriumzout |
417-640-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-453-00-9 |
4-benzyl-2,6-dihydroxy-4-aza-heptyleen-bis(2,2-dimethyloctanoaat) |
418-100-1 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
|
|
607-454-00-4 |
reactiemassa van: trans-2-(1-methylethyl)-1,3-dioxaan-5-carbonzuur; cis-2-(1-methylethyl)-1,3-dioxaan-5-carbonzuur |
418-170-3 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-455-00-X |
1-amino-4-(3-[4-chloor-6-(2,5-di-sulfofenylamino)-1,3,5-triazine-2-ylamino]-2,2-dimethyl-propylamino)-antrachinon-2-sulfonzuur, natrium-/lithiumzout |
419-520-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-456-00-5 |
3-amino-4-chloorbenzoëzuur, hexadecylester |
419-700-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-457-00-0 |
tetranatriumdiwaterstof-1,1''-dihydroxy-8,8''-[p-fenylbis(imino-{6-[4-(2-aminoëthyl)piperazine-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaftaleen-1',3,6-trisulfonaat) |
420-350-1 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
|
|
607-458-00-6 |
reactiemassa van: 2-ethyl-[2,6-dibroom-4-[1-[3,5-dibroom-4-(2-hydroxyethoxy)fenyl]-1-methylethyl]fenoxy]propenoaat; 2,2'-diëthyl-[4,4'-bis(2,6-dibroomfenoxy)-1-methylethylideen]-dipropenoaat; 2,2'-[(1-methylethylideen)bis[[2,6-dibroom-4,1-fenyleen)oxy]ethanol]] |
420-850-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-459-00-1 |
isopentyl-4-{2-[5-cyaan-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylideen]hydrazino}benzoaat |
418-930-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-460-00-7 |
3-tridecyloxypropylammonium-9-octadecenoaat |
418-990-1 |
STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H319 H315 H410 |
|
|
|
|
|
607-461-00-2 |
reactiemassa van: pentanatrium-2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-fenylazo)-naftaleen-1-ylazo]-fenylamino}-6-[3-(2-sulfato-ethaansulfonyl)-fenylamino]-1,3,5-triazine-2-ylamino}-benzeen-1,4-disulfonaat; pentanatrium-2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-fenylazo)-naftaleen-1-ylazo]-fenylamino}-6-[3-(2-sulfato-ethaansulfonyl)-fenylamino]-1,3,5-triazine-2-ylamino}-benzeen-1,4-disulfonaat |
421-160-1 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-462-00-8 |
reactiemassa van: 1-hexylacetaat; 2-methyl-1-pentylacetaat; 3-methyl-1-pentylacetaat; 4-methyl-1-pentylacetaat; andere gemengde lineaire en vertakte C6-alkylacetaten |
421-230-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-463-00-3 |
3-(fenothiazine-10-yl)propionzuur |
421-260-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-464-00-9 |
reactiemassa van: 7-chloor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-chinoline-3-carbonzuur; 5-chloor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-chinoline-3-carbonzuur |
421-280-4 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-465-00-4 |
tris(2-hydroxyethyl)ammonium-7-{4-[4-(2-cyaanamino-4-hydroxy-6-oxidopyrimidine-5-ylazo)benzamido]-2-ethoxy-fenylazo}naftaleen-1,3-disulfonaat |
421-440-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-466-00-X |
reactiemassa van: fenyl-1-(1-[2-chloor-5-(hexadecyloxycarbonyl)fenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazool-5-carboxylaat; fenyl-2-(1-(2-chloor-5-(hexadecyloxycarbonyl)fenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazool-5-carboxylaat; fenyl-3-(1-(2-chloor-5-(hexadecyloxycarbonyl)fenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazool-5-carboxylaat |
421-480-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-467-00-5 |
1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylaat |
419-430-9 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H410 |
|
|
|
|
|
607-468-00-0 |
reactiemassa van: mononatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat; dinatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat; trinatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat; tetranatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat |
419-450-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
607-469-00-6 |
dinatrium-7-((4,6-bis(3-diëthylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonaatfenylazo)fenylazo)-2-naftaleensulfonaat |
419-460-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-470-00-1 |
kaliumnatrium-6,13-dichloor-3,10-bis{2-[4-[3-(2-hydroxysulfonyloxyethaansulfonyl)fenylamino]-6-(2,5-disulfonatofenylamino)-1,3,5-triazine-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]fenoxazine-4,11-disulfonaat |
414-100-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
|
607-471-00-7 |
1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexaan |
429-280-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
▼M1 ————— |
||||||||||
|
607-473-00-8 |
pentaërytritol, dipentaërytritol, vetzuren, C6-10, gemengde esters met adipinezuur, heptaanzuur en isostearinezuur |
426-590-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-474-00-3 |
4(-4-(4-dimethylaminobenzylideen-1-yl)-3-methyl-5-oxo-2-pyrazoline-1-yl)benzoëzuur |
410-430-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-475-00-9 |
reactiemassa (50/50) van: tetranatrium-7-(4-[4-chloor-6-[methyl-(3-sulfonatofenyl)amino]-1,3,5-triazine-2-ylamino]-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat; tetranatrium-7-(4-[4-chloor-6-[methyl-(4-sulfonatofenyl)amino]-1,3,5-triazine-2-ylamino]-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat |
412-940-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-476-00-4 |
trinatrium-N,N-bis(carboxymethyl)-β-alanine |
414-070-9 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
|
607-477-00-X |
(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexaanmethaansulfonaatzout |
426-740-8 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
607-478-00-5 |
tetramethylammoniumwaterstofftalaat |
416-900-5 |
Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H400 |
|
|
|
|
|
607-479-00-0 |
hexadecyl-4-chloor-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-yl)-4,4-dimethyl-3-oxopentamido]benzoaat |
418-550-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-480-00-6 |
1,2-benzeendicarbonzuur; di-C7-11-vertakte en lineaire alkylesters |
271-084-6 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
|
|
607-481-00-1 |
reactiemassa van: trihexylcitraat; dihexyloctylcitraat; dioctylhexylcitraat; dihexyldecylcitraat |
430-290-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-482-00-7 |
N-[1-(S)-ethoxycarbonyl-3-fenylpropyl]-L-alanyl-N-carboxyanhydride |
430-360-8 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-483-00-2 |
1,2-benzeendicarbonzuur; di-C6-8-vertakte alkylesters, C7-rijk |
276-158-1 |
Repr. 1B |
H360D*** |
GHS08 Dgr |
H360D*** |
|
|
|
|
|
607-484-00-8 |
ethyl-2-{[3-acetylamino-4-(6-broom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoïndool-5-ylazo)fenyl{]ethylamino[}propionaat |
430-480-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-485-00-3 |
(3S-trans)-fenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorfenyl)-1-piperidinecarboxylaat |
430-510-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-486-00-9 |
kaliumnatrium-5'-(6-chloor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-4'-hydroxy-2,3'-azodinaftaleen-1,2',5,7'-disulfonaat |
402-110-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-487-00-4 |
reactiemassa van: dinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatofenyl)pyrazool-4-yl)penta-2,4-diënylideen)-4,5-dihydro-5-oxopyrazool-1-yl)benzeensulfonaat; trinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatofenyl)pyrazool-4-yl)penta-2,4-diënylideen)-4,5-dihydro-5-oxopyrazool-1-yl)benzeensulfonaat |
402-660-9 |
— |
Repr. 1B Aquatic Chronic 3 |
H360D *** H412 |
GHS08 Dgr |
H360D *** H412 |
|
|
|
|
607-488-00-X |
ethyl-(2-acetylamino-5-fluor-4-isothiocyanaatfenoxy)acetaat |
414-210-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-489-00-5 |
reactiemassa van: 2-ethylhexyl-linolenaat, linoleaat en oleaat; 2-ethylhexyl-epoxyoleaat; 2-ethylhexyl diëpoxylinoleaat; 2-ethylhexyl-triëpoxylinolenaat |
414-890-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-490-00-0 |
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methylglycinaat |
415-060-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-491-00-6 |
reactiemassa van: diëster van 4,4'-methyleenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonzuur (1:2); triëster van 4,4'-methyleenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonzuur (1:3) |
427-140-9 |
— |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
|
607-492-00-1 |
2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methylpropylpropanoaat |
415-490-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-493-00-7 |
methyl-(3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazool-6-carboxylaat |
415-670-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-494-00-2 |
bis(2-ethylhexyl)octylfosfonaat |
417-170-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-495-00-8 |
natrium-4-sulfofenyl-6-((1-oxononyl)amino)hexanoaat |
417-550-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-496-00-3 |
2,2'-methyleenbis(4,6-di-tert-butylfenyl)-2-ethylhexylfosfiet |
418-310-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-497-00-9 |
ceriumoxideïsostearaat |
419-760-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-498-00-4 |
(E)-3,7-dimethyl-2,6-octadiënylhexadecanoaat |
421-370-3 |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
|
|
607-499-00-X |
bis(dimethyl-(2-hydroxyethyl)ammonium)-1,2-ethaandiyl-bis(2-hexadecenylsuccinaat) |
421-660-1 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
|
607-500-00-3 |
calcium-2,2,bis[(5-tetrapropyleen-2-hydroxy)fenyl]ethanoaat |
421-670-4 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
|
607-501-00-9 |
reactiemassa van: trifenylthiofosfaat en tertiaire gebutyleerde fenylderivaten |
421-820-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-502-00-4 |
(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzeensulfonaat |
422-200-0 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H314 H302 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H411 |
|
|
|
|
|
607-503-00-X |
2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatrifosforinaan |
422-210-5 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
|
|
607-504-00-5 |
diammonium-1-hydroxy-2-(4-(4-carboxyfenylazo)-2,5-dimethoxyfenylazo)-7-amino-3-naftaleensulfonaat |
422-670-7 |
— |
Repr. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f H301 H373** H410 |
|
|
|
|
607-505-00-0 |
pentanatrium-7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonatoëthoxy)sulfonyl)fenylazo)fenylamino)-6-chloor-1,3,5-triazine-2-yl)amino-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat |
422-930-1 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
607-506-00-6 |
reactiemassa van: strontium-(4-chloor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatofenyl)-1H-pyrazool-4-yl)azo)-5-methyl)benzeensulfonaat; dinatrium-(4-chloor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatofenyl)-1H-pyrazool-4-yl)azo)-5-methyl)benzeensulfonaat |
422-970-8 |
|
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
607-507-00-1 |
kalium, natrium-2,4-diamino-3-[4-(2-sulfonatoëthoxysulfonyl)fenylazo]-5-[4-(2-sulfonatoëthoxysulfonyl)-2-sulfonatofenylazo]-benzeensulfonaat |
422-980-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-508-00-7 |
dinatrium-3,3'-[iminobis[sulfonyl-4,1-fenyleen-(5-hydroxy-3-methylpyrazool-1,4-diyl)azo-4,1-fenyleensulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-fenyleensulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzeensulfonaat)] |
423-110-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-509-00-2 |
2-fenoxyethyl 4-aminobenzoaat |
430-880-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
|
|
607-510-00-8 |
(2S,5R)-6,6-dibroom3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptaan-2-carbonzuur-4,4-dioxide |
427-200-4 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
|
|
607-511-00-3 |
reactiemassa van: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxoboterzuur; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxoboterzuur |
423-750-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
607-512-00-9 |
trinatrium-2,4-diamino-3,5-bis-[4-(2-sulfonatoëthoxy)sulfonyl)fenylazo]benzeensulfonaat |
423-970-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-513-00-4 |
reactiemassa van: trinatrium-4-benzoylamino-6-(6-etheensulfonyl-1-sulfato-naftaleen-2-ylazo)-5-hydroxynaftaleen-2,7-disulfonaat; natriumzout van 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfoxy)ethyl)sulfonyl)-2-naftyl)azo)naftaleen-2,7-disulfonzuur; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfoxy)ethyl)sulfonyl)-2-naftyl)azo)naftaleen-2,7-disulfonzuur |
423-200-3 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
|
607-514-00-X |
kalium-N-(1-methoxy-1-oxobut-2-een-3-yl)valinaat |
427-240-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-515-00-5 |
reactiemassa van: dinatriumhexyldifenyletherdisulfonaat; dinatriumdihexyldifenyletherdisulfonaat |
429-650-7 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
|
|
607-516-00-0 |
N, N'-bis(trifluoracetyl)-S, S'-bis-L-homocysteïne |
429-670-6 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
|
607-517-00-6 |
(S)-α-(acetylthio)benzeenpropaanzuur |
430-300-0 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
|
|
607-518-00-1 |
3-oxoandrost-4-een-17-β-carbonzuur |
414-990-0 |
Repr. 2 Aquatic Chronic 4 |
H361f H413 |
GHS08 Wng |
H361f H413 |
|
|
|
|
|
607-519-00-7 |
poly-[((4-((4-ethylethyleen)amino)fenyl)-(4-(ethyl-(2-oxyethyleen)amino)fenyl)methinyl)cyclohexa-2,5-diënylideen)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetaat] |
427-280-0 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
|
|
607-520-00-2 |
reactiemassa van: natrium-4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylfosfaat; dinatrium-4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylfosfaat |
427-740-0 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-521-00-8 |
tetraëthyl N, N'-(methyleendicyclohexaan-4,1-diyl)bis-DL-aspartaat |
429-270-1 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
|
|
607-522-00-3 |
natriumzout van de polymeer van: natrium-2-methyl-buta-1,3-dieen-1-sulfonaat met acrylzuur en 2-hydroxyethyl-2-methylacrylaat |
429-720-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-523-00-9 |
reactiemassa van mono- tot tetra-(lithium en/of natrium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2-ylamino]-6-13-dichloorbenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot tetra-(lithium en/of natrium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazine-2-ylamino]-6-13-dichloorbenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot penta-(lithium en/of natrium)10,10'-diamino-6,6',13,13'-tetrachloor-3,3'-[6-[methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot hepta-(lithium en/of natrium)10-amino-6,6', 13,13'-tetrachloor-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot hepta-(lithium en/of natriium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenyleendiiminobis[6-methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat |
430-200-7 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-524-00-4 |
tallolie 2-[(tetrahydro-2H-pyran-2-yl)thio]ethylesters |
430-310-5 |
— |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
|
607-525-00-X |
(Z)-2-methoxyimino-2-[2-(tritylamino)thiazool-4-yl]azijnzuur |
431-520-1 |
Flam. Sol. 1**** Carc. 2 Aquatic Chronic 3 |
H228 H351 H412 |
GHS02 GHS08 Dgr |
H228 H351 H412 |
|
|
|
|
|
607-526-00-5 |
cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propaan |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-527-00-0 |
reactiemassa van: 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-tridecafluoroctyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluordecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-heneïcosafluordodecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluortetradecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluordecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl)-12-(1''H,1''H,2''H,2''H-heneïcosafluordodecyl)dodecaandioaat |
423-180-6 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
|
607-528-00-6 |
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)boterzuur |
430-900-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
|
607-529-00-1 |
benzyl-cis-4-ammonium-4'-tolueensulfonato-1-cyclohexaancarboxylaat |
426-070-6 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-530-00-7 |
reactiemassa van isomeren van: C7-9-alkyl-3-(3,5-di-tert-butyl-4-hydroxyfenyl)propionaat |
406-040-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-531-00-2 |
methyl-3-amino-4,6-dibroom-2-methylbenzoaat |
425-190-6 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
|
|
607-532-00-8 |
(S)-1-[2-trans-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentaancarbonzuur, cyclohexylaminezout |
425-510-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-533-00-3 |
pentanatriummonowaterstof-6-chloor-3,10-bis[2-[4-chloor-6-(2,4-disulfofenylamino)-1,3,5-triazine-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]fenoxazine-4,11-disulfonaat |
414-910-4 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
|
607-534-00-9 |
ethyl-2-(3-benzoylfenyl)propanoaat |
414-920-9 |
Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H301 H372** H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H372** H317 H411 |
|
|
|
|
|
607-535-00-4 |
kalium-4-jood-2-sulfonato-benzoëzuur |
426-620-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-536-00-X |
(2,6-xylyloxy)azijnzuur |
430-910-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
|
|
607-537-00-5 |
isopropylammonium-2-(3-benzoylfenyl)propionaat |
417-970-1 |
— |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H372** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H312 H372** H318 H410 |
|
|
|
|
607-539-00-6 |
propyl((4-(5-oxo-3-propylisoxazolidine-4-ylideenmethinyl)fenyl)propoxycarbonylmethyleenamino)acetaat |
431-000-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
|
607-540-00-1 |
1-(mercaptomethyl)cyclopropylazijnzuur |
420-240-3 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H312 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H312 H302 H317 H411 |
|
|
|
|
|
607-541-00-7 |
[(1-methyl-1,2-ethaandiyl)bis[nitrilo-bis(methyleen)]]tetrakis(fosfonzuur) |
421-940-1 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
|
|
607-542-00-2 |
methyl-2-(4-butaansulfonamidofenoxy)tetradecanoaat |
422-110-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
607-543-00-8 |
poly-[((4-((4-(ethylethyleen)amino)fenyl)-(4-(ethyl-(2-oxyethyleen)amino)fenyl)methinyl)-3-methylcyclohexa-2,5-diënylideen)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetaat] |
427-480-8 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
|
|
607-544-00-3 |
ethyl-6,8-difluor-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazine-1-yl)-4-oxochinoline-3-carboxylaat |
427-490-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
|
|
607-545-00-9 |
1,2-dimethyl-3-(1-methylethenyl)cyclopentylacetaat |
424-070-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
|
|
607-546-00-4 |
reactiemassa van: methyl-{[5-acetylamino-4-(2-chloor-4-nitrofenylazo)fenyl]methoxycarbonylmethylamino}acetaat; methyl-{[5-acetylamino-4-(2-chloor-4-nitrofenylazo)fenyl]ethoxycarbonylmethylamino}acetaat |
424-290-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
607-547-00-X |
18-methylnonadecyl-2,2-dimethylpropanoaat |
424-370-1 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
|
|
607-548-00-5 |
1-(2,4-dichloorfenyl)-2-(1H-imidazool-1-yl)ethanonmethaansulfonaat |
431-010-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
|
|
607-549-00-0 |
methyl-(E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoaat |
424-430-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
|
|
607-550-00-6 |
2-amino-4-broom-5-chloorbenzoëzuur |
424-700-4 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
|
607-551-00-1 |
tetrabutylammonium-2-amino-6-joodpurinaat |
424-710-9 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H373** H315 H318 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H312 H302 H373** H315 H318 H317 H411 |
|
|
|
|
|
607-552-00-7 |
hexadecyl-amino-4-isopropoxybenzoaat |
424-830-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
607-553-00-2 |
7-amino-4-hydroxy-2-naftaleensulfonzuur, gekoppeld met 5(of 8)-amino-8(of 5)-[[4-[[4-[[4-amino-6(of 7)-sulfo-1-naftyl]azo]fenyl]amino]-3-sulfofenyl]azo]-2-naftaleensulfonzuur en 4-hydroxy-7-(fenylamino)-2-naftaleensulfonzuur, natriumzout |
424-850-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
|
607-554-00-8 |
2,4-diamino-5-[4-[(2-sulfoxylethyl)sulfonyl]fenylazo]benzeensulfonzuur |
424-870-1 |
||||||||